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Abstract
Staphylococcus aureus and Enterococcus sp. infections occur in hospital and, 
increasingly, in community settings, with the potential of having different susceptibility to 
antimicrobial agents. The purpose of this study was to investigate the effect of antimicrobial 
agents against community acquired S.aureus and investigate antibiotic characteristics, biofilm
formation and gene expression following exposure to an antimicrobial agent.
The susceptibility of S. aureus isolates and a vancomycin resistant Enterococcus 
faecium isolate to antibiotics, essential oils and disinfectants were investigated under 
planktonic conditions using standardised antimicrobial susceptibility tests and the Quantitative 
suspension and surface tests (EN 1276 and EN 13697) for the disinfectants. Biofilm 
formation, inhibition and eradication was investigated using the crystal violet (CV) assay while 
the viability of treated biofilms were investigated using the 2, 3-bis [2-methyloxy-4-nitro-5- 
sulfophenyl]-2H-tetrazolium-5-carboxanilide (XTT) reduction assay and CFU/ml assay. 
Multiplex PCR was used to determine the presence of PVL, icaA and IcaD genes as well as 
SCCmec typing while RT-PCR used to investigate changes in gene expression in five target 
genes following treatment of PVL CA MSSA and CA MRSA MW2 biofilms with grapefruit EO.
The S. aureus isolates all formed biofilms and had similar molecular characteristics 
however one isolate (CA MRSA SR) was multidrug resistant and PVL negative. The VRE 
isolate was negative for biofilm formation. In suspension, household bleach and NaDCC 
caused >5 log reduction in viable counts and on stainless steel surfaces, there was <3.5 log 
reduction. Against biofilms, Household bleach at 5000ppm caused 100% biofilm eradication 
within 10 minutes while NaDCC eradicated <50% of the biofilm within one hour at 
10,000ppm.The eco-friendly product did not demonstrate any antimicrobial activity against 
planktonic cells or biofilms. Antimicrobial activity of six essential oils (EO) (lime, lemon, 
lemongrass, geranium, grapefruit, bergamot), and two components (limonene and citral) was 
investigated for the S. aureus isolates. Following exposure to lemongrass EO extensive 
disruption to S. aureus biofilms was shown under scanning electron microscopy. The most 
notable changes in gene expression following exposure to grapefruit EO were the /caD, luxS 
and sodA genes when the PVL CA MSSA biofilms was compared to the prototype community 
acquired strain, CA MRSA MW2.
The S. aureus isolates were susceptible to the essential oils with the exception of 
limonene and lemon EO. Lemongrass EO inhibited biofilm formation, metabolic activity and 
viability. No anti-biofilm activity was observed for Grapefruit EO against S. aureus except for 
one isolate (PVL positive CA MSSA), where an increase in metabolic activity was observed 
following treatment. Lemongrass EO was effective as an antibacterial and antibiofilm agent 
and could be a potential alternative to chemical based antimicrobial agents in both healthcare 
and non-healthcare environments.
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CHAPTER ONE
Introduction
Since the 1950s the most reported infections in healthcare have been hospital acquired 
infections (HAIs), also known as nosocomial infections (Burke, 2003). The effect of HAIs 
has been felt worldwide and in Europe, about 1.75 million people are affected annually 
(Guggenbichler et al. 2011). In the UK, the cost of these infections has been calculated at 
over £1 billion annually (Graves, 2004), which highlights the impact of these infections on 
the economy.
HAIs remain a problem due to factors such as the development of multidrug resistant 
organisms and consequent difficulties, whilst the emergence of the infections with 
community origins has altered the landscape of the infection burden in healthcare. These 
infections have been termed community acquired infections (CAIs). The first known 
reports of CAIs were in the early 1980s and numbers have been on an increase since 
(Saravolatz et al. 1982; Conly and Johnston, 2003; Moran et al. 2006; File, 2007).
Some of the organisms linked to infections in the community include those of bacterial 
origin such as Staphylococcus aureus, Clostridium difficile, Escherichia coli, 
Enterococcus sp., and various other Gram-negative bacteria; those of viral origin, such as 
respiratory viruses and those of fungal origin such as Candida sp. (Lina et al. 1996; 
Warnock, 2007; Yumuk et al. 2008; Allard et al. 2011; Marcus et al. 2012). These CAIs 
are important as they lack the risk factors usually associated with the HAIs such as 
prolonged hospital stay and previous antibiotic therapy (Witte, 2009).
Some of the key problems encountered in healthcare settings with bacteria of either 
healthcare or community origin include antibiotic resistance, ease of transmission within 
hospitals and closed communities and the formation of biofilms. Since the emergence of
1
methicillin resistant strains of S. aureus (MRSA) in the 1960s (Jevons et al. 1963), 
antibiotic resistance has been an important concern for healthcare professionals. Thus, 
the emergence of community acquired (CA) S. aureus infections especially CA-MRSA, 
poses a significant challenge for the prevention and control of MRSA (File, 2007).
Alongside MRSA, another pathogen recognised for diverse antibiotic resistance 
characteristics is Enterococcus sp. Both MRSA and antibiotic resistant Enterococcus sp. 
are versatile organisms that possess transmissible genetic elements, the physiological 
mechanisms to form biofilms and to persist in the environment (Simjee and Gill, 1997; 
Wenzel and Edmond, 1998; Donlan, 2002; Hiramatsu, 2009).
To combat infections in healthcare the UK National Institute for Health and Clinical 
Excellence (NICE) published a public health guidance document (NICE, 2011) on 
prevention and control of healthcare associated infections (HCAIs) and highlighted key 
areas that form the basis of infection control policies which included hand hygiene, 
antimicrobial stewardship and environmental cleanliness Disinfectants and antiseptics 
are key examples of conventional products used in healthcare and non-healthcare 
settings and are regarded as important in combating infections caused by bacteria 
(McDonnell and Russell, 1999; Dancer, 2009). However, there have been reports of 
resistance to some conventional disinfectants (Suller and Russell, 2000) and problems of 
toxicity reported in some disinfectant products (Rutala and Weber, 1997).
In recent years, the interest in environmental friendliness and sustainability has risen 
(DEFRA, 2011; Yates, 2009). Research into the antimicrobial potential of plant based 
products such as those of essential oils (EOs) has increased (Hammer et al. 1999; 
Edwards-Jones, 2004; Fisher and Phillips, 2006). These products are now visible in 
various applications such as cosmetics and antibacterial products (Bakkali et al. 2008; 
Barker and Altman 2010).
2
Recently, the effects of these EOs on biofilms have been demonstrated (Kwiesincki et al. 
2009; Nuryastuti et al. 2009; Laird et al. 2012a). Biofilms are a complex community of 
cells attached to each other or to a surface (Davey and O’Toole, 2000) and studies have 
shown that they are highly resistant to the killing effects of antimicrobial agents (Spoering 
and Lewis, 2001) and, when compared to planktonic cells, require higher concentrations 
of antimicrobial agents (Yarwood et al. 2004).
Although antimicrobial agents have been useful alongside other infection control 
practices in managing HAIs in recent years, the emergence of CAIs with strains differing 
in susceptibility patterns and molecular features creates a need for further investigations. 
Firstly, there is a need to understand the differences between the isolates of CAI and HAI 
origin and subsequently identify tools to prevent, eradicate and/or manage infections 
especially those of CA origin.
3
CHAPTER TWO
Literature Review
2.1 Community acquired infections (CAIs)
CAIs have been defined by the Centre for Disease Control and prevention (CDC) as 
‘infections acquired by persons without recent hospitalization or invasive medical 
procedure’. Infections of community acquired origin have been identified worldwide in 
Europe, North-America, Asia, and Africa (Naimi et al. 2001; Dufour et al. 2002; Holmes et 
al. 2005; Miyashita et al. 2005; Reddy et al. 2010). A large number of cases reported for 
infections in community settings are caused by S. aureus with more mention of MRSA 
than other organisms. For many years, MRSA infections were limited to hospitals 
(Panhotra et al. 2005; Otto, 2009) and persons predisposed to infections in hospital 
environments such as elderly individuals, immune-compromised persons and patients 
undergoing surgery. However, MRSA have also been isolated from skin and soft tissue 
infections and from bacteremias among persons in the community without any health 
care contact (Chambers, 2001).
Apart from MRSA, other infections which have been identified as community acquired 
include: community acquired methicillin sensitive S. aureus infections (CA-MSSA) (Sattler 
et al. 2002), community acquired C. difficile infection (CA-CDI) (Dial et al. 2005), 
community acquired pneumonia (CAP) (Francis et al. 2005; Mandell, 2010) and 
community acquired urinary tract infections (CA-UTIs) (Prais et al. 2003).
2.1.1 Community acquired S. aureus infections
Among the early reports of CA S. aureus infections included one outbreak of CA-MRSA 
between 1980 and 1981 among injection drug users in community settings in Detroit, 
USA (Saravolatz et al. 1982) and another between 1989 and 1991, where CA-MRSA 
infections were identified in persons without contact with healthcare in Western Australia
(Udo et al. 1993). Prior to 1999, there were few reports worldwide of S. aureus infections 
of CA origin however these reports according to Conly and Johnston (2003) increased 
exponentially afterwards.
CA-MRSA infections have been reported in diverse groups such as healthy children, 
sports teams, prison inmates, and among other groups with often close physical contact 
and low hygiene (Gould, 2006). The types of infections associated with CA 
Staphylococcal infections include; skin and soft tissue, pneumonia, upper respiratory, 
urinary tract, conjunctivitis (Naimi et al. 2001). There have also been reports of fatalities 
caused by CA-MRSA and CA-MSSA (Naimi et al. 2001; Hota et al. 2007).
Said-Salim et al. (2005) suggested dividing infections caused by CA-MRSA into two 
groups i.e. infections from persons with predisposing risk factors, and from those without 
predisposing factors. Using genotyping methods, the authors found the group without 
predisposing risk factors to be mono-beta-lactam or beta-lactam ((3-lactam), erythromycin 
resistant, with the ability to infect healthy patients. Within this group, they described MW2 
as the prototype strain. In the second group, the MRSA strains are commonly resistant to 
clindamycin and fluoroquinolones and have a background referred to as archaic or 
historic. The common feature of both groups is that they both harbour a Staphylococcal 
cassette chromosome mec (SCCmec) type IV and carry the Panton Valentin Leukocidin 
(PVL) gene (Said-Salim et al. 2005; Zetola et al. 2005).
With regard to CA-MRSA origin, two hypotheses currently exist. The first suggests that 
the CA-MRSA strains originated from HA-MRSA and, due to selective antibiotic pressure, 
lost antibiotic genes. The second hypothesis suggests that the origin of CA-MRSA was a 
result of SCC mec transfer into MSSA and other staphylococci (Kwon et al. 2005; 
Mongkolrattanothai et al. 2011). Diep and Otto (2008) described five CA-MRSA lineages 
worldwide. These lineages are the ST1-IV (USA400); ST8-IV (USA300); ST30-IV
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(Pacific/Oceania); ST59-IV and V (USA1000, Taiwan) and ST80-IV (European) while 
Wulf and Voss (2008) described a worldwide emerged CC398 lineage isolated from 
livestock suggesting that some livestock are a potential source of CA-MRSA.
Two S. aureus strains have been described in the majority of CA-MRSA infections. They 
are the USA 300 and USA 400 and, in comparison to the known hospital acquired 
methicillin resistant S. aureus (HA-MRSA) strains, these strains have shown enhanced 
virulence due to an increased ability to evade killing by human neutrophils (Palazzolo- 
Ballance et al. 2008). These two strains are clones which are widely disseminated 
contain SCCmec type IVa producing PVL (Davis et al. 2007), cause leucocyte 
destruction, and tissue necrosis (Loughrey et al. 2007). Within the USA 400 cluster, one 
strain known to be associated with fatal infections is MW2 (Kaplan et al. 2005). This 
strain has been fully sequenced (Baba et al. 2002) and shown to carry unique CA-MRSA 
specific virulence factors; staphylococcal enterotoxins H and C (seh and sec) and PVL 
(Said-Saiim et al. 2005). Sec and seh are among a group of staphylococcal enterotoxins 
(SEs) which are extracellular proteins produced by some strains of S. aureus and are 
known causative agents of staphylococcal food poisoning, skin disorders, toxic shock 
syndrome (TSS) and auto-immune disorders (Jett et al. 2001). Wan et al. (2011) 
suggested a significant role of the enterotoxins in staphylococcal food poisoning following 
molecular analysis which showed most of the SE carrying MRSA strains belong to 
SCCmec types IV and V.
2.1.1.1 Panton-Valentin Leukocidin (PVL)
PVL was first reported in 1932 and has been described as the main virulence factor in 
some community-acquired MRSA strains (Gillet et al. 2002; Elston, 2007). Although the 
PVL genes are present in almost all CA-MRSA strains, they are largely absent in HA- 
MRSA strains (Gordon and Lowy, 2008; Wallin et al. 2008). In the USA, the PVL genes 
are in 40-95% of the CA-MRSA isolates but significantly lower in the UK (Hidron et al.
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2009). Denis et al. (2005) relates the acquisition of the PVL gene to horizontal transfer 
into resident S. aureus.
At present, the epidemiology of PVL-positive MSSA is not well known although MSSA 
can cause infections similar to CA-MRSA (Mongkolrattanothai and Daum, 2005). PVL- 
MSSA strains have been associated with skin infection outbreaks in Swiss school 
children, a German village and French soldiers in Cote d’Ivoire (Tinelli et al. 2009). The 
authors also identified a PVL-positive outbreak MSSA strain, characterized by 
staphylococcal protein a (spa) type t005 and ST22, related to one of the major MRSA 
clones (EMRSA-15) also known as ST22-IV. This strain is SCCmec type IV and is now 
emerging as a successful clone in several areas of the world.
There are conflicting opinions on the true role of PVL in CA-MRSA pathogenesis (Hidron 
et al. 2009). Multiple animal infection studies using isogenic deletions of the PVL- 
encoding genes in CA-MRSA strains revealed that PVL has no or only a transient role in 
CA-MRSA pathogenesis however it may still have an important role in explaining the 
pathogenic potential when CA-MRSA is compared with other MRSA strains (Otto, 2009).
2 1.1.2 SCCmec types in CA-MRSA
SCC mec is a member of the SCC family. SCC are mobile genetic elements that drive 
gene exchange among staphylococcal species (Ito et al. 2004). SCC mec is an important 
feature in MRSA epidemiological studies as it is a large mobile genetic element which 
carries the gene responsible for methicillin resistance i.e. mecA, in S. aureus (Kwon et al. 
2005). SCC mec is known to carry other resistance genes such as those for resistance to 
aminoglycosides, macrolides, tetracyclines, and heavy metals such as cadmium and 
mercury (Smyth et al. 2011) as well as genes for specific recombinases (ccr) necessary 
for its excision and integration (Ito et al. 2004, Deurenberg et al. 2007). Two specific 
genes ccrA and ccrB are carried on SCC mec which allow for movement and for specific
integration and excision of SCCmec to and from the S. aureus chromosome (Katayama 
et al. 2000; Hiramatsu et al. 2001).
According to The International Working Group on the Classification of Staphylococcal 
Cassette Chromosome Elements (IWG-SCC), there are eleven different SCC mec types (I 
to XI) noted to date. The CA-MRSA strains based on SCC mec typing have been 
categorized to be within SCC mec types IV, V and VI (Kwon et al. 2005; Milhierico et al. 
2007a).
The SCC mec type IV element is smaller in size (21 to 24 kb in comparison to the other 
SCC mec types (34 to 67 kb) found in the HA strains (Ito et al. 2001; Ma et al. 2002) but 
similar to the SCC mec type I element, referred to as the archaic SCC mec type (Fey et al. 
2003). In the SCC mec type IV, there are also subtypes. Eight subtypes of the SCC mec 
type IV have been described and designated; IVa -  IVj (IWG-SCC, 2009). The 
differences in the subtypes have been ascribed to polymorphisms and variations in the 
“joining-regions” or “J region” previously described as “junkyard regions” within the same 
ccr gene complex and mec gene complex combination (IWG-SCC, 2009; Smyth et al. 
2011). Owing to its small size, there is the possibility that more genetic backgrounds of 
MRSA will be discovered with this SCC mec type (Fey et al. 2003) due to the mobility of 
the SCC mec element (Baba et al. 2002; Noto and Archer, 2006).
2.1.1.3 Methicillin resistance and the mecA gene
SCC mec carries the mecA gene, which encodes a low affinity penicillin binding protein 
PBP2A (Wielders et al. 2002), a key factor in beta-lactam resistance in MRSA due to its 
low affinity for (3-lactam antibiotics (Lim et al. 2002). Development of methicillin resistance 
in S. aureus is associated with acquisition of the mecA gene (Lowy, 2003) although the 
origin of the mecA gene is unclear (Deplano et al. 2000). Tsubakishita et al. (2010) found 
the original chromosomal locus which they believed served as a template for the mec
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gene complex of SCCmec from Staphylococcus fleurettii, a commensal bacterium in 
animals. Other reports have suggested that another microorganism Staphylococcus sciuri 
is a natural reservoir for the mecA gene (Wu et al. 1996; Kloos et al. 1997) adding to the 
suspicion that mecA is transmissible among staphylococcal species (Katayama et al. 
2000). There is documented evidence of mecA in other Staphylococcus sp. For example 
mecA has been identified in Staphylococcus lugdunensis, a coagulase negative, biofilm 
forming pathogen isolated in Northern Europe (Starlander et al. 2011).
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2.1.2 Community acquired C. difficile infection (CA-CDI)
C. difficile is a Gram-positive bacterium first described in the 1930s and initially referred to 
as Bacillus difficilis. It was identified in 1978 as the main cause of pseudomembranous 
colitis following its isolation from faeces of patients undergoing clindamycin treatment 
(Voth and Ballard, 2005).
The first report of CA-CDI was in 1984 and the reports of the infection increased 
afterwards although, to date, little is known about the strains responsible (Limbago et al. 
2009). Although C. difficile is widely regarded as a nosocomial pathogen, the emergence 
of a hypervirulent strain, North American pulsed-field type 1 (NAP-1/B1/027) was linked 
to the increase in the rates and severity of C. difficile-associated disease (CDAD), 
(McDonald et al. 2005, Warny et al. 2005). The NAP-1/B1/027 isolates have been 
characterised and shown to be positive for a binary toxin CDT, and an 18-bp deletion in 
tcdC (McDonald et al. 2005). tcdC is one of three accessory genes located in a 
pathogenicity locus which are involved in regulation of the toxin genes tcdA and tcdB in 
C. difficile (Dupuy et al. 2008).
There is a consensus that CDI is increasing worldwide (Khanna et al. 2012; Leffler and 
Lamont, 2012). Khanna et al. (2012) reported a rise in CA-CDI infections between 1991 
and 2005 in a population-based study which showed a rise from < 2.8 cases per 100,000 
persons between 1991 and 1993 to about 15 cases for CA per 100,000 persons between 
2003 and 2005. There have been other reports of CA-CDI. Kutty et al. (2010) found 20% 
of all CDI cases to be CA which was similar to 22-28% found in studies conducted in 
Sweden (Noren et al. 2004) and in Manitoba, Canada, the incidence of CA-CDI infection 
was 23.4 cases per 100,000 (Lambert et al. 2009).
Although the structural and virulence characteristics of C. difficile are known, a common 
feature in strains associated with CA-CDI pathogenesis is the production of a binary
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toxin. However the role of this toxin in CA-CDI pathogenesis remains unclear (Terhes et 
al. 2004). Recently, ribotyping of strains isolated from CA cases showed that in 
Sherbrooke, Canada, C. difficile ribotype 027 accounted for a higher proportion of HA 
cases than CA cases (67% vs. 37%) contrary to the reports from cases in Calgary, 
(16.6%, CA vs. 7.4%, HA) (Bignardi and Settle, 2008).
2.1.3 Community acquired pneumonia (CAP)
It is estimated that about 5-6 million cases of CAP are diagnosed annually in the United 
States causing over 1 million hospitalizations and 10 million physician visits as well as an 
approximate annual cost of $8.4 billion for treatment (Colice et al. 2004). According to 
Andrews et al. (2003), CAP mortality rates are low at levels less than 1-5% in the 
outpatient setting, although in persons requiring hospital care, the mortality rate is an 
average of 12%, but is higher in some groups such as those with bacteremia and nursing 
home residents.
Two thirds of CAP is caused by Streptococcus pneumoniae, however other 
microorganisms have been associated with cases of CAP including and not limited to:- 
Haemophilus influenzae, Mycoplasma pneumoniae, Legionella spp., Pseudomonas 
aeruginosa, S. aureus, respiratory viruses such as respiratory synctical virus and 
coronaviruses (File, 2003). Two types of CAP have been described; the typical 
pneumonia caused by S. pneumoniae and the atypical pneumonia caused by the 
influenza virus, mycoplasma, chlamydia, Legionella sp., adenovirus, or other unidentified 
microorganisms with the age of the infected patient the difference between CAP types 
(Lutfiyya et al. 2006). Normally, cases of pneumoniae are diagnosed in older persons (> 
60 years) however, in the atypical cases of CAP, the infections have been observed in 
younger persons i e. < 60 years (Ruiz et al. 1999; Lutfiyya et al. 2006). Apart from age as 
a factor in CAP pathogenesis, other risk factors identified as independent in a population- 
based study by Almirall et al. (2008) included:- being underweight, cigarette smoking,
high alcohol consumption in men, contact with children and pets and other environmental 
factors. Cigarette smoking and alcohol abuse had previously been identified as risk 
factors in another study (Ruiz et al. 1999). Cigarette-smoke linked CAP was associated 
with Legionella sp. and Chlamydophila pneumoniae while alcohol related CAP was 
associated with S. pneumoniae (Ruiz et al. 1999).
The association of different organisms in cases of CAP highlights the difficulty that is 
encountered in managing the associated infections. Some of the obvious problems 
include choice of antimicrobial treatments, prescription of appropriate antibiotics as well 
as antibiotic resistance. Guest and Morris (1997) reported that 45% of all prescriptions for 
CAP are broad-spectrum antibiotics, 23% are cephalosporins, 22% are macrolides, 3% 
are aminoglycosides and 3% are mtroimidazoles To treat CAP, the pathogens should be 
eradicated which will in turn resolve the clinical features of the disease, minimize 
hospitalization and prevent reinfection (Lutfiyya et al. 2006).
2.2 Hospital acquired infections (HAIs)
HAIs were defined by Emori and Gaynes, (1993) as infections with no evidence of 
presence or incubation at the time of admission to hospital. The definition of nosocomial 
infections has been extended to include infections in any health care setting and also 
including infections acquired by staff or visitors to the healthcare or hospital setting (Ducel 
et al. 2002).
The requirements for transmission of HAIs include a source of infecting microorganism, a 
susceptible host and a transmission mechanism (Collins, 2008). In the pre-antibiotic era, 
the main pathogens responsible for nosocomial infections were Gram positive cocci -  S. 
aureus and Streptococcus species mainly S. pneumoniae and S. pyogenes (Swartz, 
1994). Both MSSA and MRSA are by far the most significant hospital acquired pathogens 
and have been implicated in surgical site infections (SSI), hospital-acquired pneumonia, 
septic arthritis, osteomyelitis, discitis, prosthesis-associated infection, and intra-abdominal 
infections (Gould, 2006). Of the nosocomial infections, UTIs have been reported as the 
most common (Mylotte et al. 2000; Ducel et al. 2002). Other important HAIs include skin 
and soft tissue infections (Gaynes et al. 2001), respiratory tract infections (Jarvis and 
Martone, 1992), bacteraemia (Correa and Pittet, 2000) and gastrointestinal infections 
(Archibald et al. 2004).
According to Guggenbichler et al. (2011) HAIs affect 1.75 million people in Europe 
annually and the authors suggest that despite a reduction in hospital admissions and 
length of stay the rates of HAIs is still increasing in Europe and in developing countries. 
The numbers of such infections are on a decline in the UK as the recent report from the 
Health Protection Health protection Agency (HPA) suggests (HPA, 2012). According to 
the report, infections caused by MRSA or C. difficile fell by 30% and 26% respectively 
between the second quarter of 2011 and the second quarter of 2012 (HPA, 2012).
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2.2.1 Risk factors for HAIs
The documented risk factors associated with the HAIs include: intrinsic factors such as 
immunosuppression and age, extrinsic factors such as use of high risk medical device 
and surgical operations (Emori and Gaynes, 1993). Hospital personnel are among those 
implicated as possible sources of these nosocomial infections (Cespedes et al. 2002). 
Gastric acid suppression following use of proton pump inhibitors has been implicated as a 
risk factor associated with C. difficile (Dial et al. 2004). This is also the case with 
antimicrobial drug therapy (Kutty et al. 2010) with antibiotics such as clindamycin, 
cephalosporin and ampicillin known to induce CDAD (Louie and Meddings, 2004). Older 
and severely ill hospitalized patients or residents of long-term care facilities are all at risk 
of infection caused by C. difficile (Kutty et al. 2010).
Similar factors have been described in infections of MRSA origin in nosocomial settings. 
These factors include recent hospitalization, antibiotic misuse or overuse, older age, 
intensive care unit (ICU) stay, use of intravenous devices, mechanical ventilators and 
more severe clinical conditions (Wang et al. 2008; Hidron et al. 2009; Vidal et al. 2009). 
Presence of a skin and soft tissue infection and HIV-seropositive status has also been 
identified as risk factors of nosocomial MRSA colonization (Hidron et al. 2009).
Nosocomial infections caused by the Gram negative bacteria P. aeruginosa and 
Acinectobacter baumannii have also shown similar risk factors to that of MRSA and C. 
difficile However in the case of A. baumannii, unique factors such as large burn wound 
areas, mechanical ventilation, multiple surgical procedures, parenteral nutrition, 
decreased fluid, electrolyte and serum protein levels have been reported to be of 
potential significance in acquisition of the infection (Wisplinghoff et al. 1999).
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2.3 Differences between HAIs and CAIs
Several characteristics have been identified that are used in the differentiation of bacterial 
strains associated with both HA and CA infections. For example, the CA-MRSA strains 
fall into the SCCmec groups IV-VI while the HA-MRSA strains belong to the SCCmec 
groups l-lll (Ito et al. 2004; Oliveira et al. 2006). Other factors have been identified that 
differentiate the CA from HA strains. These differences include virulence mechanisms 
and antibiotic susceptibility patterns. The differences in clinical and epidemiological 
features between the HA-MRSA and CA-MRSA are highlighted in Table 2.1.
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Table 2.1. A summary of the differences between CA and HA MRSA infections. (Source: Health 
Protection Agency, 2008).
H A -M R S A C A -M R S A
T y p ic a l p a tie n ts
E ld e r ly , d e b ilita te d  a n d /o r  c r it ic a lly  o r
c h ro n ic a lly  ill
Y o u n g  h e a lth y  p e o p le , s tu d e n ts , 
a th le te s , m ilita ry  s e rv ic e  p e rs o n n e l
In fe c tio n  s ite
W o u n d s / in v a s iv e  d e v ic e s  o fte n  c a u s e
b a c te ra e m ia
O fte n  s p o n ta n e o u s , 
s k in , c e llu lit is , a b s c e s s
T ra n s m is s io n
W ith in  h e a lth c a re  s e tt in g s ; litt le  s p re a d  
a m o n g  h o u s e h o ld  c o n ta c ts
C o m m u n ity -a c q u ire d ; m a n y  s p re a d  in 
c lo s e  c o m m u n ity  s e tt in g s  e  g 
F a m ilie s , s p o r ts  te a m s , v ia  p e ts  (n o t in
U K )
D ia g n o s is  is ty p ic a lly  
m a d e
In a n  in -p a t ie n t s e tt in g In  a n  o u t-p a t ie n t  s e tt in g
M e d ic a l h is to ry
H is to ry  o f  M R S A  c o lo n iz a t io n /in fe c t io n , 
re c e n t s u rg e ry , a d m is s io n  to  h o s p ita l o r 
n u rs in g  h o m e , a n tib io t ic s , re n a l d ia ly s is , 
p e rm a n e n t in d w e llin g  c a th e te r , sk in
u lc e rs , d ia b e te s
N o  s ig n if ic a n t h is to ry
V iru le n c e  fa c to rs
C o m m u n ity  s p re a d  lim ite d , P V L  g e n e s
a b s e n t
C o m m u n ity  s p re a d  re a d ily , P V L  g e n e s  
p re s e n t, p re d is p o s it io n  to  n e c ro tis in g  
s k in  a n d  s o ft  t is s u e  in fe c tio n s
A n tib io t ic
s u s c e p tib ility
C h o ic e  o f  a n t ib io t ic  a g e n ts  lim ite d C u rre n tly  m o re  s u s c e p tib le  a n tib io tic s
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2.3.1 Molecular identification methods for HA and CA isolates
Molecular methods have been used in numerous applications including characterising 
and identifying the evolutionary and epidemiological origins of microorganims. Some of 
the methods currently used in microbiological applications and in identification of 
infections caused by CA and HA associated S. aureus infections include: multi-locus 
sequence typing (MLST), staphylococcal protein A typing (spa typing), mass 
spectrophotometry, Pulsed-field gel electrophoresis (PFGE), plasmid analysis, microarray 
analysis, Matrix-assisted laser desorption/ionisation-time of flight (MALDI-TOF), 
restriction endonuclease analysis (REA), polymerase chain reaction (PCR) based 
methods which include accessory gene regulator (agr) grouping and SCCmec typing and 
ribotyping (Mongkolrattanothai and Daum, 2005; Faria et al. 2008; Tenover et al. 2011).
In differentiation and characterisation of C. difficile infection from hospital and community 
settings, PCR ribotyping has been used (Noren et al. 2004). In Europe and North 
America, PFGE and PCR ribotyping are the methods of choice for fast and convenient 
detection of C. difficile infection, whilst modified PCR ribotyping methods have been used 
for direct detection of the bacteria in stool samples (Janezic et al. 2011). PCR based 
methods are very versatile and have proved successful in determination of molecular 
characteristics of community acquired pathogens (Morozumi et al. 2006).
For MRSA investigations, the three main strain typing methods are PFGE, MLST and spa 
typing (Tenover and Pearson, 2004). Multiplex PCR was developed by Chamberlain et al. 
(1998) and has since been shown to be successful in differentiating MRSA strains. 
Numerous studies have used this approach for SCC mec typing (McClure et al. 2006; 
Faria et al. 2008). This method has also been used to differentiate other microorganisms 
(Rodas et al. 2009; Vankerckhoven et al. 2004).
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2.4 Transmission of CA-MRSA and HA-MRSA into ’non traditional settings’
Although differences have been identified between CA and HA-MRSA infections, the 
continuous evolution of MRSA infections poses challenges to healthcare professionals. 
CA-MRSA strains have now been identified in nosocomial infections while the HA-MRSA 
strains have been identified as the causative agents of MRSA infections in community 
settings. This development according to several authors has made it difficult to 
differentiate between CA-MRSA and HA-MRSA strains (File, 2003; David and Daum, 
2010).
A CA-MRSA strain (USA 300) was identified as the cause of nosocomial infections and 
responsible for 28% of healthcare associated blood stream infections (BSI) and 20% of 
nosocomial MRSA BSI (Seybold et al. 2006). Other studies that have demonstrated the 
movement of CA-MRSA into nosocomial settings include that of Saiman et al. (2003) who 
identified a community strain, MRSA USA 400, as the causative agent of skin and soft 
tissue infections in eight postpartum women. Eckhart et al. (2003) also reported a case of 
CA-MRSA transmission in a neonatal ICU.
On the other hand, Adedeji et al. (2007) identified HA-MRSA strains circulating in 
community settings in Birmingham, UK following molecular typing of isolates while 
Rollason et al. (2008) also identified strains genetically related to HA-MRSA strains 
circulating in persons without hospital contact within the West Midlands community. The 
observation of HA strains circulating in the community is not limited to the UK as 
transmission of HA-MRSA in community settings was observed in Taiwan between 1999 
and 2002 (Chi et al. 2007).
According to Eckhart et al (2003) the prevalence of MRSA in the community is likely to 
influence the number of nosocomial infections and Popovic et al. (2008) suggested the 
likelihood that CA-MRSA strains may be replacing the traditional HA-MRSA strains. This
raises other problems as the spread of strains from community settings into the hospital 
environment could have an effect on infection prevention and control measures already in 
practice (File, 2003). Benoit et al. (2008) highlighted the possibility of exchange of genetic 
material between both CA-MRSA and HA-MRSA. If this happens, there could be the 
potential for CA-MRSA strains circulating in nosocomial settings to acquire antibiotic 
resistance genes and increase the severity of disease in older persons within healthcare 
(Leclercq, 2009).
2.5 Economic burden of CA and HA MRSA
The economic impact of CA-MRSA infections remains unclear as the data on this subject 
if limited. Lee et al. (2012) recently developed a simulated model to calculate the costs of 
CA-MRSA infections. In their study, with the exception of data from infection control 
interventions, hospital transmission and associated costs, the authors found that, in the 
US, the annual burden of CA-MRSA is between $478 million and $2.2 billion on third 
party payers and between $1.4 and $13.8 billion on society (Lee et al. 2012). The third 
party payers act as intermediaries between the healthcare providers and the users of 
healthcare services and the third party payers include: insurance companies, health 
service providers and the government (Chen and Feldman, 2000)
The factors associated with the infection costs caused by CA-MRSA are similar to that 
from other studies on HA-MRSA and traditional MRSA infections. These factors include 
screening costs, hospitalization, treatment, management of patient care and more 
recently litigation costs (Stone, 2009; Gould et al. 2010; Lee et al. 2012). Although 
published data on CA-MRSA infections are lacking, economic cost calculations of the 
burden of HA-MRSA infections have been available since 2002. In the UK, the cost of 
healthcare associated infections was calculated at over £1 billion annually (Plowman et 
al 2001; Graves, 2004). In the US, the CDC estimated as many as two million infections 
a year in hospital led to about 90,000 deaths with associated costs at over $5 billion per
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year (Guggenbichler et al. 2011; Shannon, 2011). Furthermore, direct health care costs 
linked to MRSA infections in Canada amounted to an average of $82 million USD in 2004 
and was projected to increase to $129 million by 2010 (Goetghebeur et al. 2007). These 
figures all highlight the economic impact these infections have on overall national 
budgets.
Combining the cost of CA-MRSA infections from the simulated model (Lee et al. 2012) 
and the established costs associated with nosocomial infections suggests that both 
infections represent a huge burden to the overall costs of healthcare spending and 
national budgets. Thus, it is imperative that measures to prevent the transmission of both 
CA and HA MRSA infections and to manage cases of both infections are continuously 
developed and implemented.
2.6 Managing the problems of HAIs and CAIs
The UK House of Commons committee offered two suggestions for managing HAIs 
(Mayor, 2009). Firstly, that the NHS should monitor the extent and costs of the HAIs and 
secondly an indiscriminate approach is required for prevention of the HAIs involving 
everyone not just healthcare workers. Plowman et al. (2001) also suggested using 
surveillance detection methods and improved infection control strategies as a way to 
prevent HAIs.
Following the introduction of legislation on prevention of healthcare associated infections 
in the UK since 2003/2004, the rates of MRSA bloodstream infections (BSI) and C. 
difficile infections declined by 57% and 41% respectively. Treatment costs were also 
reduced as a result by £45 to £59 million for MRSA BSIs and between £97 and £204 
million for C difficile according to the UK National Audit Office (2009). Current guidelines 
available for managing infections caused by antibiotic resistant pathogens are focused on 
the HAIs. However, Barton et al. (2006) developed guidelines for managing CAIs in
Canada and suggested incorporating surveillance for CA-MRSA infections into the 
national surveillance programs, and reiterated the importance of good hygiene practices 
including hand washing in the prevention of CA-MRSA infections. Other factors have 
been addressed that could have an impact in reducing infections caused by CA-MRSA 
including early identification and proper treatment which will reduce transmission and 
infection incidences and, in turn, save the associated cost of infections (Lee et al. 2012).
2.6.1 Antimicrobial agents
Antimicrobial agents have for many years been used in treatment of infections of 
bacterial, parasitic, viral and fungal origin. In the early twentieth century, the discovery by 
Alexander Fleming that bacterial growth was prevented by a fungus, Penicillium notatum, 
heralded the development of antibiotics and in turn, a fall in mortality and morbidity (Singh 
and Barrett, 2006). Different classes of antibiotics have been developed over the years to 
treat bacterial infections. The main targets of activity have included inhibition of functions 
such as: cell wall synthesis, protein synthesis, RNA synthesis, DNA synthesis and 
metabolism (Singh and Barrett, 2006; Gwynn et al. 2010). Observation of antimicrobial 
resistance in different microorganisms, very notably in cases of MRSA (Jevons, 1963) led 
to decreased efficiency and reduced usage of certain antimicrobial agents (Coates and 
Hu, 2007). This has also led to the search for new methods, targets and products with 
antimicrobial potential such as bacteriophages, plant and animal peptides and in other 
cases combinations of antimicrobial treatments (Andreu and Rivas, 1998; Hancock and 
Sahl, 2006; Coates and Hu, 2007; Kollef, 2008). Strategies to prevent antimicrobial 
infections in both healthcare and non-healthcare settings have also seen the use of 
environmental decontaminants and recently the re-introduction of natural products as 
antimicrobial agents. Examples of environmental decontaminants and natural 
antimicrobials with known antimicrobial activity include, chlorine releasing agents (bleach, 
sodium dichloroisocyanurate), phenolics, silver, honey and EOs (Hammer et al. 1999; 
McDonnell and Russell, 1999; Cooper et al. 2002; Chopra, 2007; Edwards-Jones, 2009).
2.6.2 Cleaning and disinfection
According to Sattar, (2011) cleaning, disinfection and sterilisation are key tools in 
preventing spread of infection. The benefits of cleaning in the hospital, in the household 
and in industry have been investigated extensively (Salvat and Colin, 1995; Cooper et al. 
2007; Dancer et al. 2009; Marshall et al. 2012). It has been shown that cleaning as a 
standalone activity is not sufficient for environmental decontamination (Cooper et al. 
2007; Dancer, 2008). The current indicators for assessing cleaning effectiveness are by 
visual inspections which are unreliable and impractical as this approach does not 
consider the invisibility of bacteria to the naked eye (Cooper et al. 2007; Dancer, 2008). It 
has been demonstrated that detergent-based cleaning reduces the risk of cross 
contamination (Scott et al. 1984; Barker et al. 2003). However in both studies, greater 
reduction of contamination and risk of infection was only achieved following the use of a 
disinfectant product. McMullen et al. (2007) reported a fall in the rates of C. difficile 
infection in two hospital ICUs following enhanced environmental cleaning using a 
hypochlorite solution. The effect of cleaning against antibiotic resistant pathogens has 
also been reported, as a fall in rates of VRE was observed after routine enhanced 
cleaning measures (Hayden et al. 2007). Goodman et al. (2008) also reported a fall in 
rates of vancomycin resistant enterococci (VRE) and MRSA following increased
application of disinfectants, staff education on environmental cleaning practices and 
monitoring.
The effect of disinfectants against bacteria in the healthcare setting has been studied 
extensively. Using disinfectants correctly in healthcare and non-healthcare settings could 
significantly reduce the number of infections which in turn will reduce the need for 
antibiotic therapy (Weber and Rutala, 2006). Some of the disinfectants known to exhibit 
antimicrobial activity against hospital acquired pathogens include; chlorine releasing 
agents (sodium hypochlorite, chlorine dioxide, sodium dichloroisocyanurate), hydrogen
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peroxide and glutaraldehyde (Coates, 1996; Rutala and Weber, 1997; Fawley et al. 
2007).
Several factors have been identified as important in the activity of disinfecting agents. 
These factors include prior cleaning of the object or surface, contact time between the 
disinfectant and contaminated object or surface, temperature, organic and inorganic load, 
physical nature of the object or surface, biofilm formation and pH of the disinfection 
process (Maillard, 2005; Rutala et al. 2008). The spectrum of activity of disinfectants is 
broader than that of antibiotics (McDonnell and Russell, 1999; Rutala et al. 2008). 
According to Maillard (2002), the mechanism of action of a biocidal product is dependent 
on the bacterial structure against which it exerts its main activity. The author also 
described three levels of interaction between the biocidal products and bacteria. These 
areas of biocidal interaction in the bacteria include: the outer cellular components such as 
the cell wall and outer membrane, the cytoplasmic membrane with possible effects such 
as inhibition of enzyme activity and adenosine triphosphate (ATP) synthesis and thirdly, 
the cytoplasmic constituents which includes nucleic acids and ribosomes.
2.6.3 Environmentally friendly cleaning agents
In recent years there has been a rise in the development of household and commercial 
cleaning products considered ‘environmentally friendly’ and/or ‘green’. The Department 
for Environment Food and Rural Affairs (DEFRA) defined the term ‘‘environmentally 
friendly" as a vague and non-specific environmental claim which suggests a product is 
friendly and/or harmless to the environment (DEFRA, 2003). According to a report by Air 
Quality Sciences (2011) there was a major increase in sales of green cleaning products 
in the USA between 2003 and 2008 from $17.7 million to $64.5 million USD and the 
report also projected that by 2013, sales of these products would rise to about $623 
million USD. Based on the report, the factors driving the growth of these products include 
a need to create effective cleaning products for a variety of cleaning applications, to
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minimise health risks from indoor contaminants such as volatile organic compounds and 
to protect the outdoor environment.
In the UK, a report from the Consumer Focus Group investigating consumers 
understanding of ‘green’ claims in advertising showed that there was a 54% rise in 
consumer purchase of environmentally preferable products between 2007 and 2009 
(Yates, 2009). In the UK, there is a target to deliver products and services which aims to 
cut carbon emissions by 80% by the year 2050 (DEFRA, 2011). To ensure that goods 
and services developed with environmental claims are implemented correctly, the 
International Organisation for Standardisation (ISO) developed an international standard 
(ISO 14021:1999) on self-declared environmental claims with the aim of regulating and 
motivating the use of good quality claims (Palerm, 2000). The objective of this standard is 
to harmonize the use of self-declared environmental claims and the key elements of this 
standard include: use of symbols, evaluation and claim verification requirements and 
specific requirements for selected claims
Although the suggestion is that ‘green’ cleaning products pose less health concerns, 
there is currently no assurance of risk reduction (Markkannen et al. 2009). This is 
because of a lack of data on associated hazards, clarity on the application and disposal 
of the products, evidence of antimicrobial activity and certification issues. Currently in the 
US, the Environmental Protection Agency (EPA) does not permit products to be 
marketed as green if they do not kill microorganisms, however the EPA are exploring 
changing policies to incorporate green claims for disinfectants and sanitizers (Markkanen 
et al. 2009). Green cleaning products are marketed as containing natural materials They 
are designed to be drop-in substitutes or potential replacements for the “highly toxic” 
conventional cleaning agents or disinfectants. However factors such as the effect on 
pathogen control, impact on applicators, sensitive occupants and environment also need 
be considered (Light, 2009).
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Published data on the effects of ‘green’ cleaning products are limited, however data from 
laboratory experiments investigating the effects of alternative products are available. 
Olsen et al. (1994) compared the effects of vinegar, baking soda, ammonia and lemon 
juice with conventional hard surface disinfectants and found the alternative products to be 
less effective in both microbial reduction and soil removal. In another study, Rutala et al. 
(2000) found little or no effect of vinegar and baking soda against either Gram-positive 
and Gram-negative, bacteria which was also observed by Bauer et al. (1995) using an 
EPA Non-Food Contact Sanitizer Test.
Sattar (2010) in a review article suggested caution in the widespread use of green 
products without properly addressing any potential risks they might pose. The author also 
highlighted principles that should govern ‘green’ products which are used for disinfection 
purposes. These principles infer that the ‘green’ products and chemicals should be 
effective with no toxicity, safe, degradable and possess minimal potential for accidents 
and environmental release.
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2.7 Natural products as antimicrobial agents
Natural products have aided the discovery of new leads in the search and development of 
drugs for treatment of human diseases (Newman and Cragg, 2007). Some of the natural 
products with known antimicrobial potential have been identified and harnessed from 
various sources including: bacteria, fungi, animals, insects and plant sources. Naturally 
occurring products known to possess antimicrobial activity with potential healthcare 
applications include honey, chitosan, silver (Cooper et al. 1999; Chopra, 2007; Raafat 
and Sahl, 2009). The potential of natural antimicrobial products is not only applicable in 
the health sector as some of these natural compounds have been used in other areas 
such as food preservation, household cleaning and detergent products, cosmetics and 
beauty products (Roller, 2003; Tiwari et al. 2009; Ponce et al. 2011).
2.7.1 EOs
EOs are defined as “complex mixtures of volatile compounds produced by living 
organisms and isolated by physical means only (pressing and distillation) from a whole 
plant or plant of known taxonomical origin’’ (Franz and Novak, 2009). The use of essential 
oils for medicinal purposes is dated back to 3000BC (Haber, 2010) and in the 16,h 
century, EOs and separation methods for essences from aromatic waters were 
established while the 21st century has seen a rise in popularity of these compounds 
(Vidal, 2010).
To obtain essential oils from the plants, different extraction methods have been used. 
Commercially, steam or hydrodistillation is the most commonly used while other methods 
such as cold pressing and dry distillation have been described (Kubeczka, 2009). Over 
the years numerous studies have shown essential oils to be antibacterial, antitoxigenic, 
antimycotic, antiparasitic, antiviral and possessing insecticidal properties (Burt, 2004).
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2.7A A Essential oils as antimicrobial agents
In recent years the antimicrobial properties of essential oils have been investigated in 
vitro against Gram-positive bacteria, Gram-negative bacteria and fungi (Hammer et al. 
1998; Hammer et al. 1999; Dorman and Deans, 2000; Prabuseenivasan et al. 2006). 
Some of the essential oils studied for antimicrobial potential include: tea tree oil, thyme, 
geranium, manuka, lemongrass, lavender and citrus-based oils (Lis-Balchin et al. 1998; 
Williams et al. 1998; Lis-Balchin and Roth, 2000; Takarada et al. 2004; Fisher and 
Phillips, 2009). In a study by Hammer et al. (1999), the minimum inhibitory concentration 
(MICs) of 52 plant oils against ten organisms were investigated and of those, lemongrass, 
oregano and bay inhibited all the organisms which included Gram-positive bacteria, 
Gram-negative bacteria and fungi at the concentration < 2% (v/v) while nine other 
essential oils (rosewood, coriander, palmarosa, tea tree, niaouli, peppermint, spearmint, 
sage and majoram) inhibited all the strains at a concentration < 2% (v/v) with the 
exception of P. aeruginosa.
The antimicrobial effects of essential oils have also been observed when different 
essential oils were combined with each other. Fisher and Phillips (2009), blended two 
EOs (orange and bergamot) at a ratio 1:1 and 2% (v/v) concentration with the EO 
combination demonstrating antimicrobial activity by growth inhibition and cell death in 
E.faecium and E.faecalis. Patrone et al. (2009) also observed synergistic properties when 
essential oils with surfactants were combined with cosmetic preservatives suggesting 
potential for enhancement of biocidal activity and improvement of cosmetic preparations. 
In other studies, Hendry et al. (2009) and Karpanen et al. (2008), both assessed the 
combination of eucalyptus oil and 1, 8-cineole with chlorhexidine digluconate (CHG) 
against planktonic and biofilm cells and observed synergistic activity both in suspension 
and against biofilms. The antibiofilm effects of essential oils against biofilms of bacteria 
and fungi have been demonstrated previously (Kwiesincki et al. 2009; Budzynska et al. 
2011; Laird et al. 2012a).
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2 8 Surface attached bacteria and biofilms
Bacteria attached to a surface experience different conditions in comparison to planktonic 
cells. These conditions include higher osmolarity, differences in nutrient availability 
(limited in embedded bacteria), higher cell density, different growth rates and genetic 
responses (Fux et al. 2003).
2.8.1 Surface attached bacteria
Investigations on the effect of antimicrobial compounds on bacteria adhered to surfaces 
have been performed for many years. Contact with inert surfaces and attachment to 
these surfaces has been described as a contributing factor in infection outbreaks in food 
processing environments (Mafu et al. 1991). Surface adhered bacteria have been 
investigated in numerous studies and Wider et al. (1991) reported the potential to 
successfully treat established device related infections by using drugs or treatment that 
kill adherent and non-adherent bacteria. Surface adhered bacteria have been isolated 
from various surfaces. For example, Salmonella enteritidis Phage type 4 (PT4) was 
isolated from domestic toilets and bathrooms (Barker and Bloomfield, 2000) while in a 
different study, Listeria monocytogenes was found to be adherent to materials in food 
processing environments (Beresford et al. 2001). In laboratory investigations, other 
surfaces such as ceramics, stainless steel and polyvinyl chloride (PVC) plastic have been 
used to determine the effect of antimicrobial agents (Norwood and Gilmour, 1999; 
Katsikogianni and Missirlis, 2004; Laird et al. 2012a). Although non-sporing bacteria such 
as Enterococcus sp. and S. aureus have been isolated from inert surfaces, spore-forming 
bacteria such as Bacillus cereus, Bacillus subtilis and C. difficile have also been isolated 
(Waligora et al. 1999; Faille etal. 2002).
It is still unknown what the key factor is in initial bacterial attachment to a surface. 
However in a review article; Palmer et al. (2007) discusses a number of factors which 
included surface conditioning, mass transport, surface charge, hydrophobicity, surface
roughness and surface micro-topography. Busscher et al. (2012) highlighted that the 
forces of adhesion tend to strengthen during the first minutes of contact leading to a 
switch from reversible to irreversible adhesion. The authors also proposed three adhesion 
force regimes once bacteria come in contact with a surface; the planktonic regime, the 
interaction regime and the lethal regime. The first phase of adherence of bacteria to 
surfaces is however said to be as a result of Van der Waals forces (Skvarla, 1993). 
Bacterial attachment to surfaces is important as it is the first stage in development of 
biofilms following irreversible attachment (Hinsa et al. 2003).
2.8.2 Biofilms
Biofilms have been defined as communities of microorganisms attached to a surface 
(O'Toole et al. 2000). Donlan and Costerton (2002) have also provided a definition of 
biofilms as; “microbially derived sessile community characterized by cells that are 
irreversibly attached to a substratum or interface or to each other, are embedded in a 
matrix of extracellular polymeric substances that they have produced, and exhibit an 
altered phenotype with respect to growth rate and gene transcription
Formation of biofilms has been observed in both bacteria and fungi and is an important 
factor in survival and virulence (Vuong et al. 2004). Examples of organisms studied 
extensively for the ability to form biofilms include P. aeruginosa (O’Toole and Kolter, 
1998), E. coli (Pratt and Kolter, 1998), C. albicans (Ramage et al. 2002), S. aureus and 
Staphylococcus epidermidis (Otto, 2008) among others. According to Prigent-Combaret 
et al. (1999), biofilm formation occurs as a response to certain environmental signals 
such as nutrient availability, cell to cell signalling, oxygen concentration, osmolarity and 
genetic mechanisms.
Biofilm formation has also been associated with treatment failures in healthcare and 
increased antibiotic resistance (Fux et al. 2003). The antimicrobial susceptibilities
demonstrated by bacteria in biofilms differ from planktonically growing bacterial cells as 
the cells in biofilms show reduced susceptibility to the effect of antimicrobial agents (Ceri 
etal. 1999).
The key stages of biofilm development have been demonstrated in Figure 2.1. These 
stages are: attachment (this could be either to other bacteria or a surface) an irreversible 
binding or attachment phase usually on surfaces, maturation of the biofilm, maintenance 
of the biofilm and dissolution or cell dispersal from the biofilms (O’Toole et al. 2000; 
Aparna and Yadav, 2008). Thomas et al. (2006) described three spatial regions within the 
biofilm. These three levels or spatial regions were the glycocalyx layer also referred to as 
the slime layer which serves a protective barrier, a resistance transfer layer and thirdly 
the innermost part of the biofilm which constitutes cells that are metabolically inactive. 
The latter is perhaps the layer harbouring persister cells.
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Attachment
Planktonic cells
Antibiotic (low penetration rate)
Nutrients and 
oxygen gradient
Accumulation of enzymes 
(e.g. p-lactamases)
Persistercell
Mature biofilm
Figure 2.1. Stages in the development of a biofilm. (Schematic image from Fernandez et 
al. 2011). The process of biofilm formation begins with the attachment of planktonic cells to 
a surface or to each other and a subsequent period of irreversible attachment, maturation 
and finally dispersal of the biofilm. (O’Toole et al. 2000).
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2 8.2.1 Biofilm formation in S. aureus
S. aureus is known to form biofilms (Gotz, 2002) and, in other staphylococci, biofilm 
formation is a common feature, for example, in S. epidermidis (Knobloch et at. 2001), S. 
saprophyticus (Cernohorska and Votava, 2010), Staphylococcus haemolyticus (Fredheim 
et at. 2009) and in S. sciuri (Stepanovic et at. 2003). Biofilm formation in the 
staphylococci begins when the organism attaches to host tissue or a surface (Heilmann 
and Gotz, 2010; Periasamy et at. 2012). In S. aureus, initial adherence to abiotic surfaces 
is associated with the charge of its techoic acid, while attachment to both abiotic and 
biotic surfaces such as implanted material is linked to host-factor binding proteins, the 
microbial surface components recognizing adhesive matrix molecules or MSCRAMMS 
(Heilmann and Gotz, 2010).
Following initial attachment, formation of biofilm occurs in S. aureus by accumulation of 
bacteria mediated by extracellular polysaccharides (Fluckiger et at. 2005). The best 
known mechanism mediating attachment and accumulation of bacteria in S. aureus is the 
polysaccharide intercellular adhesin (PIA) or polymeric N-acetyl-glucosamine (PNAG) 
produced by ica operon-encoded enzymes (O’Gara, 2007; Heilmann and Gotz, 2010). 
The model of PIA biosynthesis and function of the Ica genes are shown in Figure 2.2. PIA 
plays a role in biofilm formation in both S. epidermidis and S. aureus and is the main 
molecule responsible for intracellular adhesion supposedly working like ‘glue’ sticking 
cells together by electrostatic interaction (Otto, 2008). Fluckiger et at. (2005) 
demonstrated that, during infections associated with medical devices, PIA production is 
induced and the authors concluded that, for colonization and survival of S. aureus on 
implants, the genes on the ica locus and biofilm formation are important factors.
The ica locus is made up of five genes; a regulatory gene icaR and four other genes on 
the locus icaADBC Several laboratory-based assessments have investigated the role of 
the ica genes in biofilm development in both S. epidermidis and S. aureus (Arciola et at.
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2001; Gad et al. 2009). The icaA and icaD genes work together to synthesise sugar 
oligomers in vitro with UDP-/V-acetylglucosamine as substrate (Crampton et al. 1999). 
The icaD acts as a chaperone directing the folding and membrane insertion of icaA and 
also as a link between icaA and icaD although the true function of icaC is unclear (Gotz et 
al. 2006). The icaB is regarded as important as it has a crucial function in biofilm 
formation and virulence and is the only extracellular protein of the ica system (Vuong et
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Figure 2.2. The model of PIA biosynthesis showing the genes of the ica locus and their 
functions. Source: Vuong et al. 2004)
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The role of the ica locus in biofilm development is under debate as biofilm phenotypes 
have been observed which are PIA independent (Qin et al. 2007; Rohde et al. 2007). In 
cases of PIA-independent biofilm formation, adhesive proteins are the ‘most likely 
substitute for PIA' (Otto, 2008). Examples of biofilm associated proteins in S. aureus 
include S. aureus surface protein G, S. aureus surface protein C, biofilm associated 
protein and catabolite control protein A (Corrigan et al. 2007; Seidl et al. 2008; Schroeder 
et al. 2009; Gruszka et al. 2012).
Other mechanisms have been observed as being involved in biofilm formation in S. 
aureus. Of these mechanisms, quorum sensing (QS) and regulation of certain genes 
have been studied in recent years. In S. aureus, cell to cell signalling is mediated by the 
genes of the agr locus which consists of five genes including; agrA, agrC, agrD, agrB and 
hid (Vuong et al. 2000; Sakoulas et al. 2002). However, recently, other studies have 
suggested another QS system governed by a gene luxS (Xu et al. 2006) although the role 
of this gene in QS has been debated (Doherty et al. 2006). Unlike previous observations 
in P. aeruginosa biofilms, in S. aureus, the agr mediated QS system impedes attachment 
and low agr is important for biofilm development (Boles and Horswill, 2008). It has been 
suggested that perhaps the QS system in S. aureus {agr) is involved in detachment of the 
biofilms (Yarwood et al. 2004).
Expression of the factors described as associated with biofilm formation is due to the 
activity of regulatory genes. To identify these genes, molecular methods have been used 
such as microarrays, western blotting analysis and gene expression studies. For 
regulation of the ica and the agr dependent genes, a gene staphylococcal accessory 
regulator (SarA) is responsible. Beenken et al. (2003) showed that mutation in the SarA 
gene led to a reduced ability for S. aureus to form biofilms while agr mutation is 
associated with increased biofilm formation suggesting opposing activity. Beenken et al. 
(2010) also demonstrated that SarA has an epistatic relationship to agr and regardless of 
the presence of mutation in the agr, the biofilm formation is dependent on SarA Other
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factors that have been identified in S. aureus biofilm development include proteins such 
as the stress induced sigma factor SigB and rbf. The role of SigB is still unclear (Rachid 
et al. 2000), however Lim et al. (2004) suggested that rbf is associated with regulation of 
multicellular aggregation in response to glucose and salt in S. aureus biofilms. Cue et al. 
(2009) further demonstrated that rbf promotes biofilm formation in S. aureus by controlling 
an unknown factor which represses IcaR which is a negative regulator of the icaADBC 
locus.
2.8.2.2 Biofilm formation in Enterococci
The enterococci are opportunistic Gram-positive bacteria linked to a range of infections in 
humans and in animal populations. The most common of the Enterococcus species are 
E. faecalis and E. faecium which cause over 95 % of enterococcal infections (Mohammed 
and Huang, 2007). Both E. faecalis and E. faecium are clinically relevant organisms and 
have been associated with infections from indwelling medical devices, venous and 
urinary catheters (Garsin and Willems, 2010). It is apparent that more is known about E. 
faecalis than E. faecium strains with regard to their pathogenic factors and biofilm 
determinants (Di Rosa et al. 2006).
Biofilm formation is regarded as an important virulence factor in pathogenesis of 
enterococcal infections (Kouldhi et al. 2011) and is also associated with increased 
antibiotic resistance (O’Toole et al. 2000). Di Rosa et al. (2006) found higher numbers of 
biofilm formers in E. faecalis (85.2%) compared with E. faecium isolates (31.1%) 
suggesting that, regardless of the source, biofilm formation is common in E. faecalis. In 
another study, Ramadhan and Hegedus (2005) investigated biofilm formation in VRE and 
VSE isolates from a single hospital and found no biofilm formation in seven VRE isolates 
although nine out of twenty eight VSE isolates were positive for biofilm formation. In a 
review article by Mohamed and Huang (2007), the authors concluded that, E. faecalis
produces more biofilm than E. faecium and that biofilm formation may be an important 
pathogenicity factor in infections caused by Enterococcus sp.
Factors that have been associated with biofilm formation in Enterococcus sp. include 
nutritional factors such as nutrient availability, changes in osmotic strength and other 
environmental cues (Mohamed and Huang, 2007). Also important in the process of 
biofilm formation are involvement of surface proteins, QS systems and other gene 
products (Tendolkar et at. 2004; Mohamed and Huang, 2007).
The presence of an enterococcal surface protein (esp) was suggested as an important 
factor in biofilm formation in Enterococcus sp. (Toledo-Arana et at. 2001; Tendolkar et at. 
2004). This was thrown into question when esp-independent biofilm formation was 
observed in E. faecalis (Kristich et at. 2004). Ramadhan and Hegedius (2005) concluded 
that this gene is neither necessary for biofilm formation nor sufficient for biofilm 
production in enterococci. However Di Rosa et al. (2006) observed that clinical isolates of 
E. faecium, positive for biofilm formation also possessed the esp gene and further 
concluded that although neither esp nor geiatinase are responsible for biofilm formation in 
E. faecium strains, both factors act in synergy in the establishment of infection.
A two-component QS system designated fsr has been demonstrated as a factor in biofilm 
formation in E. faecalis. Pillai et al. (2004) demonstrated that losing the function of fsr led 
to a reduced ability of E. faecalis to form biofilms. Fsr is a homologue of the agr locus, a 
QS cluster in S. aureus with known involvement in virulence and biofilm formation (Qin et 
al. 2000). The fsr locus is composed of three genes frsA, fsrB and fsrC and the resulting 
proteins FsrABC are important for producing two secreted proteases, geiatinase and 
serine proteinase (Hancock and Perego, 2004), with the former associated with the early 
stages of biofilm formation in E. faecalis (Kristich et al. 2004; Wang et al. 2011)
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Other genes that have been associated with biofilm formation include; epa (enterococcal 
polysaccharide antigen), bee (biofilm enhancer in enterococcus), bop (biofilms on plastic 
surface), eta (Enterococcal two-component system regulator) as described by Mohamed 
and Huang (2007).
2.8.2.3 Biofilms in diverse environments
In healthcare settings biofilms have been observed in medical devices such as contact 
lenses (McLaughlin-Borlace et at. 1998), venous and urinary catheters (Sandoe et at. 
2003), intrauterine devices (Auler et at. 2010), and dental applications (Subramani et al. 
2009). In humans, a known environment of biofilm development is in dental plaques (Ten 
Cate, 2006) and in chronic wounds (James et al. 2008). Outside the healthcare 
environment, biofilms have been observed in food processing environments (Wong, 
1998) and in swimming pools, hot tubs and piping systems (Lutz and Lee, 2011).
2.8.2.4 Significance of biofilms
Biofilms are important in both healthcare and non-healthcare settings. Biofilms 
demonstrate certain characteristics which are of clinical relevance such as resistance to 
antimicrobial agents, a harbour for pathogenic organisms with potential for resistance 
plasmid exchange, and a persistent source of infection (Donlan, 2001). An important 
aspect of biofilm development is the ability of bacteria in the biofilms to resist the action of 
antimicrobial compounds and protection against some antimicrobial compounds 
(Yarwood et al. 2004), by reducing antimicrobial susceptibility and increasing tolerance 
up to 1,000-fold (Thomas et al. 2006).
According to Anwar et al. (1992), formation of biofilms generates a sheltered 
encapsulated community of cells and this makes the cells less vulnerable to different 
stresses and the action of phagocytes. Stewart and Costerton (2001) offered three
hypotheses for biofilm resistance mechanisms; firstly, slow or incomplete penetration of 
the antibiotic into the biofilm, secondly, altered conditions in the microenvironment of the 
biofilms such as changes in depleted oxygen concentrations and altered osmotic 
environment, and thirdly, cell differentiation in a biofilm similar to spore formation. In a 
review article by Mah and O’Toole (2001), it was reported that lack of inhibition of 
diffusion of an antimicrobial into a biofilm does not always explain resistance. The authors 
also suggested that other factors such as slow growth rate of the bacteria in biofilms, 
heterogeneity of cells within the biofilms, general stress responses, involvement of genes 
in the biofilm phenotype and QS could be involved.
According to Hoiby et al. (2011), bacteria remain non-pathogenic and only colonise their 
hosts until QS is activated. The QS system was described by the authors as one which 
allows bacteria to sense the concentration of other bacteria within a limited 
microenvironment which in turn leads to gene activation that produces proteins, enzymes 
or toxins. To date, QS systems have been identified in many pathogens including S. 
aureus (Yarwood et al. 2004), Vibrio chlorerae (Hammer and Bassler, 2003), 
Streptococcus sp. (Cvitkovitch et al. 2003), P. aeruginosa (Hentzer etal. 2002).
QS in Gram-positive and Gram-negative bacteria uses different signalling molecules
Those in Gram-negative bacteria use the N-acyl homoserine lactones (AHL) which in
high concentrations bind to activate a transcriptional regulator while in Gram-positive
bacteria, posttranslational peptide signal molecules are the signalling molecules (Kievit
and Iglewski, 2000). In S. aureus strains, QS is encoded by the accessory gene regulator
(agr) locus which produces a molecule called autoinducing peptide (AIP) (Boles and
Horswill, 2008). While QS has been suggested to be involved in biofilm development,
Boles and Horswill (2008) reported the importance of agr repression in biofilm 
development in S. aureus.
2.9 Conclusion
The emergence of CAIs has altered the way the health community views and responds to 
certain pathogenic infections. At present the investigative tools which use phenotypic, 
genetic and epidemiological methods have been helpful in providing information on 
characteristics of the causative organisms of CAIs and the spectrum of disease. Also, 
good personal hygiene, early detection of CA-MRSA and decolonisation are measures 
that could control, limit or prevent infection spread (Witte, 2009).
Although disinfectants have been important in infection prevention to control 
environmental contamination and nosocomial infections, the emergence of new strains 
and the continuously growing knowledge of bacterial biofilms shows that there is a need 
for development of new products to support the already existing tools used in infection 
prevention. Also as the demand for products of natural origin continues to increase and 
the quest for greener and safer alternatives for the environment remains, there is a need 
to increase research activity on naturally occurring plant based materials such as 
essential oils which have shown promising results in many antimicrobial studies.
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2.10 Aims
The aims of this study were to evaluate the differences in physiological and genetic 
characteristics between S. aureus isolates of CA and non-CA origin and a vancomycin 
resistant E. faecium strain and to determine the sensitivity of the isolates to antimicrobial 
agents.
This would be achieved by -
• Identifying the phenotypic characteristics of S. aureus strains including antibiotic 
susceptibility, slime formation and biofilm formation.
• To determine the SCCmec type of the S. aureus isolates and the presence of 
certain genes including: mecA, ccrB2, icaA, icaD and pvl.
• To investigate the effect of disinfectants and an environmentally friendly cleaning 
product against one VRE strain and six S. aureus strains, including a HA- 
methicillin sensitive and two CA S. aureus strains.
• To determine the antibacterial and antibiofilm effect of range of EOs against S. 
aureus strains
• To identify the differences in gene expression between two S. aureus strains 
following exposure to EOs.
CHAPTER THREE
General materials and methods
3.1 General Methods
3.1.1 Microorganisms
The test organisms used in this study included: vancomycin resistant E. faecium NCTC 
12202 (Health protection Agency, London, UK), hospital MSSA isolate, methicillin 
sensitive S. aureus NCTC 13297, PVL positive CA MSSA, PVL positive CA MRSA, CA 
MRSA MW2 and CA MRSA SR donated by Prof. Mark Fielder from the Kingston 
University culture collection.
3.1.2 Preparation and maintenance of cultures
All culture media were prepared as recommended by the manufacturers. The list of 
microbiological media and chemicals used are shown in Appendix I. Stock cultures were 
stored on beads (Microbank PL 160/M, Pro-lab diagnostics, Cheshire, UK) at -80°C. 
Working cultures were maintained on BHI agar, sub-culturing weekly for a maximum of 
three weeks to maintain viability and colony characteristics. The isolates were 
subcultured on brain heart infusion (BHI) agar (70138-500G; Fluka Analytical, Sigma-
Aldrich, UK) at 37°C and recultured on fresh BHI agar plates weekly to maintain viability 
and phenotypic characteristics.
3.1.3 Preparation of inoculum
Single colonies were picked from a BHI agar plate into BHI broth (CM225, Oxoid Ltd, 
Basingstoke, UK) and incubated overnight at 37°C. Enumeration of viable bacterial 
colonies was on BHI agar and the colony forming units (cfu) for each isolate determined 
using spread plating or the Miles and Misra method (1938). In each case, 20 pi of serial 
10-fold dilutions of the overnight cultures of each organism was spotted onto BHI agar,
left to dry and incubated overnight at 37°C after which the numbers of colonies were 
enumerated.
3.1.4 Formation and quantification of biofilms in S. aureus and VRE
The method used was adapted from Stepanovic et al. (2007). 100 pi of overnight culture 
was diluted 1:100 in BHI broth supplemented with 1% (w/v) glucose. 200 pi was pipetted 
into the wells of a sterile 96-well plate. Negative controls were wells containing the BHI 
broth without organism. The contents of the wells were decanted, discarded and each 
well washed three times with 300 pi of sterile PBS (pH: 7.3 ± 0.3). Prior to fixation the 
plates were drained in an inverted position. The plates were then air dried for one hour 
and stained with 0.1% crystal violet (w/v) for 30 minutes at room temperature (Wijman et 
al. 2007), aspirated, washed three times with PBS (200 pi per well) before drying. The 
crystal violet was then solubilised using 10% (v/v) glacial acetic acid and the resultant OD 
measured at 595nm using a Microplate reader (Bio-Rad 680XR, Hertfordshire, UK).
3.1.5 Statistical Analysis
Statistical analysis was conducted using SPSS v17 0. Significance levels were set at 
P=0.05. Assumptions of normality of the distributions and homogeneity of variances were 
checked. For parametric data, where assumptions of normality and variance were met, t- 
tests and one way analysis of variance (ANOVA) was performed while in cases were 
assumptions of normality and variance were not met, the Mann Whitney and Kruskall- 
Wallis tests were used for non-parametric data.
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CHAPTER FOUR
Identification of phenotypic and genetic characteristics of the 
bacterial isolates.
4.0 Introduction
S. aureus remains a very important human pathogen and infections caused by the 
methicillin resistant strains continue to be a problem within healthcare. Since the 
detection of methicillin resistance in the 1960s (Jevons, 1963), there has been a rise in 
the rates of methicillin resistance and resistance to antibiotics in general (Brown et al. 
2005) and also other antimicrobial agents such as triclosan and quartenary ammonium 
compounds (McDonnell and Russell, 1999). There has also been the emergence of HA- 
MRSA and, even more recently, CA-MRSA infections with phenotypic and genetically 
distinct characteristics from HA-MRSA (Nathwani et al. 2008). An important characteristic 
used in differentiating HA from the CA MRSA is in SCCmec type. Of the eleven SCCmec 
types, I to III are associated with traditional hospital infections while the types IV to VI are 
characteristic of CA-MRSA (Chen et al. 2009; Boyle-Vavra and Daum, 2007). The 
differences observed between CA strains and HA strains also include antibiotic 
susceptibility where currently CA-MRSA are known to be more susceptible to non p- 
lactam antibiotics (Elston etal. 2009; Fey etal. 2003) than HA-MRSA.
Identifying antibiotic susceptibility patterns in microorganisms is important in antibiotic 
treatment, epidemiological investigations and development of infection control policies 
(Marias et al. 2009; Brown et al. 2005). Alongside the development of resistance traits, 
another important feature of S. aureus is the ability to form biofilms. Biofilm formation in 
bacteria has been described as a means of survival (Donlan and Costerton, 2002) and a 
virulence characteristic (Vuong and Otto, 2002). Certain genetic characteristics in S. 
aureus are related to virulence, resistance and survival. One of the genes associated with 
virulence, is PVL linked with virulence in CA-MRSA (Boyle-Varva and Daum, 2007). 
Another gene associated with biofilm formation and virulence in S. aureus is the
intracellular adhesion gene (/ca), which is involved in mediation of cell to cell adhesion 
and initiation of biofilm formation (Gardner et al. 2011).
The objective of this study was to investigate the phenotypic characteristics of the 
S. aureus strains including antibiotic susceptibility and biofilm formation and subsequently 
investigate the genetic characteristics of the S. aureus strains. Multiplex PCR was used 
to determine genetic characteristics of the S. aureus isolates in this study. Since it was 
first developed by Chamberlain et al. (1988), multiplex PCR has also been applied in 
other investigations to determine genetic characteristics of MRSA (Oliveira and 
Lencastre, 2002; Mason et al. 2001).
4.1 Materials and Methods
4.1.1 Antibiotic Screening Tests
4.1.1.1 Bacterial strains
Six bacterial strains were investigated for antibiotic susceptibility (section 3.1.1). The 
control strain was S. aureus NCTC 12981 based on British Society for Antimicrobial 
Chemotherapy (BSAC) Guidelines; version 10.2 (Andrews and Howe, 2011).
4.1.1.2 Inoculum preparation
Following BSAC guidelines three to four colonies of each organism were taken from Iso- 
Sensitest Agar (ISA) (Oxoid Basingstoke, UK) using a sterile loop, added to 1ml sterile 
PBS and vortexed for one minute. Optical densities (OD) were measured using a CE 
1011 spectrophotometer (Cecil Instruments Ltd, Cambridge, UK) at 600nm for each strain 
and standardised to between OD 0.8 and OD 1.2 to attain semi-confluent growth. The 
cultures were then spread onto agar plates using sterile cotton swabs.
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4.1 1.3 Selection of antibiotics
The antibiotics selected for this study including the concentrations and breakpoints are 
shown in Table 4.1.
4.1.14 Disc diffusion
Susceptibility of the bacteria to antibiotics was assessed using the disc diffusion assay 
according to BSAC guidelines on Iso-Sensitest agar (ISA) plates. The antibiotic discs 
(Table 4.1) were deposited on the ISA agar within 30 minutes of spreading the cultures 
and the plates incubated overnight at 37°C. After incubation, diameters of the zones of 
inhibition were measured using vernier callipers to the nearest millimetre at the inner 
edges of the zones observed. Interpretation of sensitivity or resistance was confirmed 
using the recommended breakpoints.
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Table 4.1. Antibiotics Tested.
Antibiotic group Antibiotics
Concentration of
antibiotic disk(pg)
Zone interpretation (mm)
R £ S>
Quinolones Ciprofloxacin 1 13 14
Aminoglycosides Gentamicin 19
10
20
P-lactam ’ cefoxitin 10 21 22
Miscellaneous antibiotics Rifampicin 23 24-29 30
Macrolides. Iincosamines
and streptogramins
Erythromycin 16 17-19 20
Tetracyclines Tetracycline 10 19 20
‘ Cefoxitin was selected for measurement o f methicillin resistance (following BSAC 
recommendations).
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4.1.2 Phenotypic determination of slime and biofilm formation
4.1.2.1 Mannitol fermentation using mannitol salt agar (MSA)
MSA was prepared according to manufacturer’s instructions. Single colonies of S. aureus 
strains were streaked onto the MSA and incubated overnight at 37°C for 24 hours. 
Observation of yellow colonies indicated positive mannitol fermentation, hence confirming 
the isolates as S. aureus while pink colonies were negative for mannitol fermentation 
hence non-S. aureus isolates. All tests were performed in triplicate and on three separate 
occasions. The negative control strains were S. epidermidis NCTC 13360 and S. 
epidermidis NCTC 11047.
4.1.2.2 Determination of slime formation using Congo red agar (CRA)
This was performed according to the methods of Mathur et al. (2006) and Mariana et al. 
(2009). Briefly, the S. aureus strains and the VRE NCTC 12202 isolate were streaked 
onto media containing BHI (52g/L, Sigma), sucrose (36g/L), Congo red dye (0.8g/L) and 
incubated at 37°C for 24 hours . Black colonies indicated the strain was positive for slime 
production while pink colonies indicated weak slime production. All tests were performed 
in triplicate and on three separate occasions. The control strain for this experiment was 
the S. epidermidis NCTC 13360, known to be negative for slime formation.
4.1.2.3 Time dependent determination of biofilm formation
Overnight cultures of the S. aureus isolates and the VRE NCTC 12202 strain were diluted 
1:100 to give approximately 1 x 108 Cfu/ml in BHI supplemented with glucose and added 
to wells of a 96 well plate (Nunclon™ surface, Denmark). To determine the time required 
for biofilm formation, 200 pi of diluted overnight cultures were incubated on 96-well plates 
for 24 hours, 48 hours or 72 hours. At each time point the wells were rinsed and the 
crystal violet staining method was applied (Section 3.2) and the absorbances were 
measured at 595nm using the Bio-Rad 680XR Microplate reader.
4.1.2.4 Biofilm growth with adjustment of growth media
200 pi of overnight cultures of each S. aureus strain at approximately 1 x 108 cfu/ml were 
added to the wells of 96-well plates and incubated at 37°C for 24 hours. Following 
overnight incubation, 100 pi was gently removed from the wells and replaced with 100 pi 
sterile broth. The 96-well plates were incubated for a further 24 or 48 hours dependent on 
the organism after which, the plates were rinsed, stained with crystal violet (Section 3.2) 
and the absorbances measured at 595nm using the Bio-Rad 680XR Microplate reader.
4.1.3 Detection of mecA, PVL, SCCmec and IcaA and IcaD in S. aureus strains.
4.1.3.1 Selection of bacterial strains
Six bacterial strains were investigated for antibiotic susceptibility (Section 3.1.1). The 
control strains were S. epidermidis NCTC 11047 which is negative for both PVL and the 
mecA gene, and S.epidermidis NCTC 13360 which is negative for both IcaA and IcaD 
genes.
4.1.3.2 Primers
The primers used in this study were purchased from MWG Biotech, UK (Table 4.2).
Table 4.2. Selected genes and primer sequences
Oligonucleotide sequence (5'-3') Control strain
size (up)
Staph 756-F AACTCTG TTATTAG G G AAG AACA 756 McClure e t  a l. 2006
Staph 750-R CCACCTTCCTCCGGTTTGTCACC
luk-PV-F ATCATTAG G TAAAATG TCTG G ACATG ATCCA 433 McClure e t  a l. 2006
luk-PV-R GCAT CAAGT GTATT GGATAGCAAAAGC
m e c A  - F G TAG AAATG ACTG AACG TCCG ATAA 310 McClure e t  a l. 2006
m e c A  - R CCAATTCCACATTGTTTCGGTCTAA
Ic a A - F CCTAACTAACGAAAGGTAG 1315 Dhanawade e t  a l. 2010
Ic a A  - R AAGATATAGCGATAAGTGC
Ic a D - F AAACGTAAG AGAG G TG G  381 Dhanawade e t  a l 2010
Ic a D  - R GGCAATATGATCAAGATA
ccrB2 F GAAGGTTATAGTATCGACGGACAAATC 66 Valvatne e t  a l 2009
ccrB2 R ACCACGGTCAGCGTATATATCTTTAA
Type IVa F ATAAGAGATCGAACAGAAGC 278 M ilheirico e t a l. 2007
Type IVa R T GAAG AAAT CATGCCTAT CG
Primer specificity for each gene was checked using single PCR analysis. The internal control 
reference gene was the 16S rRNA gene.
4.1.3.3 DNA extraction
DNA was extracted from cultures of each of the strains using the GenElute bacterial 
Genomic DNA kit (Sigma-Aldrich, UK) and performed according to the manufacturer’s 
instructions (Appendix I).
4.1.3.4 Quantification of Deoxyribonucleic acid (DNA)
Following isolation of DNA using the GenElute kit, the yield and concentration of the 
extracted DNA was measured using the GeneQuant-Pro Quartz spectrophotometer 
(Amersham Bioscience, UK) measuring absorbances at 260, 280 and 320 nm. 
Absorbance of 1.0 at 260 nm for DNA corresponds to approximately 50 mg/ml of double- 
stranded DNA and the value of the A260-A 320/A280-A 320 ratio should be 1.6-1.9. To 
quantify the DNA, 6 pi DNA sample was added to 114 pi of the elution solution in a 
cuvette and the absorbances measured. 20 ng of extracted DNA per sample was 
subsequently subjected to amplification by multiplex PCR.
4.1.3.5 Multiplex PCR protocol
Single PCR amplification reactions were used to test for primer adequacy before 
performing the multiplex PCR assay. The total volume used for the multiplex PCR 
amplification was 25 pi and the PCR reaction was performed according to the 
manufacturer’s instructions. 1 pi of genomic DNA was added to 24 pi of the QIAGEN 
Multiplex PCR Master mix which also included 0.2 pM of the forward and reverse primers. 
The PCR was performed using the My Cycler™ Thermal Cycler (Bio-Rad, UK) using the 
following parameters: an initial PCR activation step for 5 minutes at 95 °C to activate the 
HotStar Taq Plus DNA polymerase, followed by 35 cycles at 95 °C for 30 seconds 
(denaturation), 57 °C for 90 seconds (annealing), 72 °C for 30 seconds (extension) and a 
final extension step at 68 °C for 10 minutes.
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4.1.3.6 MecA and PVL gene
The method for simultaneous detection of the mecA and PVL genes by multiplex PCR 
approach was adapted from and McClure et al. (2006). A single target PCR assay was 
applied with each primer pair to check for amplification and specificity of each gene 
target. The expected sizes of each fragment and the genes are shown in Table 4.2. The 
internal control was the 16S rRNA gene. The primers were the Staph756F and 
Staph750R and the control strain was S.epidermidis (NCTC11047) which is negative for 
both the PVL and mecA genes.
4.1.3.7 IcaA and IcaD Genes
Simultaneous detection of IcaA and IcaD was performed. The primers used were chosen 
from studies by Duran et al. (2010) and Crampton et al. (1999). The control strain was S. 
epidermidis NCTC 13360 which is negative for both IcaA and IcaD genes and the 16S 
rRNA gene was the internal control.
4.1.3.8 SCCmec type IV Screening
Determination of the SCCmec type for the S. aureus strains was also performed using 
multiplex PCR. The CA MRSA (MW2) strain was used as a positive control as it is 
positive for the SCCmec type IV (Maree et al. 2007) and the 16S rRNA was used as an 
internal control. The PVL CA MSSA strain was used as a negative control as it is 
negative for mecA encoded by SCCmec.
4.1.3.9 Gel Electrophoresis
For resolution of amplification products, a 2% (w/v) agarose gel (Duran et al. 2010; 
Arciola et al. 2001) in 1 x Tris-acetate-EDTA (TAE) buffer was used at 100V and this was 
visualised using the Gel Doc 1000 (Bio-Rad) following addition of ethidium bromide 
(Sigma-Aldrich, UK) An aliquot of 0.8 pi of a 100 bp DNA ladder (Promega, UK) was 
used to determine the size of the amplified products.
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4.2 Results
4.2.1 Antibiotic Screening Results
In the strains under investigation methicillin sensitivity and/or resistance was confirmed 
using cefoxitin following the BSAC guidelines. There was no difference in the antibiotic 
sensitivity profiles between the hospital, type and community acquired assigned MSSA 
strains as all three strains were sensitive to all six antibiotic groups with no antibiotic 
resistance patterns determined (Table 4.1).
Methicillin resistance was confirmed in the three CA-MRSA strains as these strains were 
resistant to cefoxitin. The CA-MRSA (MW2) and the PVL CA MRSA strains showed a 
similar antibiotic profile with sensitivity to the other antibiotic groups. However the CA- 
MRSA (SR) strain showed a different susceptibility pattern in that it was resistant to four 
antibiotics: ciprofloxacin (quinolones), Gentamicin (aminoglycosides), cefoxitin (P-lactam) 
and the erythromycin (macrolides, lincosamines and streptogramins). Antibiotic sensitivity 
was observed with rifampicin (miscellaneous antibiotics) and tetracycline (tetracyclines). 
The control strain (S. aureus NCTC 12981) was sensitive to all the antibiotics selected 
(Table 4.3).
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4.2.2 Phenotypic identification by MSA and Congo red agar (CRA)
All the S. aureus strains tested were positive for mannitol salt fermentation while the S. 
epidermidis strains (NCTC 11047 and NCTC 13360) were both negative demonstrated by 
the colonies on the plates remaining pink (Table 4.4).
Table 4.4. Determination of mannitol fermentation by S. aureus strains
Bacterial isolates Mannitol ferm entation (MSA agar)
Hospital MSSA isolate positive
PVL CA MSSA positive
MSSA NCTC 13297 positive
CA MRSA (MW2) positive
PVL CA MRSA positive
CA MRSA (SR) positive
S. e p id e rm id is  NCTC 11047 negative
S. e p id e rm id is  NCTC 13360 negative
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For slime production by the Congo red method, the six S. aureus strains were positive as 
the enumerated colonies were black however the S. epidermidis strains and VRE NCTC 
12202 were negative producing pink colonies.
Table 4.5. Slime production on Congo red agar. Classification of slime formation was adopted from 
Mariana et al. (2009) with the slime producers forming black to slightly black colonies while the non 
slime producing strains produce strong red colonies.
Bacterial isolates Phenotype Slime formation (CRA Agar)
Hospital MSSA Black positive
MSSA NCTC 13297 Strong black positive
PVL CA MSSA Strong black positive
CA MRSA MW2 Strong black positive
PVL CA MRSA Strong black positive
CA MRSA (SR) Strong black positive
S. a u re u s  NCTC 12981 Strong black positive
S e p id e rm id is  NCTC 13360 Red negative
VRE NCTC 12202 Red negative
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4.2.3 Biofilm formation in S. aureus strains
All the S. aureus strains were positive for biofilm formation after incubation for 48 hours 
using the 96-well plate method. The PVL CA MSSA strain formed a higher amount of 
biofilm with an OD of 1.4 compared to the other strains ranging between OD 0.54 
and1.18 (Figure 4.1). When biofilm formation was compared between the strains, ANOVA 
showed there was a significant difference F (5) = 21.199, p < 0.001. Post hoc analysis 
further showed that biofilm formation in the PVL MSSA strain was significantly higher 
than in Hosp MSSA, MSSA NCTC 13297, CA MRSA MW2 and the PVL CA MRSA 
isolates p < 0.007, while there was no significant difference between biofilm formation in 
PVL CA MSSA and CA MRSA SR isolates, p = 0.229.
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Figure 4.1. Biofilm formation (mean ± SE), after 24 hours in microtitre wells in six S. 
aureus strains and S. epidermidis NCTC 13360 (control contained BHI broth without any
organism). The experiment was performed in quadruplicate wells and at three separate 
occasions.
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4.2.3.1 Effect of nutrient media change
Biofilm formation was higher in the wells with the changed media compared to the wells 
without (Figure 4.2). Comparison of the results following media change showed 
differences between biofilms with and without changing the media in all four strains. 
Assumptions of normality were met and independent f-tests showed that there were no 
significant differences between changing the media at the 24 hour time point for the Hosp 
MSSA and PVL CA MSSA isolates p > 0.05. However, t-test analysis showed significant 
differences in biofilm formation after the media was changed for CA MRSA MW2 t (14) = 
0.010, p = 0.010 and PVL CA MRSA t (14) = 11.014, p < 0.001.
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Figure 4.2. Preliminary data showing comparison of biofilm formation (mean ± SE), with 
and without replenished nutrient media (BHI broth supplemented with 1% glucose) as
measured by the Microplate reader (Bio-Rad 680XR) with OD at 595nm. Key: IZU (OD
results following nutrient media replenishment),!^ (OD results without media 
replenishment). The experiment was performed in quadruplicate wells and at three 
separate occasions.
4.2.3.2 Time dependent measurement of biofilm formation
Figure 4.3 demonstrates the growth of PVL CA MSSA, MSSA NCTC 13297 and E. 
faecium NCTC 12202 over a 72 hour period following initial incubation in a 96-well plate. 
The E. faecium NCTC 12202 strain did not form a biofilm as measured by CV staining 
with absorbance measurements below OD=0.2 at all time points. Between 24 and 48 
hour time points, biofilm formation in the MSSA NCTC 13297 increased from OD 1.74 to 
OD 1.97 but reduced at 72 hours with an OD 1.0. Comparison of biofilm formation over 
the three day period showed significant difference F (2) = 45.049, p < 0.001. Post hoc 
analysis within the group showed that at 72 hours, biofilm formation was significantly 
reduced p <0.001.
There was a reduction in biofilm formation in PVL CA MSSA between 24 and 48 hours 
from OD 2.05 to 1.84 however there was an increase in biofilm formation at 72 hours. 
ANOVA was carried out between the time points, the difference in biofilm formation was 
significant F (2) = 68.725, p <0.001 and post hoc analysis showed that biofilm formation 
between each time point was significantly different for this isolate p < 0.002. Biofilm 
formation was also significantly greater in the PVL CA MSSA isolate compared to the 
MSSA NCTC 13297 as confirmed by t-test t (22) = 3.356, p <0.001 at 72 hours.
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Figure 4.3. Preliminary data showing time dependent measurement of biofilm formation
(OD595nm) in □  MSSA NCTC 13297, □  PVL CA MSSA and I  E faecium NCTC 
12202 over a three day incubation at 37 °C in 96-well plates as measured by the 
Microplate reader (Bio-Rad 680XR) with OD at 595nm (mean ± SE). The experiment was 
performed in quadruplicate wells and at three separate occasions.
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4.2.4 Molecular analysis of genetic characteristics
4.2.4.1 MecA and PVL
The single PCR protocol showed the presence of the 16S rRNA, mecA and PVL genes in 
the CA MRSA MW2 strain which is known to possess all three genes and was used as a 
positive control (Figure 4.4). In the negative control strain (S. epidermidis NCTC 11047) 
the presence of the 16S rRNA was demonstrated but both mecA and PVL genes were 
absent. All six S. aureus strains were positive for the 16S rRNA reference gene: the three 
MSSA strains and the negative control strain lacked the mecA gene, while the PVL gene 
was present in the PVL CA MSSA strain as well as the CA MRSA MW2 and the PVL CA 
MRSA strains confirming the presence of these genes in all three strains (Figure 4.5). In 
the CA MRSA (SR) strain, the PVL gene was absent although this strain was positive for 
the mecA gene.
4.2.4.2 IcaA and IcaD
The presence of both IcaA and IcaD genes was confirmed in the CA MRSA MW2 strain 
using the single PCR (Figure 4.6). Figure 4.7 shows the presence of both IcaA and IcaD 
genes in all six S. aureus strains. In the S. epidermidis NCTC 13360 (the negative control 
strain), both genes were absent (Figure 4.6 and 4.7).
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Figure 4.4. PCR amplification of 16S rRNA, PVL and mecA  genes in CA-MRSA (MW2) and S. 
epiderm idis NCTC 11047. Lane 1: DNA molecular size marker (100 bp ladder); Lane 3: mecA (MW2); Lane 
5. PVL (MW2); Lane 7: 16S RNA (MW2); Lane 9: 16S RNA, PVL & mecA (MW2); Lane 11: mecA 
{S epidermidis NCTC 11047); Lane 13: PVL (S.epidermidis NCTC 11047); Lane 15: 16S RNA, PVL, mecA 
(S.epidermidis NCTC 11047); Lane 17: 16S RNA, PVL, mecA {S.epidermidis NCTC 11047).
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Figure 4.5. Multiplex PCR amplification of 16S, PVL and mecA  genes in six S. aureus  strains and 
S. epidermidis NCTC 11047. Lane 1 DNA molecular size marker (100 bp ladder); Lane 3: 16S RNA 
(Hospital MSSA); Lane 5: 16S RNA, PVL, mecA (PVL CA MSSA); Lane 7: 16S RNA, PVL, mecA (MSSA NCTC 
13297); Lane 9 16S RNA. PVL, mecA (CA MRSA MW2); Lane 11: 16S RNA, PVL, mecA (PVL CA MRSA
)Lane 13: 16S RNA, PVL, mecA (CA MRSA (SR); Lane 15: 16S RNA, PVL. mecA (S epidermidis NCTC 
11047).
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Figure 4.6. PCR amplification o f icaA  and icaD  genes in the CA MRSA (MW2) strains and controls 
strain S. epiderm idis NCTC 13360. Lane 1: DNA molecular size marker (100 bp ladder); Lane 3: IcaA 
(MW2); Lane 5: IcaD (MW2); Lane 7: IcaA and IcaD (MW2); Lanes 9-13 negative for IcaA, IcaD and both IcaA 
and IcaD in the control strain.
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Figure 4.7. Multiplex PCR amplification of icaA and icaD  genes in six S. aureus  strains and S. 
epidermidis NCTC 13360. Lane 1: DNA molecular size marker (100 bp ladder); Lanes 3 to 13 were positive 
for IcaA and IcaD for the following organisms in the order (L3 -  Hospital MSSA, L5 -  PVL CA MSSA, L7 -  
MSSA NCTC 13297, L9 -  CA MRSA MW2, L11 -  PVL CA MRSA, L13 -  CA MRSA (SR); Lane 15 was negative 
for both IcaA and IcaD (S. epidermidis NCTC 13360).
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4.2.4.3 Detection of Type IVa SCCmec and CCRB2
Lanes 3, 5 and 7 in Figure 4.8 show that both the SCC mec type IVa and CCRB2 genes 
were present in the CA MRSA MW2 strain while lane 9 showed that the PVL CA MSSA 
strain was negative for both SCC mec type IV and the CCRB2. The PVL CA MRSA and 
CA MRSA (SR) strains in Lanes 11 and 13 respectively were both positive for the CCRB2 
gene but lacked the SCC mec type IVa.
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Figure 4.8. Multiplex PCR amplification of the 16S rRNA, SCC m ec  type IVa and CCRB2 genes in 
the CA MRSA MW2 and the experimental control (PVL CA MSSA). Lane 1: DNA molecular size marker 
(100 bp ladder); Lanes 3: CCRB2 (CA MRSA MW2); Lane 5: Type IVa (CA MRSA MW2); Lane 7: 16S RNA, 
CCRB2 (?bp) and SCC mec (CA MRSA MW2); Lane 9: 16S RNA (PVL CA MSSA); Lane 11 16S RNA and 
CCRB2 (PVL CA MRSA) and Lane 13: 16S RNA and CCRB2 [CA MRSA (SR).
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Summary
Table 4,6 shows a summary of the physiological and genetic characteristics identified in 
the S. aureus strains used in this study.
Table 4.6. Summary table of the phenotypic and genetic characteristics identified in six S. aureus 
test strains.
Hospital
MSSA
PVL CA 
MSSA
MSSA
NCTC
13297
CA
MRSA
(MW2)
PVL CA 
MRSA
CA
MRSA
(SR)
Antibiotic susceptibility
Ciprofloxacin S S S S S R
Gentamicin S S S S S R
cefoxitin S S S R R R
Rifampicin S S S S S S
Erythromycin S S S S S R
Tetracycline S S S S S S
Mannitol fermentation
(MSA) + + + + + +
Slime formation (CRA) + + + + + +
Biofilm formation (CV
method) + + + + + +
Investigated genes
mecA - - - + + +
PVL - + - + + -
IcaA + + + + + +
IcaD + + + + + +
SCCmec type IVa ND - ND + ̶ -
CCRB2 ND - ND + + +
Key -  (S) -  sensitive; (R) - resistant; (+) - positive; (-) -  negative.
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4.3 Discussion
Determination of methicillin susceptibility in the S. aureus strains was confirmed using 
cefoxitin and all the strains were confirmed as either sensitive or resistant to methicillin 
using this antibiotic based on BSAC guidelines. The hospital MSSA strain, the PVL CA 
MSSA and MSSA NCTC 13297 strains were all sensitive to all the antibiotic groups with 
no difference between the Hospital MSSA and the PVL CA MSSA strain in antibiotic 
profile. With the MRSA strains, cefoxitin resistance was observed which confirmed 
methicillin resistance in these strains. Both PVL CA MRSA and CA MRSA MW2 strains 
demonstrated similar antibiotic susceptibility patterns as both strains were susceptible to 
five of six antibiotic groups. The antibiotic susceptibility profiles of both CA-MRSA strains 
have been demonstrated previously and these strains are sensitive to the effects of the 
antibiotic groups tested in this study (Vandenesch et al. 2003; Millar et al. 2008).
The antibiotic susceptibility profile of the CA MRSA SR isolate was different from the 
other two strains and fits the profile of the HA-MRSA strains according to the 
susceptibility patterns described by Millar et al. (2008) as HA-MRSA are not susceptible 
to fluoroquinolones, aminoglycosides, erythromycin and clindamycin. However the CA- 
MRSA strains are generally sensitive to both tetracycline and rifampicin (Vandenesch et 
al. 2003; Delorme et al. 2009) which was observed in the CA MRSA SR strain. The CA- 
MRSA (SR) strain was multidrug resistant (resistant to four of six antibiotics classes). 
Multidrug resistance is defined as resistance to three or more representatives of the 
following classes of antibiotics: quinolones, extended-spectrum cephalosporins, (3- 
lactams, aminoglycosides and carbapenems (Hujer et al. 2006).
Slime production was determined in the six S. aureus strains although absent in the two 
S. epidermidis strains, NCTC 11047 and NCTC 13360. The S. aureus strains were all 
positive for biofilm formation using the crystal violet staining method and in previous 
studies by Jain and Argawal, (2009) and Grinholc et al. (2007), there was a 91% and
96% correlation between the Congo red agar (qualitative) and CV staining (quantitative) 
methods. Kouidhi et al. (2011) also showed a correlation between slime production and 
biofilm formation using the CV staining method following investigation of biofilm formation 
in Enterococcus sp. However according to Croes et al. (2009) CRA screening should not 
be used as an alternative method to other methods of biofilm detection. In this study, 
although a small sample size, the S.aureus strains that were positive for slime production 
were also found to be positive for biofilm formation.
It has been suggested that differences exist in the mechanisms and regulation of biofilm 
formation in MRSA and MSSA (O'Neill et al. 2007) and that biofilm development in MRSA 
is primarily glucose-induced while in MSSA NaCI is more likely to induce biofilm 
development. However according to Fitzpatrick et al. (2006) in media supplemented with 
glucose, both MSSA and MRSA are likely to form biofilms. In this study, both MSSA and 
MRSA formed biofilms in the presence of glucose as observed in previous studies 
(Stepanovic et al. 2007; Croes et al. 2009). Biofilm formation was determined to be 
highest in the PVL CA MSSA strain compared with the other MSSA and MRSA strains. 
When the two strains with the most biofilms were compared i.e. PVL CA MSSA and CA 
MRSA (SR), the difference in the absorbance measurement (1.395 for PVL CA MSSA 
and 1.183 for CA MRSA SR) between the strains was not significant p=0.229
In a review article by O'Toole (2000), it was reported that changes in environmental cues 
including nutritional conditions, temperature, osmolarity, pH, iron and oxygen, can 
influence biofilm formation. After changing the nutrient media in the microtitre plates after 
24 hour biofilm formation, a higher amount of biofilm was formed. However as the 
biofilms formed withought nutrient media change were sufficient to perform experiments, 
subsequent biofilm formation experiments were performed without changing the growth 
media over 48 hour incubation.
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Using multiplex PCR, methicillin susceptibility was confirmed in the strains tested. The 
cefoxitin resistant strains were mecA positive thus methicillin resistant while the cefoxitin 
sensitive strains were mecA negative hence methicillin sensitive. In the CA-MRSA strains 
the PVL genes are common (File, 2007) and (Zhao et al. 2012) demonstrated a high 
prevalence of the PVL (41.5%) in CA-MSSA infections. In this study, only six S. aureus 
strains were analysed and of these strains, three of the four community strains were PVL 
positive while one the CA-MRSA (SR) was PVL negative.
According to Vourli et al. (2009) introduction of a PVL-positive CA-MRSA strain (ST80- 
MRSA Type IV) into hospitals in Greece was linked to an increased severity of disease 
mainly due to the presence of the PVL gene, and other studies have shown that PVL 
does indeed contribute to disease severity (Etienne, 2005; Lipinska et al. 2011). Etienne 
et al. (2005) suggested that clinical laboratories routinely screen for the PVL toxin in S. 
aureus isolates due to the increasing prevalence of PVL positive CA-MRSA. Absence of 
the PVL gene in the CA-MRSA (SR) strain does not automatically suggest a lack of 
pathogenic potential as PVL negative CA-MRSA have been identified in other studies and 
are known to be pathogenic. For example, PVL negative CA-MRSA strains have been 
disseminated in Japan (Hisata et al. 2005; Kikuta et al. 2011) and Kikuta et al. (2011) 
found that their PVL negative CA-MRSA strains also caused impetigo which had 
previously been associated with the SCCmec type IVa (Takizawa et al. 2005) and 
SCCmec type V CA-MRSA (Yamamoto et al. 2010).
In the HA-MSSA strain in this study, mecA and PVL genes were not found and where this 
strain had previously shown sensitivity to cefoxitin hence methicillin sensitivity, the 
absence of the PVL was unsurprising as Dufour et al. (2002) previously found that MRSA 
strains isolated from hospital acquired infections were negative for the PVL gene
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SCCmec types are defined based on the ccrAB allotype and mecA gene locus in 
staphylococci (Ito et al. 2001). The ccrB2 gene had been used previously as a internal 
positive control in the SCCmec IV multiplex (Milheirico et al. 2007b). Oliveira et al. (2008) 
proposed that sequencing an internal fragment of the ccrB is a promising tool for typing 
SCCmec as there is a correlation between ccrB allelic clusters and SCC mec types. 
Following multiplex PCR analysis it was determined that all three CA-MRSA strains were 
positive for ccrB2 although the CA-MRSA MW2 strain was the only strain positive for the 
SCC mec type IVa which was expected. It is also worth noting that the mecA negative 
PCL CA-MSSA strain used in this study as a negative control strain in multiplex PCR for 
SCC mec did not possess the ccrB2 gene. In a previous study (Sabet et al. 2012) the 
methicillin sensitive strains lacked the ccr genes hence SCC mec was deemed absent in 
these strains. The SCC mec IV observed in CA-MRSA is important and there is also the 
suggestion that the SCC mec IV subtypes play a role in spread of beta-lactam resistance 
between species and populations and could provide a selective advantage to 
staphylococci (Smyth et al. 2011).
Another important characteristic of S. aureus is the presence of intracellular adhesion
genes which has been associated with biofilm formation (Crampton et al. 1999) In this
study, both the icaA and icaD genes were identified in the six S. aureus strains tested.
Crampton et al. (1999) suggested that the ica locus is present in nearly all S. aureus
strains. In the study by Arciola et al. (2001), the authors reported that the ica locus was
present in a majority of clinical slime producing staphylococcal isolates and suggested
that the icaA and icaD genes play a role in the pathogenesis of catheter associated 
infections.
All six S. aureus strains in this study were shown to be positive for biofilm formation and 
were also positive for slime formation following enumeration on Congo red agar Several 
studies have shown the association between the ica locus and biofilm formation in
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staphylococci (Rohde et al. 2001; Cerca et al. 2005; Oliveira and Cunha, 2010) and the 
data presented here suggest a link between presence of the icaA and icaD genes with 
the formation of slime and biofilms in the S. aureus strains tested. Arciola et al. (2001) 
suggested a strong link between the phenotypic characteristic of slime production and the 
genotypic detection of the ica locus. Molecular analysis of the ica genes by Resch et al. 
(2005) also showed that the ica genes are up-regulated in a S. aureus biofilm and are 
necessary for adhesion and the initiation of biofilm formation. This further highlights the 
importance of the ica locus and determination of the genes present in the ica locus could 
help in routine diagnostic identification of particularly virulent S. aureus strains (Arciola et 
al. 2001). The presence of the icaA and icaD genes in all six investigated S. aureus 
strains in this study, coupled with the knowledge that these genes are present in majority 
of S. aureus isolates (Arciola et al. 2001) suggest a potential role of the ica locus as 
genetic markers in the identification of S. aureus.
Understanding the antibiotic susceptibility profiles, phenotypic and molecular 
characteristics of the community acquired isolates would provide support to the 
development of effective therapeutic options. However as shown in this study, the genetic 
changes that have occurred in S. aureus since the emergence of methicillin resistance 
continues to pose a problem for healthcare. Further research is required to identify the 
origin of the CA MRSA (SR) strain as this organism showed a multidrug resistant profile 
which is not a common characteristic of CA-MRSA strains.
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CHAPTER FIVE
Antibacterial and antibiofilm activity of two disinfectants and an 
ecofriendly cleaner on Staphylococcus aureus and vancomycin 
resistant Enterococcus faecium
5.0 Introduction
In the past 20 years, there has been an increase in the number of antibacterial products and 
disinfectants sold commercially. For example, in 1994, only a dozen products containing 
antibacterial agents were marketed for use in the home. However by 2001, more than 700 
were found to be available in the US for the same purpose (Levy, 2001). This observed rise 
in the number of antibacterial and disinfectant products has been attributed to media 
attention and subsequently an increase in products labelled as antibacterial has followed 
(Larson et al. 2004).
Disinfectants have been used extensively for topical and hard surface applications in 
healthcare and non-healthcare settings (Kagan et al. 2002; McDonnell and Russell, 1999) 
and remain an important tool in reducing microbial infections (Dancer, 2009). However, there 
are concerns of toxicity from conventional disinfectants such as chlorine releasing agents 
(Rutala and Weber, 1997). Cleaning products labelled and marketed as ‘environmentally’ 
friendly, with potentially less harmful health and environmental effects, have been developed 
in recent years (Markkanen et al. 2009). This is possibly due to the movement towards 'green 
consumerism’ and the resurgence and development of supposedly less harmful natural 
animal and plant based products (Tuley de Silva, 1996). From in vitro studies, certain factors 
have been identified which cause variations in the efficacy of disinfectant products These 
factors include those relating to the disinfectant or biocidal product such as concentration, 
contact time, organic load, formulation, temperature, pH and those which relate to the
organism such as the type of the organism, the amount or numbers of organisms present 
and/or presence of biofilms Maillard (2005).
The effect of disinfectants and cleaning agents has been studied extensively against hospital 
acquired infections (Rutala and Weber, 1997) however data on the effect of these products 
against bacteria of community origin is limited. There is also a lack of information made 
available to consumers on eco friendly or ‘green’ products despite an increase in the number 
of marketed products regarded as environmentally friendly, making product comparison 
difficult (Yates, 2009).
The objective of this study was to investigate the antibacterial activity and biofilm eradication 
ability of two chlorine based disinfectants and a commercially available eco friendly cleaning 
product (EFCP) against a vancomycin resistant E. faecium strain and four S. aureus strains.
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5.1 Materials and Methods
5.1.1 Micro-organisms
Four S. aureus strains, MSSA NCTC 13297, HA-MSSA isolate, a PVL CA-MSSA and the 
PVL CA-MRSA and VRE strain E. faecium NCTC 12202 (Section 3.1.1) were used in this 
study. The media used and culture maintenance procedures are as described in Section 
3.1.2.
5.1.2 Disinfectants
Two chlorine releasing disinfectants were selected for susceptibility testing; household bleach 
with sodium hypochlorite as the active ingredient and effervescent chlorine tablets containing 
sodium dichloroisocyanurate (NaDCC) as the active ingredient. An EFCP containing alcohol, 
sodium citrate, lactic acid, limonene and other ingredients in its composition was also tested 
(the amounts of each component was not specified by the manufacturer). The 'use' dilution 
for these products was 1.2% (v/v) or 500 ppm free available chlorine (FAC) for the household 
bleach, 1000 ppm FAC for the NaDCC and 1.2% (v/v) for the EFCP The household bleach 
and the ecofriendly cleaner were purchased from a retail store while the NaDCC based 
disinfectant was purchased directly from the suppliers (Hydrachem, UK). The disinfectants 
were stored in the dark and in dry conditions and were prepared at the concentrations 
required on the day of the experiments. The disinfectant products were used within the shelf 
life as instructed by the manufacturer.
5.1.3 Determination of disinfectant activity against planktonic cells 
5.1.3.1 Neutralizer efficacy
A neutralizer assay was performed based on previous methods (Rutala et al. 2000; Johnston 
et al. 2002) as neutralizer efficacy is critical in determining disinfectant activity (Sutton, 2002). 
Briefly, 1 ml of the disinfectant at the recommended use concentration was added to 9 ml of
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neutralizer 1.1% sodium thiosulphate for the household bleach, and a universal quenching 
agent consisting of 1.0% (w/v) sodium thiosulphate, 0.07% (w/v) lecithin, 0.5% (v/v) Tween 
20 and 0.1% (w/v) peptone for the NaDCC and 0.1 ml of an overnight culture at a final 
concentration of 104 cfu/ml was added to the mix and left for 60 minutes. Aliquots (0.1 ml) 
were spread on duplicate BHI agar plates and incubated at 37 °C for 24 hours before 
enumeration. Log recovery was calculated from each test sample. The experimental Controls 
contained neutraliser but no disinfectant/cleaner solution.
5.1.3.2 Quantitative suspension test (QST)
This was performed according to EN 1276:1997 with adaptations in the contact times and 
enumeration media The experiments were performed under clean and dirty (in the presence 
of 0.3% w/v BSA) conditions at 1 minute, 5 minutes and 10 minutes. 0.1 ml of an overnight 
culture at approximately 10' cfu/ml was added to 9.9ml of disinfectant at the recommended 
use-dilution and to the control (sterile distilled water) at the contact times. After each contact 
time, 1 ml of the challenged sample was added to 9 ml of appropriate neutralizer, from which 
200 pi was spread onto BHI agar and incubated at 37°C for 24 hours before enumeration. 
For dirty conditions, the same experimental method was used however, 1 ml of 0.3% (w/v) 
BSA was mixed with 1 ml of an overnight culture at ratio 1:1 and incubated at room 
temperature for 5 minutes before mixing with 9 ml of the disinfectant solution (test sample) or 
into 9 ml of sterile distilled water (control).
5.1.3.3 Quantitative surface test
This was performed in accordance with EN 13697 - Quantitative Surface test under both 
clean and dirty conditions with adaptations in the contact times and enumeration media 0.1 
ml of an overnight culture at approximately 107 cfu/ml was inoculated onto 2 cm stainless 
steel discs (Goodfellows Cambridge Ltd, UK) and left to dry in a sterile laminar flow cabinet
for 30 minutes. Once the discs were dried, 0.1 ml of the disinfectant or sterile distilled water 
(control) was gently deposited on the surface of the discs. The discs were then transferred 
into 50ml polypropylene centrifuge tubes (Scientific Laboratory Supplies, UK) containing the 
neutralizer and 3.5 -  4g of sterile glass beads (3-7mm; Scientific Laboratory Supplies, UK) at 
the contact times; 1 minute, 5 minutes and 10 minutes and immediately vortexed for two 
minutes (Autovortex SA6; Stuart Scientific, UK). Recovery was calculated using the Miles 
and Misra (1938) method after incubation on BHI at 37°C for 24 hours. For dirty conditions, 1 
ml of 0.3% (w/v) BSA was mixed with 1ml of an overnight culture at ratio 1:1 for 5 minutes to 
attain an approximate concentration of 107 cfu/ml after which 0.1 ml of the culture was 
deposited on the discs and similar procedure to that of the clean conditions was performed
5.1.4 Determination of disinfectant activity against biofilms 
5.1.4.1 Bacterial strains
Two S. aureus strains were selected for biofilm experiments. The two S. aureus strains 
investigated for were PVL CA MSSA and MSSA NCTC 13297 as both strains had been 
demonstrated previously as efficient biofilm formers and demonstrated similar amounts of 
biofilm formation following 48 hour incubation (Figure 4.3).
5.1.4 2 Biofilm Formation
The method used was adapted from Stepanovic et al. (2007). 100 pi of overnight culture was 
diluted 1:100 in BHI broth supplemented with 1% (w/v) glucose. 200 pi of this was pipetted 
into the wells of a sterile 96-well plate and incubated at 37°C for 48 hours. Negative controls 
were wells containing BHI broth without the organism. The contents of the wells were 
decanted and discarded and each well washed three times with 300 pi of sterile PBS (pH: 7.3 
± 0 3) using a micropipette. Prior to fixation the plates were drained in an inverted position. 
The plates were then air dried for one hour, stained with 0.1% (w/v) CV diluted in sterile
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distilled water for 30 minutes at room temperature (Wijman et al. 2007), aspirated and 
washed three times with PBS (200 pi per well) before drying. The CV was then solubilised 
using 10% (v/v) glacial acetic acid and OD measured at 595nm using a Microplate reader 
(Bio-Rad 680XR, Hertfordshire, UK).
5.1.4.3 Biofilm Eradication
After formation of biofilms in microtitre wells for 48 hours, the contents of the wells were 
discarded and 200 pi of either household bleach, NaDCC or the cleaning product added into 
the wells for the following contact times; 10 minutes, 30 minutes and 1 hour, after which the 
disinfectants were neutralized with sodium thiosulphate and universal quenching agent for 
one minute, and the wells rinsed with PBS three times. CV staining for biofilm quantification 
was performed and absorbances measured at 595nm using the Microplate reader (Bio-Rad 
680XR, Hertfordshire, UK).
5.1.5 Statistical Analysis
Statistical analysis was conducted as described in Section 3.3.
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5.2 Results
Sodium thiosulphate at 1.1% (v/v) was effective at neutralizing the household bleach and the 
universal quenching agent was effective at neutralizing NaDCC and the EFCP (Figures 5.1 
and 5.2). In the suspension test household bleach reduced the viable counts of all the strains 
tested by >5 log within one minute at both 500 ppm (FAC) and 50 ppm (FAC) even in the 
presence of 0.3% (w/v) BSA (Table 5.1). Although the recommended use concentration for 
household bleach is 500 ppm (FAC), general use of this product by consumers in household 
environments is not regulated hence the rationale for testing its effect at a lower 
concentration.
NaDCC-based disinfectants are marketed under different brand names but generally used in 
industrial and healthcare environments with a recommended use concentration of 1,000 ppm. 
When tested at 1,000 ppm a >5 log reduction occurred within one minute for all strains tested 
both in the absence and presence of 0.3% (w/v) BSA (Table 5.1). Following exposure to the 
EFCP for 10 minutes, no significant reduction was determined for any of the strains in clean 
conditions (Table 5.1) and there was no significant difference between the strains after 10 
minutes F(4) =2.34, p = 0.07 determined by ANOVA. As a result, the effect of organic
contamination was not determined and the product was not tested for activity against surface 
contamination.
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Figure 5.1 Log (10) recovery (mean ±SE; n=3) of MSSA NCTC 13697 after quenching of (a) NaDCC at 
1000 ppm FAC (b) EFCP at 12% (v/v) (c) HB at 500 ppm FAC The contact time was 60 minutes. N=3
Key: HB -  household bleach; EFC -  Environmentally friendly cleaning product; Na2S20 3 -  Sodium thiosulphate; 
UQA -  universal quenching agent; PBS -  Phosphate buffered saline.
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Figure 5 2 Log (i0) recovery (mean ±SE, n=3) of E. faecium NCTC 12202 after quenching of (a) NaDCC
at 1000 ppm FAC (b) EFCP at 12%  (v/v) (c) HB at 500 ppm FAC The contact time was 60 minutes 
N=3
Key: HB -  household bleach; EFCP -  Environmentally friendly cleaning agent; Na2S203 -  Sodium thiosulphate; 
UQA -  universal quenching agent; PBS -  Phosphate buffered saline.
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In the surface tests, treatment with household bleach caused a log reduction ranging 
between 0.11-1.03, 1.06-1.80 and 1.57-2.51 at 1, 5 and 10 minutes respectively in clean 
conditions (Table 5.2). In the presence of 0.3% (w/v) BSA, the corresponding log reductions 
in viable counts were 0.30-1.03, 0 71-2.10 and 1.64-3.57. The greatest log(10) reduction in 
viable count was observed with the PVL CA MRSA isolate at 2.35 (±0.55) in clean conditions 
and in dirty conditions, the greatest log(10) reduction in viable counts at 10 minutes was 
observed with the Hosp MSSA isolate at 3.57 (±0.40). The log(10) reduction in viable counts 
following exposure to NaDCC under clean conditions were between 0.86-1.02, 1.09-2.99 and 
2.15-3.48 at 1 minute, 5 and 10 minutes respectively for all five strains tested with the 
greatest reduction observed for E. faecium NCTC 12202 at 3.48 (±0.39). In dirty conditions, 
the log(10) reductions ranged from 0.91-1.51, 1.40-2.16 and 2.29-3.07 at 1 minute, 5 and 10 
minutes respectively (Table 5.2).
The differences in log(10) reductions between clean and dirty conditions were also compared 
using f-test where assumptions of normality were met and at 5 minutes, following exposure to 
household bleach at 500 ppm, the log(10) reduction was significantly greater in dirty conditions 
than in clean conditions t (16) = 3.391, p = 0.002 for the Hosp MSSA isolate and in the E. 
faecium NCTC 12202 isolate, the log(10) reduction was significantly greater in clean conditions 
than in dirty conditions (U = 15.5, p = 0.024) while there were no significant differences 
between both conditions in the other strains p > 0.05.
When the same isolates were exposed to 1000 ppm NaDCC at the 5 minute contact time, the 
lo9ao) reduction in E. faecium NCTC 12202 was significantly lower in dirty conditions than in 
clean conditions (U = 3.00, p = 0.01) however there were no significant differences between 
both conditions in the other strains p > 0.05. At the 10 minute contact time, when the effect of 
clean and dirty conditions were compared between all the isolates tested, with the exception
8
of E. faecium NCTC 12202, there were no significant differences between the isolates. The
log(10) reduction was significantly greater in clean conditions f(14) = 26.692, p = 0.02 following 
exposure of E. faecium NCTC 12202 to household bleach and U = 15.00, p = 0.024, after 
exposure to NaDCC.
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Biofilm formation was observed in the two S. aureus strains (MSSA NCTC 13297 and 
PVL CA MSSA) but the E. faecium strain (NCTC 12202) did not form any biofilms (Figure 
4.3). Exposure to household bleach at 5,000 ppm caused a total eradication of both PVL 
CA MSSA and MSSA NCTC 13297 biofilms within 10 minutes. Relative biofilm 
eradication at 500 ppm was 62% for MSSA NCTC 13297 and 78% for PVL CA MSSA 
within 10 minutes (Figure 5.3). When the biofilms were exposed to household bleach at 
500 ppm, there was no significant difference in biofilm eradication at the 10 minutes, 30 
minutes and one hour as determined by ANOVA, F(2) = 0.450, p = 0.643 for MSSA 
NCTC 13297 where assumptions of normality were met and by the Kruskall-Wallis test 
where assumptions of normality were not met, H(2) = 2.668, p = 0.263 for PVL CA 
MSSA. At 50 ppm, household bleach caused a 33 - 53% reduction in relative biofilm 
formation for MSSA NCTC 13297 at the three contact times while for PVL CA MSSA 
biofilms, relative biofilm formation was reduced by 38% at 10 minutes, 40% at 30 minutes 
and 63% at one hour (Figure 5.3).
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Figure 5.3. Relative biofilm eradication (mean ±SE; n=3) of (a) MSSA NCTC 13297 and (b) PVL 
(+) CA MSSA biofilms after 48 hour incubation and exposure to household bleach for 10 minutes,
30 minutes and 1 hour. (CD 500 ppm, □  50 ppm and I  0 ppm)
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Exposure of established biofilms to NaDCC at 10,000 ppm and 1,000 ppm resulted in a 
reduction in relative biofilm formation at one hour only for MSSA NCTC 13297. There was 
an increase in the OD when the MSSA NCTC 13297 biofilm was exposed to 10,000 ppm 
and 1,000 ppm of NaDCC at 10 minutes. There was no reduction in the MSSA NCTC 
13297 biofilm at the 30 minute contact time however both concentrations caused a 
significant reduction in the amount of biofilm formed (U = 12.00, p = 0.011) for 10,000 
ppm and f(16) = 3.550, p = 0.027 for 1,000 ppm at one hour.
Following exposure of the PVL CA MSSA biofilm to NaDCC at 10,000 ppm and 1,000 
ppm within 30 minutes there was a approximately a 27% reduction in biofilm formation 
however at one hour, the amount of biofilm eradicated was approximately 54% for 10,000 
ppm and 44% for 1,000 ppm (Figure 5.4). The reduction in biofilm formation was 
significant when the PVL CA MSSA biofilm was exposed to both concentrations of 
NaDCC at the one hour contact time confirmed by independent f-test analysis; f(16) = 
6.651, p < 0.001 for NaDCC at 10,000 ppm and t{ 15) =8.881, p = 0.002 for NaDCC at 
1,000 ppm.
86
2.0
o
o
10 min 30 min 1hr
(a)
2.0
10 min 30 min
(b)
Figure 5.4. Relative biofilm eradication (mean ±SE; n=3) of (a) MSSA NCTC 13297 and (b) PVL 
(+) CA MSSA biofilms after 48 hour incubation and exposure to NaDCC for 10 minutes, 30 minutes
and 1 hour. (EH 10,000 ppm, EH 1000 ppm and I  0 ppm)
87
Exposure of the biofilms to the EFCP at 100% and 1.2% (v/v) did not cause any 
significant reduction in relative biofilm formation at 10 minutes, 30 minutes or one hour. At 
10 minutes there was an increase in relative biofilm formation of 12% and 21% for PVL 
CA MSSA and MSSA NCTC 13297 respectively (Figure 5.5).
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Figure 5.5. Relative biofilm eradication (mean ±SE; n=3) of (a) MSSA NCTC 13297 and (b) PVL 
CA MSSA biofilms after 48 hour incubation and exposure to the EFCP for 10 minutes, 30 minutes
and 1 hour. (CD 10 min, CD 30 min and I  1 hr)
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5.3 Discussion
The antibacterial and sporicidal effect of sodium hypochlorite in household bleach and 
NaDCC has previously been demonstrated (Block, 2004; Heling et al. 2001; Rutala et al. 
2000), however the continued emergence of community acquired infections and newly 
emerging bacterial strains emphasizes the need to investigate the effect of conventional 
disinfectant products and eco-friendly products against these pathogens.
The effectiveness of sodium hypochlorite has previously been demonstrated against E. 
faecalis (Gomes et al. 2001), and against S. aureus (Bloomfield and Uso, 1985), which 
corresponds with the results presented here. It has been suggested that, in the presence 
of organic matter, compounds such as sodium hypochlorite is less effective (Pappen et 
al. 2010). However in this study, both household bleach and the NaDCC-based 
disinfectant caused >5 log reduction within 1 minute in both ‘clean’ and ‘dirty’ conditions 
in suspension Marques et al. (2007) did observe a reduction in the cfu/ml of biofilms of S. 
aureus after treating with NaDCC however the authors concluded that this disinfectant at 
the concentrations tested (100mg/L) was not effective at removing surface adhered cells 
from glass and stainless steel surfaces. In this study, no reduction in biofilm formation 
was observed following treatment with NaDCC using the CV method and this could 
perhaps be as a result of the differences between the strains used in this study or the 
nature of the surfaces in which the biofilms were formed.
The effect of disinfectants in suspension does not necessarily reflect their ability to 
eliminate microorganisms dried on surfaces (Rutala et al. 2000). Surface disinfection is 
an important hygiene control measure which can control dissemination of pathogens 
(Exner et al. 2004). For a disinfectant to be regarded as effective on surfaces, a 4 log 
reduction of a test organism must be achieved under defined conditions (Holah, 1996; 
Moretro et al. 2009). Both chlorine based disinfectants tested in this study in clean and 
dirty conditions caused less than 4 log reduction against all five organisms on stainless
steel surfaces with the greatest log reduction (3.48) in viable counts observed with the E. 
faecium strain at 10 minutes following NaDCC exposure.
Comparisons have been made in previous studies between sodium hypochlorite and 
associated products and NaDCC, with the latter being recommended as an alternative to 
sodium hypochlorite for disinfection (Clasen and Edmondson, 2006; Mazzola et al. 2003). 
This is because of its slower decomposition, and factors such as release of hypochlorous 
acid, stable chlorine levels, low toxicity and low corrosivity (Mazzola et al. 2003). In this 
study, both household bleach and the NaDCC-based disinfectant showed similar activity 
in suspension but on surface-attached bacteria, the NaDCC-based disinfectant was more 
effective. However this effect was reversed when the disinfectants were compared for 
anti-biofilm activity, with household bleach at the different concentrations (including the 
use dilution) removing biofilms while the NaDCC-based product was less effective. There 
have been a few previous reports on the anti-biofilm effect of NaDCC (Morgenthau et al. 
2012; Marques et al. 2007).
The antibiofilm activity of the disinfectants was not investigated against the VRE isolate in 
this study as this isolate was negative for biofilm formation (Figure 4.3). In a previous 
study by Tote et a/.(2010), exposure of S. aureus biofilms to sodium hypochlorite for 60 
minutes demonstrated an increase in antibiofilm activity (0 to 55%). In this study, higher 
concentrations of household bleach resulted in greater antibiofilm activity; 5,000 ppm 
completely eradicating established biofilms while at the use dilution (500 ppm), only 63% 
of the biofilm was eradicated The use of sodium hypochlorite at a 2% (v/v) concentration 
has been recommended for biofilm removal (Lee et al. 2009).
Marketing of eco-friendly products is on the basis that they contain natural materials and 
are designed as potential replacements or drop-in substitutes for disinfectants (Light, 
2009) and have been used in the hospital environment (Markkanen et al. 2009) although
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they are also likely to be used in community settings. The product tested in this study 
showed no anti-biofilm activity against the community isolates. Biofilms of the community 
S. aureus strain were more susceptible to both bleach and NaDCC than MSSA NCTC 
13297 suggesting that household bleach would be most effective at reducing bacterial 
load in a non healthcare setting. There is therefore a need to provide information for 
consumers to enable proper selection of antibacterial products and their appropriate use 
in order to protect the population from infectious diseases (Bloomfield, 2007; Larson et al. 
2004).
The results in this study demonstrate that disinfectants are effective in reducing bacterial 
contamination in different conditions and diverse S. aureus strains. The lack of 
antimicrobial activity in the eco-friendly cleaning product highlights the need for further 
research on the antimicrobial potential of these products occasionally marketed as 
‘alternatives’ to conventional disinfectants and cleaning products.
CHAPTER SIX
Antimicrobial activity and antibiofilm activity of essential oils against 
S. aureus strains.
6.0 Introduction
Interest in natural antimicrobials has grown in recent years and the most important and 
well researched of these are plant products which have many medicinal and antimicrobial 
properties (Bourne et al. 1999; Cowan, 1999). EOs extracted from plants have been 
shown to possess antimicrobial activity in in vitro assays against a range of bacteria 
including known antibiotic resistant strains (Fisher and Phillips 2006; Warnke et al. 2009). 
EOs have been used as topical antimicrobials (Barker and Altman 2010; Dai et al. 2010), 
as dental and oral treatments (Palombo 2011; Jeon et al. 2011), and for burns and wound 
healing (Edwards-Jones et al. 2004; Thakur et al. 2011). Recently the use of EOs in 
vapour phase has also been shown to be antibacterial and antifungal, as reviewed by 
Laird and Phillips (2012).
In recent years, reports of studies on the anti-biofilm activity of EOs have been 
increasing For example, cinnamon EO against Candida sp. (Pires et al. 2011) a citrus 
EO in vapour phase against E. faecium (Laird et al. 2012) and lemongrass EO against 
biofilm formation in L. monocytogenes (De Oliveira et al. 2010). The resistance of biofilm- 
associated organisms is estimated at 50 to 500 times more than planktonic cells (Jabra- 
Rizk et al. 2006). The effect of different EOs on biofilms has been investigated with the 
effects identified ranging from inhibition, reduction, attenuation and eradication of biofilms 
in both Gram positive bacteria, Gram negative bacteria and fungi (Kavanaugh and 
Ribbeck, 2012; Jia et al. 2011; Nuryastuti et al. 2009; Argawal et al. 2008; Nostro et al. 
2007). In other in vitro studies, there was increased activity in biofilms exposed to EOs 
when compared to the effect of the essential oils against cells in suspension (Kavanaugh 
and Ribbeck, 2012, Karpanen et al 2008; Al-Shuneigat et al. 2005).
The objective of this study was to determine the anti-staphyloccocal activity of a range of 
EOs against six strains which included those of community acquired origin using in vitro 
screening assays and to further investigate the anti-biofilm effect of the EOs found to be 
the most effective after initial screening
Materials and Methods
6.1.1 Essential Oils and Components
The EOs used in this study were lemongrass (Cymbopogon flexuosus), grapefruit (Citrus 
paradisi), lime (Citrus aurantifolia), bergamot (Citrus bergamia) and lemon (Citrus limon) 
obtained from Belmay Pic., Northampton, UK. Two known EO components limonene 
(Sigma-Aldrich, Dorset. UK) and citral (95%, natural; SAFC Supply Solutions, St Louis, 
USA) were also investigated.
6.1.2 Microorganisms
The Six S. aureus strains listed in section 3.1.1 were investigated for susceptibility to the 
essential oils. The media used and culture maintenance procedures are as described in 
Section 3.1.2.
6.1.3 Disc Diffusion
The screening method was adapted from Prabuseenivasan et al. (2006) and the British 
Society for Antimicrobial Chemotherapy (BSAC) guidelines Version 10 (Andrews and 
Howe 2011). Briefly, 100 pi of each of the EOs was deposited onto sterile 2cm diameter 
filter paper discs placed on the surface of BHI plates previously spread with 107 cfu/ml. 
The plates were left to dry for 15 minutes in a sterile environment, inverted and incubated 
at 37°C for 24 hours. The diameters of zones of inhibition (ZOI) were measured using 
Vernier callipers. The controls were bacterial cultures without EO exposure.
6.1.4 Minimum Inhibitory and Minimum Bactericidal Concentrations
The method used was adapted from Hammer et al. (1998). An aliquot (20 pi) of a 108
cfu/ml overnight culture was added to wells of a sterile 96-well microtitre plate. Each EO 
was diluted in BHI broth containing 0 5% (v/v) Tween 20 and added to wells to give final 
EO concentrations of 0.03%, 0 06%, 0.12%, 0.5%, 1%, 2% and 4% (v/v). The positive
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control wells contained BHI broth and cells without EOs while the negative control wells 
contained BHI only. Optical density was measured at 595nm using a microplate reader 
(Bio-Rad 680XR, Hertfordshire, UK) and again after incubation for 24 hours at 37°C. The 
MIC was determined as the lowest EO concentration at which the OD at 24 hours of the 
inoculum remained the same or reduced compared with the initial reading.
For MBC determination, 10 pi was taken from each well after incubation and spot 
inoculated (Hammer et al. 1998) onto BHI agar and incubated for 24 hours at 37°C. The 
concentration at which no growth was observed on subculture was determined as the 
MBC.
6.1.5 Minimum Biofilm Inhibitory Concentration (MBIC)
Inhibition of biofilm formation was assessed using a method adapted from Nostro et al. 
(2007). An aliquot (100 pi) from an overnight culture diluted in BHI broth supplemented 
with 1% (w/v) glucose to 108 cfu/ml was dispensed into each test well of a 96 well plate. 
100pl of the EOs at concentrations 0.06% to 4% (v/v) for lemongrass EO and 1% to 4% 
(v/v) for grapefruit EO were added into the wells. The negative control was BHI broth only 
while the positive control contained cell cultures alone with no added EO. Following 24 
hours incubation at 37 °C, the contents of the wells were decanted and each well gently 
rinsed twice with 300 pi of sterile phosphate buffered saline (PBS) (pH: 7.3 ± 0.3). The 
plates were air dried for 30 minutes, stained with 0.1% (w/v) crystal violet for 30 minutes 
at room temperature (Wijman et al. 2007), washed three times with PBS (200 pi per well) 
and dried. The crystal violet was then solubilized using 10% (v/v) glacial acetic acid and 
the OD measured at 595nm using a Microplate reader (Bio-Rad 680XR, Hertfordshire, 
UK). The MBIC was determined as the EO concentration at which the OD < negative 
control (Pettit et al. 2005; Sandoe et al. 2006). Each experiment was performed in 
quadruplicate and performed on four separate occasions.
6.1.6 Minimum Biofilm Eradication Concentration (MBEC)
The method used was similar to that described by Kwiecinski et al. (2009). After biofilm 
formation for 48 hours, the medium was discarded and the wells gently rinsed twice with 
PBS. 200 pi of the EOs (lemongrass or grapefruit) were serially diluted and added into 
the wells ranging from 0.06% to 4% (v/v) for lemongrass EO and 1% to 4% (v/v) for 
grapefruit EO. The plates were then incubated for 24 hours at 37°C after which the wells 
were washed with PBS and stained using the CV staining method as described 
previously. The positive control was biofilm without EO. The concentration at which 
already established biofilms were removed from the bottom of the treated wells was 
determined as the minimum biofilm eradication concentration or MBEC (Muli and 
Struthers 1998: Ceri et al. 1999). Each experiment was performed in quadruplicate and 
performed on four separate occasions.
6.1.7 Biofilm metabolism assay - XTT reduction
This method is based on reduction of tetrazolium salt XTT [2, 3-bis (2-methyloxy-4-nitro- 
5-sulphophenyl)-2H-tetrazolium-5-carboxanilalide] and was performed to determine the 
metabolic activity of the biofilm formed using methods described by Cerca et al. (2005) 
and Laird et al. (2012). Stock solutions of XTT in PBS (cfu/ml) and menadione (1 mM) 
were prepared. At the start of each experiment, a fresh solution of XTT/menadione was 
prepared at a ratio of (12.5/1 v/v). Biofilms were formed for 48 hours in the wells of 96 
well plates and 200 pi of the XTT/menadione mix was added into each test and control 
well, incubated in the dark at 37 °C for 24 hours and the OD measured at 450nm.
6.1.8 Biofilm viability assay (cfu/ml)
Biofilm viability was measured using a method adapted from Pettit et al. (2005). Following 
24 hours exposure of biofilms to lemongrass or grapefruit EO, a sterile scraper was used 
to dislodge each biofilm into the micro-titre wells, 100 pi of the well contents removed and 
spread onto BHI agar Plates were incubated for 24 hours at 37 °C before enumeration
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6.1.9 Gas Chromatography Mass Spectrometry (GC-MS)
GC/MS analysis of the EOs was performed at Belmay Pic. This analysis was using the
Perkin-Elmer (Turbo Mass™) instrument with column 1 stationary phase Rtx 1 column
(60m x 0.25 mm I D.; film thickness: 0.25 pm; Restek). The oven temperature program
was: initial temperature of 50 °C; increasing by 3 °C/min to 265 °C; and held for 13
minutes. Helium was used as the carrier gas with a 1 pi injector volume, an injector
temperature of 285 °C and a split ratio 30:1. The MS was performed with an EI+ source
and operated in scan mode, from 35 to 350 m/z at a detector temperature of 300 °C. The
compounds were identified by comparing retention times and mass spectra with those of
standards or their retention indices (Rl) with published data and their mass spectra with
the National Institute of Standards and Technology (NIST) library.
6. 1.10 Scanning Electron Microscopy (SEM)
PVL CA MSSA was selected for SEM observations due to its higher biofilm OD values
compared with the other strains (Figure 4.2). 2 cm diameter sterile stainless steel discs
(Goodfellows Cambridge Ltd, UK) were immersed in 6 well plates (NunclonTM surface,
Denmark) containing 5 ml of BHI broth supplemented with 1% (w/v) glucose for 48 hours.
100 pi of a 108 cfu/ml overnight culture was then added and the plates incubated for 48
hours in a shaking incubator. After incubation the discs were removed and gently rinsed
with sterile PBS to remove loosely attached cells and re-suspended in 0.125%, 0.5% and
1% (v/v) lemongrass or 4% (v/v) grapefruit EO. After exposure to the EOs, the discs were
washed three times with PBS and fixed with 2.5% (v/v) glutaraldehyde in PBS solution for
2 hours at 4 °C, washed twice with PBS and dehydrated for 10 minutes using a graded
ethanol series; 30, 50, 70, 90, 100% (v/v). The samples were then dried prior to coating
with gold and observed using a Hitachi S-3000 Scanning Electron Microscope (Hitachi
High-Technologies Europe, Maidenhead, UK)
Statistical Analysis
Statistical analysis was conducted as described in Section 3.3
6.2 Results
Screening - No ZOIs were observed with either lemon EO or limonene while lemongrass 
EO and citral, the major component in lemongrass EO both demonstrated total zone 
inhibition with ZOI of >8.60 cm (Table 6.1). Grapefruit, lime and bergamot EOs produced 
ZOIs ranging from 2.85 cm to 4.63 cm (Table 6.1). Consequentially lemongrass and 
grapefruit EOs were selected for determination of MICs and MBCs and for anti-biofilm 
activity as these were the most effective at >8.60 cm and 3.48 cm respectively (Table 
6.2). Although ZOI produced by the latter was only marginally more effective than lime 
EO (ZOI =3.47 cm) it was selected for further studies since it has been shown to have 
anti-bacterial activity and potential in other antimicrobial applications (Williams et al. 
2007; Uysal et al. 2011).
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The MIC for lemongrass EO at 0 06% (v/v) was lower than that of geranium 0.13% (v/v) 
and grapefruit EO [range 0.5-2% (v/v)] for all strains tested. The MBC was also lower 
than that of lemongrass EO and the other EOs. The MBC for lemongrass EO was at the 
same concentration for all the strains tested (0.125% v/v) while geranium EO had MICs at 
0.13% for all the strains and MBCs ranging between 0.25% (v/v) for the MSSA NCTC 
13297 and 4% (v/v) for the two PVL positive strains. Of the EOs and components tested 
the MIC was highest with grapefruit EO ranging between 0.5% (v/v) for MSSA NCTC 
13297 and 2% (v/v) for the CA MRSA (SR) while the MBC was 2% (v/v) for the hospital 
MSSA isolate and MSSA NCTC 13297 and 4% (v/v) for the three community strains; PVL 
CA MSSA, CA-MRSA (MW2) and PVL CA MRSA (Table 6.2). The MBC for the CA 
MRSA (SR) strain was >4% (v/v).
Lemongrass EO prevented biofilm formation at 0.06% (v/v) for the hospital MSSA strain 
and 0.125 % (v/v) for the other strains tested (Table 6.3) which, for four of the five strains 
was the same concentration as the MBC. However lemongrass EO did not remove 
already formed biofilms (MBEC) at any of the concentrations tested i.e. 0.06% to 4% 
(v/v). Grapefruit EO did not either prevent biofilm formation or remove already formed 
biofilms at 1% to 4% (v/v).
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Table 6.2. Minimum inhibitory concentration and minimum bactericidal concentration, (% v/v) for 
lemongrass EO, citral, grapefruit EO and geranium EO against S. aureus strains (N=4).
Bacterial strains Lemongrass Citral Grapefruit Geranium
M IC M B C M IC M B C M IC M B C M IC M B C
MSSA 110 0.06% 0.13% 0.02% 0.06% 1% 2% 0.13% 2%
PVL CA-MSSA 0 06% 0.13% 0.03% 0.06% 1% 4% 0.13% 4%
MSSA NCTC 
13297 0.06% 0.13%
0.03% 0.06% 0.5% 2% 0.13% 0.25%
MRS A MW2 0.06% 0.13% 0.03% 0.06% 1% 4% 0.13% 1%
PVL CA-MRSA 0.06% 0.13% 0.03% 0.06% 1% 4% 0.13% 4%
CA MRSA (SR) 0 06% 0.13% 0.03% 0.06% 2% >4% 0.13% 2%
Table 6.3. Minimum biofilm inhibitory concentration and minimum biofilm eradication concentration 
(% v/v) for lemongrass EO, citral, grapefruit EO and geranium EO against S. aureus strains (N=4)
m
Bacterial strains Lemongrass EO Grapefruit EO
M B IC M B E C M B IC M B E C
H o s p ita l MSSA 0.06% >4% >4% >4%
PVL CA-MSSA 0.13% >4% >4% >4%
MRSA NCTC 13297 0.13% >4% >4% >4%
CA MRSA (MW2) 0.13% >4% >4% >4%
PVL CA-MRSA 0.13% >4% >4% >4%
CA -MRSA (SR) 0.13% >4% >4% >4%
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Inhibition of metabolic activity occurred in the presence of lemongrass EO after 24 hours 
for all six S. aureus strains at 0.125% and 0.06% (v/v) with no significant difference in the 
reduction brought about by these two concentrations (Figure 6.1a). At 0.25% (v/v), no 
metabolic activity was observed (results not shown). Grapefruit EO did not reduce the 
metabolic activity as measured by the XTT assay after 24 hours incubation. When the 
effect of grapefruit EO was compared for four strains (not including PVL CA MSSA) there 
was no significant difference in metabolic activity between the strains as determined by 
the ANOVA for 1% F (4) = 1.753, p = 0.152, 2% F(4) = 2.248, p = 0.076 EO however at 
4% there was a significant difference F(4) = 2.793, p = 0.035 with post hoc analysis 
showing metabolic activity in PVL CA MRSA biofilm as significantly different from Hosp 
MSSA p = 0.001 following treatment with 4% grapefruit EO.
There was a significant difference between the metabolic activity of PVL CA MSSA and 
the other strains at all the concentrations of grapefruit EO tested at 4%, F (5) = 2.574, p = 
0.035; at 2%, F (5) = 3.010, p = 0.017; at 1%, F (5) = 3.013, p = 0.016 with PVL CA 
MSSA having a metabolic activity approximately 2.7 times that of the control compared to 
the other four strains (Figure 6.1 b).
Figure 6.1. Changes in metabolic activity following 24 hours exposure of biofilms of S. aureus
strains to a) lemongrass EO (CH 0.125%, CH 0.06% and I  0%) and b) grapefruit EO (CH 4%, CH
2%, ^  1% and I  0%) as determined by the XTT assay (control = biofilms not exposed to EO; 
N=4 for each treatment and for each strain).
Following lemongrass EO treatment for 24 hours, biofilms from all six S. aureus isolates 
showed total loss of viability at concentrations between 0.125% to 4% (v/v) (results not 
shown) however at 0.06% (v/v) some viable cells were recovered (Figure 6.2a) there was 
approximately a 35-43% reduction in biofilm viability between the strains relative to the 
untreated controls. A 0.06%, there were no significant differences between the relative 
biofilm viability for the six isolates F (5) = 0.637, p = 0.673.
Following exposure of the biofilms to grapefruit EO, there was no reduction in viability at 
any of the concentrations tested (Figure 6.2b). The only visible reduction in biofilm 
viability was the Hospital MSSA isolate at 4% however this was not statistically significant 
H (5) = 6.977, p = 0.222 determined by the Kruskall-Wallis test as assumptions of 
normality were not met.
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Figure 6.2. Effects of a) lemongrass EO (El 0.06% and I  0%) and b) grapefruit EO (El 4%, EH
2%, S  1% and I  0%) on the relative biofilm viability of S. aureus strains following 24 hour 
exposure as determined by the cfu ml'1 assay (control = biofilms not exposed to EO; N=4 for each 
treatment and for each strain).
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Following biofilm quantification by the CV staining method the PVL CA MSSA strain 
consistently showed increased biofilm formation compared to the other strains tested, 
and therefore was chosen for SEM. After 24 hours exposure to lemongrass EO, the 
control (Figure 6.3a) showed intact biofilm structure, and at 0.125% (v/v) (Figure 6.3b) it 
was observed that the integrity of the biofilm structure was disrupted. At 0.5% (v/v) 
lemongrass EO, there was evident damage on the biofilm structure (Figure 6.3c) and at 
1% (v/v) of lemongrass EO treatment, no biofilms were observed on the discs although 
biofilm debris remained (Figure 6.3d).
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When PVL CA MSSA was treated with 4% (v/v) grapefruit EO, no effect on biofilm 
formation and integrity was observed (Figure 6.4b) in comparison to the control (Figure 
6.4a).
Figure 6.4. Scanning electron micrographs of a PVL CA MSSA biofilm following treatment with 
grapefruit EO at a) 0% (control) b) 4% (v/v) after 24 hour exposure (Magnification x5000, Scale 
10pm). Arrows indicate biofilm formation although b suggests lack of penetration of the grapefruit 
EO into the biofilm.
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6.3 Discussion
Lemongrass EO at concentrations of between 0.03% and 0.06% (v/v) was effective at 
inhibiting the growth of all six S. aureus strains and at 0.125% (v/v) the effect of 
lemongrass EO was bactericidal. The results presented here are consistent with those of 
a previous study (Barbosa et al. 2009) in which it was demonstrated that lemongrass EO 
inhibited the growth of Gram positive bacteria, including S. aureus at a concentration of 
0.05% (v/v). In this present study the MIC for grapefruit EO was higher than that for 
lemongrass EO for all the strains i.e. between 0.5% and 2% (v/v), while bactericidal 
activity was observed between 2% and 4% (v/v) EO. To date, there are very few studies 
that have investigated the antimicrobial activity of grapefruit EO however it has been 
shown to possess both antifungal and anti-bacterial activity (Viuda-Martos et al. 2008;
Uysal et al. 2011).
When the effects of the components were compared to the overall effect of the EO, 
contrasting results were observed Firstly, citral, the major component in lemongrass EO, 
showed total zone inhibition at screening with MICs ranging from 0.02 - 0.03% (v/v), and 
approximately one fold lower than that of lemongrass EO. Therefore citral may be 
considered as being responsible for the majority of the antibacterial activity observed in 
lemongrass EO This activity by citral has been previously reported (Hayes and Markovic 
2002; Da Silva et al. 2008; Aiemsaard et al. 2011). Limonene is the major component in 
the grapefruit EO used, at approximately 94% (v/v), (Appendix IV: GC-MS results), but it 
did not show any antimicrobial effect as demonstrated by the screening results (Table 
6.1) which has also been observed in previous studies by Fisher and Phillips (2006) and 
Inouye et al. (2001). In comparison to this inactivity by limonene, grapefruit EO produces 
inhibition zones for the S. aureus strains of between 2.85 and 3.96 cm which suggests 
that other components of the grapefruit EO are involved in the antibacterial activity 
observed. Previous reported that myrcene show no antibacterial activity per se but its 
presence enhanced activity of other EO components suggesting that the presence of
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other components in small amounts enhances the EO antimicrobial activity (Onawunmi 
et al. 1984). Although the individual components of EOs are important, they act in a 
synergistic manner so that the EO exhibits a greater antibacterial activity than the sum of 
that brought about by its components (Gill et al. 2002).
The results of this study demonstrate that lemongrass EO possesses anti-biofilm activity 
at low concentrations of between 0.06% and 0.125% (v/v) which has been reported 
previously (Aiemsaard et al. 2011). Since biofilm formation is a survival mechanism but 
also contributes to virulence and persistence (Vuong et al. 2004; Soto et al 2006) it has 
been suggested that preventing biofilm attachment is a way of dealing with the problem of 
biofilms in the food industry (Sinde and Carballo 2000). Therefore considering the results 
presented here there may be a possible potential for lemongrass EO use in food 
processing environments. The effect on the organoleptic properties of the foodstuff at the 
anti-biofilm concentrations would need to be determined, although lemongrass per se is 
GRAS (Generally Recognised as Safe) and is used a food ingredient world-wide
(USFDA, 2012).
This is the first time the anti-biofilm activity of grapefruit EO has been reported. The 
results described here demonstrate that, although grapefruit EO is bactericidal at 2% to 
4% (v/v) against the different S. aureus strains tested, it has limited or no activity against 
biofilm formation (Table 6.3). This suggests that biofilm formation could offer protection 
against EOs or at least against grapefruit EO. In a previous study, it was reported that 
some biofilms could be more susceptible to EOs than their planktonic counterparts 
(Kavanaugh and Ribbeck, 2012). The authors suggested that this action could be as a 
result of differential gene expression within the biofilm or an increase in local 
concentration of the essential oils in the extracellular matrix of the biofilm. Previous 
studies have shown however that when grapefruit EO was combined with other EOs 
against MRSA (not in biofilms), there was synergistic activity and improved antimicrobial
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potential (Edwards-Jones et al. 2004) hence, combining grapefruit EO with other EOs or 
antimicrobial compounds might also enhance its activity against biofilms. The synergistic 
action of EOs against surface adhered cells has previously been demonstrated by the 
results of a study by De Oliveira et al. (2010) who reported a 100% log reduction of a 
mature L. monocytogenes biofilm after 60 minute contact time with a combination of 
Cymbopogon citratus (DC) Staph and Cymbopogon nardus (L) EOs.
Both lemongrass and grapefruit EOs were unable to eradicate already established 
biofilms (Table 6.3). The inability of antimicrobial compounds to remove biofilm deposits 
has been observed previously (Lin et al. 2011). As biofilms develop, they undergo 
irreversible attachment leading up to maturation (Mittelman, 1998) and at this point, 
removal of biofilms is said to be difficult and would require mechanical force or chemical 
disruption (De Oliveira etal. 2010). In addition to this, Pitts et al. (2003) after investigating 
reductions in Ps. aeruginosa and S. epidermidis biofilms using chemical agents such as 
hydrogen peroxide and 1M NaCI, suggest that such reductions are microorganism and 
antimicrobial agent specific highlighting the difficulty with regard to biofilm removal. For 
example, 1M NaCI significantly reduces P. aeruginosa biofilms but not those of S. 
epidermidis while hydrogen peroxide has the reverse effect (Pitts et al. 2003). To control 
biofilms, and to avoid the associated problems with biofilm formation such as antibiotic 
resistance, persistence and treatment difficulties, preventing the formation of biofilms is 
an important measure (Kelly et al. 2012).
The difference in anti-biofilm activity of various interventions i.e. the ability of treatments 
to prevent formation and eradicate pre-formed biofilms or reduce metabolic activity has 
been previously reported. For example, Babu et al. (2012), using a high molecular weight 
component extracted from cranberry reported they were unable to detach Streptococcus 
gordonii from the preformed biofilm mass however they inhibited biofilm metabolic 
activity. On treatment with a citrus EO in vapour form MSSA and MRSA biofilms were
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reduced both during and after formation, while Enterococcus sp. biofilms were 
significantly reduced (p < 0.05) only after formation (Kelly et al. 2012; Laird et al. 2012) 
Complete suppression of metabolic activity indicates effective killing (Flemming et al. 
2009) although even cells that have lost metabolic activity are able to contribute to the 
total biofilm biomass (Pitts et al. 2003). In this study the lemongrass EO treated biofilms 
showed loss of metabolic activity as well as total loss of viability at low concentrations of 
EO of between 0.125% and 0.25% (v/v) dependent on strain.
Biofilms tolerate higher amounts of antibiotic between 10 to 1000 fold when compared to 
planktonic cells (Yarwood et al. 2004; Resch et al. 2006; Kelly et al. 2012). However in 
this study, lemongrass at twice the MIC and same concentration as the MBC prevented 
biofilm formation highlighting antimicrobial activity as well as its potential as an anti-
biofilm agent. Exposure of the biofilms to grapefruit EO showed no reduction in metabolic 
activity in five of the six S. aureus strains and an increased metabolic activity in the PVL 
positive MSSA strain (Figure 6.1b). The reason for such increase in metabolic activity is 
unclear. However, a study by Kwiecinski et al. (2009) using the MTT 3-(4,5- 
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) colorimetric assay reported an 
increase in metabolism in S. aureus biofilms when treated with tea tree oil (TTO) at 
concentrations lower than the MBEC which, it was suggested, could be a result of a 
stress response. Whether this is the case for the increase in metabolic activity in PVL 
positive MSSA strain when treated with grapefruit EO is unclear and will be investigated 
further.
Lemongrass EO at 0.125% (v/v), the MBC and MBIC concentrations, disrupted the 
biofilms of PVL CA MSSA (Figure 6.3b) and at 0.5% (v/v) of lemongrass EO, damage to 
the biofilm was increased further (Figure 6.3c) while at 1% (v/v) of the EO treatment, total 
destruction of the biofilm was observed (Figure 6.3d). Kwiecinski et al. (2009) has 
suggested that TTO treatment of S aureus biofilms causes damage to the extracellular
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matrix and in this present study, damage to the biofilm structure was observed on 
treatment with 1% (v/v) lemongrass EO suggesting a similar mode of action. With the 
grapefruit EO, SEM images did not show any disruption of the biofilm structure (Figure 
6.4b) which further confirms the lack of anti-biofilm activity and indicates the importance 
of biofilm formation as a protective mechanism against EOs.
This study is one of few that have investigated the anti-biofilm properties of EOs 
especially the effect of lemongrass EOs against S. aureus biofilms. Where previously 
(Bearden et al. 2008), investigated commercial formulations containing EOs against 
community acquired MRSA, this is first study that has demonstrated the anti-biofilm 
activity of lemongrass EO against biofilms of community acquired MSSA and MRSA 
including PVL positive strains. The results of this study also demonstrate that EOs 
exhibit antimicrobial potential and could offer a promising development in the search for 
new and novel antimicrobial agents.
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CHAPTER SEVEN
Investigating the effect of grapefruit EO on metabolic activity in two S. 
aureus strains by RT-PCR.
7.0 Introduction
In chapter 6, it was demonstrated that exposure of the PVL CA MSSA biofilms to grapefruit 
EO yielded different responses as measured by the XTT reduction assay compared with five 
other S. aureus strains. PVL CA MSSA showed more than twice the metabolic activity in the 
biofilms treated with 1-4% (v/v) grapefruit EO than in the untreated biofilms while there was 
little or no difference in metabolic activity in the other strains tested (Figure 6.1b).
According to Secor et al. (2011), there are links between metabolic processes in S. aureus 
and its pathogenicity and these metabolic states are different in planktonic cells compared 
with biofilms. Following extensive studies on biofilm characteristics in S. aureus and the 
advancement of molecular identification analytical tools, numerous factors have been 
identified which are involved in the process of biofilm formation. Some of the factors identified 
include genetic mechanisms such as the genes of the ica operon known to be involved in 
intercellular adhesion, regulatory genes such as accessory gene regulator agr and 
staphylococcal accessory regulator sarA and the QS system. In S. aureus, previous studies 
have also suggested the role of a gene luxS in bacterial metabolism and as a QS regulator
(Lebeer et al. 2007).
In this study, five genes were investigated for the change in metabolic activity observed in the 
PVL CA MSSA biofilm (Figure 6.1b). The genes investigated were icaA, icaD, cap8C, luxS 
and sodA These genes have been implicated in previous studies in biofilm formation and
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involvement in metabolic processes in (Doherty et al. 2007; Fuchs et al. 2007; Resch et al. 
2005; Beenken et al. 2004).
The objective of this study was to investigate the differences in expression for five target 
genes in CA MRSA MW2 and PVL CA MSSA biofilms following exposure to grapefruit EO.
1 1 6
7.1 Materials and Methods
7.1.1 Bacterial strains and culture conditions
CA MRSA MW2 and PVL CA MSSA were used in this study. Maintenance of cultures was 
performed as previously described in Section 3.1.2.
7.1.1.1 Exponential phase cultures
Sterile polypropylene tubes containing 10 ml BHI broth were inoculated with single colonies 
of each microorganism and incubated at 37°C in a shaking incubator, SI500 (Fisher 
Scientific, Loughborough, UK) for six hours.
7.1.1.2 Biofilm formation
Overnight cultures at approximately 1 x 108 cfu/ml were dispensed into wells of a 24 well 
plate and incubated under shaking conditions for 48 hours in BHI broth supplemented with 
1% (w/v) glucose. Following incubation, planktonic cells were gently discarded and the 
grapefruit EO was added at 2% (v/v) and incubated for another 24 hours under shaking 
conditions at 37°C. After incubation, the contents of the wells were discarded, the bottom of 
the wells scrapped and the biofilms collected.
7.1.2 Isolation and quantification of RNA 
7.1.2.1 Nucleic acid stabilization
This was performed using the RNA Protect Bacteria Mini Prep kit (Qiagen, Manchester, UK). 
Briefly, 0.5 ml bacterial culture (exponential phase or biofilms) was added to 1 ml of 
RNAprotect Bacteria Reagent, vortexed for 5 seconds and centrifuged at 5,000g for 10 
minutes The supernatant was discarded and the pellet collected and stored at -20°C until
needed
7.1.2.2 Initial lysis step
Before RNA extraction, the pellet was removed from storage at -20°C, centrifuged at 10,000g 
for 1 minute to remove any residual liquid and resuspended in 10 pi (v/v) of lysostaphin (1 
mg/ml; Sigma-Aldrich, UK) for 5 minutes at 37°C. This was then followed by the addition of 
40 pi Tris EDTA (TE) buffer (30mM Tris-CI, 1 mM EDTA, pH 8.0), 40 pi lysozyme (40 mg/ml; 
Sigma-Aldrich, UK) and 20 pi (v/v) of Proteinase K (Qiagen, UK) and incubated further for 30 
minutes, vortexing every 5 minutes.
(a) RNA extraction using the Qiagen RNeasy kit - planktonic cells and biofilms
This was performed according to manufacturer instructions with minor adjustments 
(Appendix I: materials and methods). On-column DNA digestion using RNase-free DNase 
(Qiagen) was also performed and the total RNA was eluted using 100 pi RNase-free water.
(b) RNA extraction using the PowerBiofilm™ RNA Isolation Kit -  biofilms only
Following biofilm formation, initial lysis was performed prior to extraction of the RNA using the 
PowerBiofilm™ RNA Isolation Kit (MO BIO Laboratories Inc., Carlsbad, California, USA) 
according to manufacturer's instructions This protocol included the utilization of a patented 
Inhibitor Removal Technology® (IRT) and on-column RNase-Free DNase I digestion 
(Appendix I: materials and methods).
7.1.3 RNA quantification
RNA quantification and checks for purity were performed using the Nanodrop 2000 (Thermo 
fisher Scientific, Loughborough, UK). Briefly 2 pi of RNase free water was used as controls 
and subsequently 2 pi of the eluate was measured for concentration, purity and yield.
7.1.4 Primers
The primers used were those previously used in published reports. In the absence of any 
such data, they were designed online using the NCBI database 
(http://www.ncbi.nlm.nih.gov/). The primers were purchased from MWG Biotech, UK and 
details of the genes and primer sequences are shown in Table 7.1.
Table 7.1 Sequences of primers used for RT-PCR amplification assay
G e n e S e q u e n c e  (5 -3 ') R e fe re n c e s
G yrB F A G T  A A C G G A T  A A C G G A C G T  G G T  A B o re  e t al. (2007 ); 
B e e n k e n  e ta l.  (2 0 0 4 )
R C C A A C  A C C A T  G T  A A A C C A C C A G A T
16S F C C A G C A G C C G C G G T A A T B o re  e t al. (2 0 0 7 )
R C G C G C T T T A C G C C C A A T A
C a p 8 C F C C A G A G C G G A A T A A A G C A A T A A G K o re m  e ta l.  (2 0 1 0 )
R T  G A C G C C G T T  G T  C A C T T  G A C
S odA F T  A T T T  G G A T  C A G G T T  G G A C T T  G G T K o re m  e ta l.  (2010 )
R T  G G T T T G G C G T T  G T  C A C A A T
L u xS F G G G T T  G C C A A A C T  G G T T T  C T
R G C C C A G C C  A C A T T  G T  A C T T  C
IcaD F G G G T  G G A T  C C T T  A G T  G T T  A C A A T T T T K o re m  e t a l. (2 0 1 0 )
R T  G A C T T T T T  G G T  A A T T  C A A G G T T  G T  C
IcaA F T  A T  G A A C C G C T T  G C C A T G T G K o re m  e ta l.  (2 0 1 0 )
R T  C A C G C G T T  G C T T  C C A A A G
‘ Primers designed using the NCBI BLAST software
7.1.5 Quantitative reverse transcriptase PCR (QRT-PCR)
The RNA was reverse transcribed using the Power cells to CT OneStep RT-PCR kit (Life 
Technologies, UK) was used to perform the RT-PCR according to manufacturer’s 
instructions, the reaction mixture contained: 10pl of 2x PowerSYBR® Green RT-PCR Mix 
containing (SYBR® Green I dye, AmpliTaq Gold® DNA Polymerase, UP (Ultra Pure), 
dNTPs, ROX™ passive reference and Optimized buffer components); 0.16 pi per 
reaction of RT Enzyme Mix containing ArrayScript™ UP Reverse Transcriptase and 
RNase inhibitor; 1 pl/reaction of each primer; 100 ng/reaction of the template RNA and 
RNase free water for a final volume of 10 pi.
The conditions selected for the RT-PCR amplification protocol is shown in table 7.2.
Table 7.2. Amplification conditions for RT-PCR reaction
Stage Step Temperature Time
Holding Reverse transcription 48°C 30 minutes
Activation of AmpliTaq Gold®
Holding DNA Polymerase, UP (Ultra 95°C 10 minutes
Pure)
Cycling 
(40 cycles)
Denaturation
Annealing /Extension
95°C 15 seconds
60°C 1 minute
7.1.6 Analysis of RT-PCR Data
The RT-PCR experiment was performed using the MJ MimOpticon real-time 
PCR detection system (Bio-Rad, Hertfordshire, UK). For both planktonic cells and 
biofilms, analysis of data was performed using the delta-delta Ct method without 
efficiency correction (Pfaffl, 2006). For the biofilms, following exposure to the EOs, the 
RT-PCR was only performed once.
The formula for this method is R = 2^ACP samp,e“ ACPcon,ro"
7.2 Results
7.2.1 RNA Ex traction
Using the Qiagen RNA extraction kit, exponentially growing planktonic S. aureus cells 
(CA MRSA MW2 and PVL CA MSSA) yielded RNA concentrations of 286.6 ng/pl and 
329.45 respectively The measurements for RNA purity based on A260/280 and 
A260/230 respectively gave values at 2.07 for the MW2 strain and 2.08 for PVL CA 
MSSA indicating high purity levels from the extracted RNA samples. The A260/230 
values were 2.21 and 1.97 for CA MRSA MW2 and PVL CA MSSA respectively (Table 
7.3). Since the results were acceptable, no other kits were used for extraction of RNA 
from planktonic cells.
When RNA was extracted from biofilms using the Qiagen kit, lower RNA concentration 
(A260/280 and A260/230) values than that of planktonic cells were determined (Table 
7.3). RNA concentrations from the treated and untreated biofilms ranged between 28.85 
and 42.25 ng/pl, the A260/280 values ranged between 1.72 and 1.99 and the A260/230 
values were between 0.65 and 0.92. When the PowerBiofilm™ RNA Isolation Kit was
used for RNA extraction from biofilms, RNA concentrations ranged between 95 and 248.5 
ng/pl for the two strains tested (Table 7.3). The A260/230 was between 1.9 and 2.15 
while the A260/230 values ranged between 1.17 and 1.78.
123
Table 7.3. RNA yields and purity from exponential and biofilm cells of CA MRSA MW2 and PVL CA 
MSSA.
Qiagen kit Power Bio
B a c te r ia l s tra in s RNA
Concentration
ng/pl
A260/280 A260/230
RNA
Concentration
ng/pl
A260/280 A260/230
CA MRSA (MW2) 
Exponential cells 329.45 2.07 2.21 ND* ND* ND*
PVL CA MSSA 
Exponential cells 286 6 2.08 1.94 ND* ND ND*
CA MRSA (MW2) 
Untreated biofilms 28.85 1.88 0.65 149.7 2.14 1.78
CA MRSA (MW2) 
Treated biofilms 39.7 1.72 0.67 118.6 2.01 1.2
PVL CA MSSA 
Untreated biofilms
42.25 1.99 0.77 95.0 2.15 1.72
PVL CA MSSA 
Treated biofilms 33.15 1.94 0.92 248.5 1.87 1.17
*RNA extraction was not performed with this kit for the biofilm cells as the Qiagen kit had provided 
RNA of good yield and purity.
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7.2.2 RT-PCR Results
Two housekeeping genes (16S and gyrB) were checked for suitability in this experiment 
against both strains (Figure 7.1). There was a similarity in the C, values for the 16S gene 
between (28.15 and 28.91) for the two strains tested (Figure 7.1a) while the variation 
between the Ct values for the gyrB gene was larger, between 23.06 and 29.06 for both 
strains (Figure 7.1b). As a result, the 16S gene was selected as the reference gene for 
the RT-PCR reaction because there was less variation in the Ct values between both
strains
Figure 7.1. Amplification curves for the (a) 16S and (b) gyrB genes in CA MRSA MW2 and PVL 
CA MSSA strains. The C, values are shown for each strain.
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Prior to investigating the effect of grapefruit EO on the expression of the selected genes 
in the biofilms, the gene expression or presence of the target genes (icaA, icaD, cap8C 
and sodA) were determined from RNA extracted from untreated exponentially growing 
planktonic cells (Figure 7.2). All four target genes were expressed in exponential cells in 
both CA MRSA MW2 and PVL CA MSSA strains (Figure 7.2a and 2b) although the 
lowest level of gene expression was observed with the icaD gene with a fold change of 
1.5 between icaD and the 16S housekeeping gene. There were differences in the gene 
expression between the CA MRSA MW2 and PVL CA MSSA strains and, for all target 
genes, the gene expression was higher in the MW2 strain than in the PVL CA MSSA 
strain (Figure 7.2c).
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Figure 7 2. Relative quantification of four target genes relative to the 16S housekeeping gene in 
planktonic (a) CA MRSA MW2 (b) PVL CA MSSA and (c) comparison between the relative
Im W2 and D  PVL CA MSSA (n=3).quantities of
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In exponentially growing planktonic cells, the luxS gene was expressed in both CA MRSA 
MW2 and PVL CA MSSA with a fold change in gene expression approximately fourty six 
times in the CA MRSA MW2 and ten times in the PVL MSSA strain both relative to the
housekeeping gene (16S). When both strains were compared, the level of gene 
expression in the CA MRSA MW2 strain was 4.7 times higher than in the PVL CA MSSA 
strain (Figure 7.3)
50.0
40.0
30.0
20.0 
10.0
0.0
Figure 7.3. Relative quantification of luxS gene expression in planktonic ■  CA MRSA MW2 and 
CH PVL CA MSSA. Housekeeping gene (16S rRNA) (n=1).
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Table 7.4 shows a summary of the relative quantities of the five target genes comparative 
to the housekeeping gene in the exponentially growing planktonic cells.
Table 7.4. Summary table of the quantities of the five target genes comparative to the 
housekeeping gene in CA MRSA MW2 and PVL CA MSSA.
Genes CA MRSA (MW2) PVL CA MSSA
icaA 54.77 13.5
ica D 42 1.5
c a p 8 C 97.53 14
sodA 110.07 26.33
lu xS 45 6 9.7
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Although in the exponential cells, the icaA gene expression was higher in the CA MRSA 
MW2 strain than in the PVL CA MSSA strain, in biofilms following exposure to the EO, 
there was no difference in relative quantification between both strains (Figure 7.4). The 
icaD gene was up-regulated in the biofilms of MW2 with a fold change of 3.2. However, in 
the PVL MSSA strain, this gene was down-regulated by more than a 100 fold.
The cap8C gene was up-regulated in both strains with a fold change of 4.8 and 3.1 for 
the MW2 and PVL CA MSSA strains respectively. With the cap8C the gene expression 
was higher in the CA MRSA MW2 biofilms than the PVL MSSA biofilms following 
treatment with grapefruit EO by 1.5 times.
The luxS gene was up-regulated in the biofilms of both strains however the relative 
quantities for this gene was 12.4 for the MW2 strain and 3.1 for the PVL CA MSSA 
strains with the gene expression in the MW2 strain four times that of the PVL CA MSSA 
strain following treatment with grapefruit EO With the sodA gene, following treatment of 
the MW2 biofilm with grapefruit EO, this gene was down regulated by 1.1 fold relative to 
the housekeeping gene while in the PVL CA MSSA biofilm, this gene was up-regulated 
by 3.4 fold (Figure 7.4).
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Figure 7.4. Changes oberserved in expression of five target genes between treated [2% (v/v)
Grapefruit EO] and untreated biofilm cells of H  CA MRSA MW2 and D  PVL CA MSSA as 
determined by fold change measurements using the delta-delta Ct method. (ISM)
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7.3 Discussion
The process of extracting RNA from biofilms proved to be challenging and this is as a 
result of varying factors including the extracellular matrix which affects both the nucleic 
acid extraction and the purification process coupled with the presence of residual 
genomic DNA (Cury et al. 2008; Franca et al. 2011; Asthan et al. 2012). In this study, 
problems with RNA extraction from biofilm cultures were encountered. Using the Qiagen 
RNA isolation kit according to manufacturer’s protocols produced high RNA yields with 
good purity levels from the exponentially growing planktonic cells. In contrast, RNA 
extraction from biofilms required many extraction attempts and the yields were at much 
lower levels; almost 10 times lower than that of the planktonic cells. This could be as a 
result of the extracellular matrices in the biofilms although, Cury et al. (2008) previously 
found that the Qiagen RNeasy RNA extraction kit using on-column DNase digestion was 
less effective in comparison to other RNA isolation kits in recovering purified RNA 
samples especially with regard to genomic DNA contamination of the extracted RNA 
sample.
The PowerBiofilm™ RNA isolation kit used in this study was more effective at extracting 
RNA from the S. aureus biofilms however this protocol was supported with prior 
stabilization of the cells and an initial lysis step which involved the use of lysozyme and 
lysostaphin. This kit has not been used extensively in studies involving RNA extraction 
from bacteria however it has been used in some recent studies (Callahan, 2010; 
Zahreddine et al. 2012). Callahan (2010) however identified that the PowerBiofilm™ RNA 
and DNA extraction kits produce optimal yields and inhibitor free extracts and related that 
to the patented inhibitor removal technology (IRT) utilised by the both kits.
In this study, five genes were investigated for possibility of involvement in the observed 
increase in the metabolic activity of the PVL CA MSSA biofilms following exposure to
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three different concentrations of grapefruit EO (Figure 6.1b). Using RT-PCR, the selected
genes (icaA, /caD, cap8C, luxS and sodA) were all expressed in the exponential cultures
without treatment with the grapefruit EO albeit at varying levels. The relative quantities of
all five genes were higher in the exponential cells than in biofilm cells. Lenz et al. (2008) 
also found mRNA levels of two genes to be higher in exponentially growing planktonic
cells than in an equivalent volume of biofilms while Beaudoin et al. (2012) observed 
increased gene expression in biofilms than in planktonic cells, however according to Lenz
et al. (2008), mRNA amounts are at the highest at the top zone of biofilms, with RNA 
abundances not uniformly distributed throughout the biofilms which could lead to varying 
and generally reduced amounts of gene expression in comparison to the planktonic cells.
The 16S rRNA was selected as the housekeeping gene and according to Lenz et al. 
(2008), the amounts of this gene is fairly consistent throughout the biofilm and is used as 
an internal control for differentially regulated genes in biofilms. Following treatment of the 
two S.aureus biofilms with grapefruit EO, the preliminary results showed differences in 
gene expression between the two strains tested. For four of the five target genes, gene 
expression was observed to be higher in the CA MRSA MW2 strain than in the PVL CA 
MSSA strain following treatment with the EO even though the same RNA templates were 
used and at the same concentrations. As the results from a single experiment and as the 
PCR efficiency was not tested for the housekeeper or target, it is difficult to determine the 
significance and conclusivity of the data.
From the observed data, looking at the five target genes under investigation, the 
variability in gene expression was greater with the luxS, icaD and sodA genes between 
the two strains tested. The luxS gene was upregulated in both CA MRSA MW2 and PVL 
CA MSSA biofilms although the gene expression was higher in the CA MRSA MW2 strain 
by four fold The expression of this gene was also higher in the exponentially growing 
planktonic cells by approximately five fold in the CA MRSA MW2 strain which may
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suggest an increased expression of this gene in one strain than the other. The luxS gene 
is a QS gene which is involved with the production of an auto inducer molecule, AI-2 
(Winzer et al. 2002; Xu et at. 2006). When these molecules reach concentrations above 
their threshold, the QS system is activated leading to the control and regulation of target 
genes (Xu et al. 2006).
There are contrasting opinions on the exact role of the luxS gene. In relation to metabolic 
activity, Xu et al. (2006) did not find any significant effect of luxS on basic cellular 
metabolic processes in vitro in S. epidermidis however in other studies (McNab et al. 
2003; Doherty et al. 2006; Lebeer et al. 2007) the luxS gene was associated with sulphur, 
amino acid and carbohydrate metabolism in different organisms including S. aureus. The 
absence of the luxS gene has also been shown to affect formation of biofilms (Merritt et 
al. 2003) and in a study by McNab et al. (2003) a luxS mutant Streptococcus gordonii 
strain was unable to form normal biofilms. It is still possible however, that the production 
and degradation of the AI-2 molecule which is produced by luxS could affect the 
metabolic state of the cells as suggested by Winzer et al. (2002). Surette and Bassler 
(1998) previously demonstrated a strong induction of AI-2 when glucose was present in 
growth media. With both strains expressing the luxS gene, it is difficult to determine if the 
luxS gene was of any impact in this investigation. It might perhaps be worth assessing 
the effect of the luxS gene in both strains without glucose supplementation to ascertain 
whether the presence of glucose in the growth media influences the metabolic activity in 
the PVL CA MSSA strain.
Following treatment of the S. aureus biofilms with the grapefruit EO, the preliminary 
results showed two interesting observations. Firstly, there was an upregulation of the 
icaD in the CA MRSA MW2 biofilm while the opposite was observed in the PVL CA 
MSSA biofilm even though the icaA gene was expressed at similar levels in the biofilms 
of both strains. In a previous study, Vandecasteele et al. (2003) observed similar levels of
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expression of icaA and icaC and suggested that this similarity should be expected from 
two genes transcribed in the same operon. The exact function of the icaD is unclear 
(Vuong et al. 2004) although for the icaD gene to function, interaction with icaA is 
required prior to membrane integration (Gerke et al. 1998) therefore suggesting a 
chaperone-like action of the icaD gene, directing the membrane insertion of icaA. Cafiso 
et al. (2004) also investigated the transcriptional activity of the ica genes in biofilm 
positive and negative isolates and observed that although the icaD was always 
expressed, biofilm formation only occurred when the icaA was also expressed. According 
to Oliveira and Cunha (2010), gene expression of the ica locus is variable and is induced 
by variations in culture conditions, such as increase in sugar or other stress inducing 
substances. Chang et al. (2006) previously observed that the ica ADBC locus was 
repressed due to oxidative stress following exposure to hydrogen peroxide.
The second observation, was the downregulation of the sodA gene in the CA MRSA 
MW2 biofilm with the opposite response in the PVL CA MSSA biofilm this. In the S. 
aureus strains, the genes which encode the superoxide dismutases (SODS) are the sodA 
and sodM genes. Ballal and Manna (2009) demonstrated that expression of the sodA 
gene is dependent on oxygen availability. However in biofilms, bacterial growth is under 
microaerophillic or anaerobic conditions (Resch et al. 2005). Whilst in another study by 
Jakubovics et al. (2002), the SOD band was barely visible in extracts from cells grown 
anaerobically and this band was also absent in sodA mutant cell extracts in S. gordonii. 
Bizzini et al. (2009) reported no change in viability of a sodA mutant E. faecalis strain 
following exposure to bacteriostatic agent. No change in viability was observed in the 
biofilms of both CA MRSA MW2 and PVL CA MSSA after grapefruit EO exposure (Figure 
6.2b) and in Chapter 6, the effect of grapefruit EO was determined to be bacteriostatic 
against both S. aureus strains in planktonic conditions. Roslev and King (1993) observed 
an increase in XTT reduction in the presence of methanol and suggested this action to be 
caused by a general increase in electron transport system activity. This observation by
Roslev and King and the data from another study by Martinez and Casadevall (2006) who 
observed greater metabolic activity in biofilms than in planktonic cells following exposure 
to nitric oxide suggests the problem of oxidative stress. Oxidative stresses in bacteria can 
be caused by reactive oxygen species (Cabiscol et al. 2010). Endogenous production of 
ROS in biofilms causes variability in the biofilm cells as well as acting as a signal which 
mediates cell death of subpopulation of the cells leading to metabolic differentiation in 
other parts of the biofilm (Cap et al. 2012). Hence, there is a possibility that the changes 
observed in metabolic activity in the PVLCA MSSA strain may have been mainly affected 
by the production of ROS which mediated the upregulation of the sodA.
Recent studies have shown that oxidative stresses are produced within biofilms and are 
capable of affecting the growth of the biofilm and subsequently leading to production of 
ROS and decrease in the extracellular matrix (Arce Miranda et al. 2011). The increase in 
sodA expression and the decrease in icaD in the PVL CA MSSA suggests that oxidative 
stress following exposure to the EO was perhaps responsible for the increase in XTT 
reduction observed in PVL CA MSSA however as the result was from a single 
experiment, this is not conclusive and requires further investigation. The differences in 
gene expression observed between the CA MRSA MW2 and PVL CA MSSA biofilms 
does suggest that gene expression is strain dependent which adds to the current ideas 
surrounding the interactions of the genes involved in biofilm formation and the 
multivariable activity of the genes in biofilm conditions.
CHAPTER EIGHT
General Discussion
8.1 Physiological differences between the S. aureus strains
Results from antibiotic susceptibility testing of the six S. aureus strains (Chapter 4) 
showed that the strains mostly confirmed the sources from which the organisms were 
collected. Four strains PVL CA MSSA, MRSA MW2, PVL CA MRSA and MRSA SR were 
provided as community acquired isolates while the other two strains were a hospital strain 
(Hospital MSSA) and a type MRSA strain (MRSA NCTC 13297). The CA strains are 
known to be more susceptible to antibiotics than the HA isolates (Rice, 2006; Boyle- 
Vavra and Daum, 2007). In this study, the CA isolates were found to be sensitive to the 
different antibiotic groups with the exception of the p-lactam antibiotics as was expected 
(Vandenesch et al. 2003; Wallin et al. 2008) however, one of the strains provided was 
multi drug resistant. Multidrug resistance has been reported predominantly in the HA 
rather than CA MRSA strains (Wallin et al. 2008; Chambers and DeLeo, 2009) and 
according to Chambers and DeLeo (2009), this is a problem as it limits options for 
treatment.
According to Vandenesch et al. (2003) although CA-MRSA isolates are more susceptible 
to non p-lactam antibiotics, European CA MRSA isolates appear more resistant to several 
antibiotics than US and Oceanian isolates. Also, a recent study by Wang et al. (2012) 
identified multidrug resistant clones of CA-MRSA from Chinese children. The origin of the 
multidrug resistant CA MRSA (SR) strain used in this study needs to be investigated 
further as the antibiotic profiles and genetic characteristics suggest a different 
background from the other CA MRSA isolates.
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The ability of S. aureus to colonise different surfaces including those of medical devices 
and to form biofilms is an important phenotypic characteristic which enhances its 
pathogenicity. The investigated S. aureus strains were all positive for biofilm formation 
regardless of the origins of the strains (Chapter 4) when the 96-well plate method was 
used. There was a correlation between biofilm formation using this method and the CRA 
method for slime formation. Although there was a correlation between the two methods, 
some authors have suggested the CRA method should not be used as a standalone 
method in determining biofilm formation as clinical S. aureus strains have been observed 
which, although positive for CRA method, were negative for biofilm formation and vice 
versa (Fitzpatrick et al. 2006; Croes et al. 2009; Nasr et al. 2012). It is currently known 
that biofilm formation is a means of survival (Donlan, 2002) and the ability of the CA 
S. aureus strains to form biofilms could be a factor in survival and dissemination within 
community settings.
8.2 Molecular differences between the CA and non-CA isolates
The PVL gene was present in three of the four CA strains confirmed by multiplex PCR, 
where the only exception was the CA MRSA (SR) strain, which was negative for this 
gene. The PVL gene is rarely found in HA strains and frequent in the CA isolates (David 
and Daum, 2010) however PVL negative CA S. aureus strains have been identified 
previously (Takizawa et al. 2005; David and Daum, 2010). There is still debate on the 
main role of PVL in pathogenesis, which has been reviewed by David and Daum (2010).
Biofilm formation had been demonstrated in all six S. aureus strains and was negative in 
the E. faecium isolate in this study (Chapter 4). In early stages of biofilm development 
genes of the ica operon are usually expressed leading to production of PIA (Moretro et al. 
2003). The investigation in Chapter 4 using multiplex PCR demonstrated the presence of 
both icaA and icaD genes in all six S. aureus strains. As these strains were also biofilm 
positive and CRA positive, the results observed suggested that the Ica operon is present
in a high proportion and supports other studies which have reported that the majority of 
clinical S. aureus strains have both the icaA and icaD genes (Crampton et al. 1999; 
Arciola et al. 2001).
Although various methods are available for typing MRSA including PFGE, MLST and spa 
typing, SCCmec typing of S. aureus was used in this investigation as variations in 
SCCmec types have been used in differentiation of MRSA (Mehndiratta and Bhalla, 
2012). Results from the SCC mec typing (Chapter 4; Section 4.2.2.4) suggested that the 
community strains were all type IV based on the presence of the CCRB2 gene. There 
were differences between the strains with regard to the SCC mec type IV status as only 
the MW2 was SCC mec type IVa and this raises the possibility that the other strains are of 
different subtypes of the SCC mec type IV. To clarify the exact origins of the other CA 
isolates, identifying what subtypes the other strains belong to would be necessary as the 
reports suggest that the presence of these different subtypes of the SCC mec IV 
contributes to the ease of transmission of the SCC mec type IV CA MRSA (David and 
Daum, 2010).
8.3 Effects of the disinfectants against S. aureus and E. faecium
McDonnell and Russell (1999) reviewed the activity and action of disinfectants and 
antiseptics and described the chlorine and iodine-based compounds as the most 
significant microbicidal halogens used in the clinic. However the authors suggested that 
the actual mechanism of action is not fully known. In this study (Chapter 5) the 
antibacterial activity of household bleach containing sodium hypochlorite and a 
disinfectant with NaDCC as the main compound were effective as antibacterial agents 
when the bacteria were in suspension Both compounds release hypochlorous acid in 
aqueous solution (Bloomfield, 1996). Hypochlorous acids primarily affect the oxidation of 
sulfhydryl groups of essential enzymes and antioxidants and also have an effect on DNA 
synthesis (Fukuzaki, 2006).
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Against surface-attached and biofilm cells of S. aureus and VRE, both disinfectants were 
less effective than in suspension, confirming the reports from previous studies (Rutala et 
al. 2000). The factors considered to cause a reduced effect on surfaces include the 
contact times and the concentrations used. These two factors have been mentioned as 
the two key variables when determining disinfectant efficacy (Fukuzaki, 2006). Although 
these two disinfectant products at the recommended concentrations were effective in 
suspension within one minute, against the same organisms on surfaces, the reduction by 
these disinfectants was more than two logs. However, it was observed that as the 
concentrations increased the log reduction increased, hence an extended contact time 
might be required for the cleaning and disinfection of surface-adhered cells.
The results obtained following exposure of the mature S. aureus biofilms to the 
disinfectants suggest that extending the contact time and increasing the concentration of 
the disinfectant (to safe and non-toxic levels) could be an important factor in reducing 
bacterial colonisation. Increasing the concentration of household bleach to 5000 ppm 
caused a 100% effect within 10 minutes against the biofilms while extending contact time 
to one hour caused a reduction in biofilm formation by both household bleach and 
NaDCC at the concentrations tested.
As Kim et al. (2007) demonstrated in their study, levels the disinfectant efficacy ranged 
from planktonic cells, to surface-attached cells and then biofilms. This highlights that 
although both disinfectants are chlorine releasing agents and have been used for 
cleaning and disinfection purposes, the effect of these products against biofilms requires 
further investigation and the concentrations required for biofilm killing and removal needs 
to be established.
The EFCP showed no antibacterial activity and did not possess any antibiofilm effect 
against the S. aureus strains and VRE The product contains approximately 5% of non-
ionic surfactants which are generally used in detergents and cleaning products. In other
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studies, cleaning using surfactants in combination with other disinfectants and/or 
components was effective in reducing bacterial contamination (Barker et al. 2004; 
Lankford et al. 2006) however the assumption is that non-ionic surfactants are inactive 
(Glover et al. 2006).
An observation made on purchase of this EFCP was the lack of distinction between the 
placement of conventional antibacterial disinfectants and EFCPs at the time of purchase 
as well as the absence of clearly defined labels which inform the consumers on the lack 
of antibacterial properties of these products. In the US, standards based certifications 
such as Green Seal and Ecologo with standard labels are in place to help the end users 
in identification of green cleaning or EFCPs (Green Seal, 2012). Alongside the current 
guidelines produced for companies involved in developing EFCPs (DEFRA, 2011), there 
is a need for adherence to the international standards (ISO 14021:1999) and better 
information for consumers to restore confidence in making choices (Yates, 2009).
8.4 Effects of the essential oils against S. aureus isolates
Essential oils at low concentrations have been demonstrated in a number of studies to 
possess antimicrobial activity (Hammer et al. 1999; Fisher and Phillips, 2006). At 0.06% 
lemongrass oil (Cymbopogon flexuosus) was able to inhibit the growth of six S. aureus 
strains of diverse origins (Chapter 6). The type strain, hospital acquired and community 
acquired strains were all susceptible to the action of this EO. This EO was the most 
effective following screening by the disk diffusion assay in comparison to the other EOs; 
lime, geranium, grapefruit, lemon and bergamot. With the exception of lemon, the other 
EOs demonstrated antimicrobial activity with ZOIs observed after 24 hour incubation 
(Table 6.1) demonstrating that essential oils from different sources possess antimicrobial 
activity albeit at different levels.
The effect of essential oils including lemongrass has been investigated previously 
however this study is the first to our knowledge that has demonstrated the effect of this 
essential oil on community acquired S. aureus MSSA and MRSA PVL and non-PVL 
producing isolates. The effect of lemongrass oil was also observed against biofilms and 
at 0.13% (v/v), biofilm inhibition was achieved (Chapter 6).
Evaluation of the GCMS data provided by Belmay Pic. (Appendix II) showed that the 
lemongrass EO was composed of approximately 80% citral. Lemongrass EO and citral 
and its derivatives have been investigated and the effects on bacteria and other 
microorganisms suggest a broad spectrum of activity (Saddiq and Khayyat, 2010; Tyagi 
and Malik, 2010). The antimicrobial activity demonstrated by the lemongrass EO 
included biofilm inhibition, inhibition of metabolic activity and reduction of viability of the 
cells within the biofilm. The ability of this essential oil to prevent biofilm formation and 
inhibit metabolic activity in biofilms of clinical S. aureus coupled with lack of data 
demonstrating resistance of these organisms to the effect of EO exposure suggest that 
this essential oil, if used correctly could prevent infection and reduce bacterial 
contamination in healthcare and non-healthcare settings.
8.5 Effect of grapefruit EO on S.aureus gene expression
In bacteria, genes are expressed differently when the organisms are in either planktonic 
or biofilm conditions. The observation in this study was that gene expression of the target 
genes in planktonic cells was much higher than that observed in the untreated biofilm 
cells. In the planktonic cells it was also observed that the gene expression of the target 
genes in the untreated planktonic MRSA strain was higher than in the untreated MSSA 
strain. The differences between the MSSA and MRSA strains have been investigated in 
previous studies (Edwards-Jones et al. 2000; Hallin et al. 2007; Rozgonyi et al. 2007).
According to Rozgonyi et al. (2007), there is a need for comparison of congenic MRSA 
and MSSA sub-populations to understand what differences exist between these groups 
however, the authors mentioned that the MRSA strains consist of heterogenous 
populations of cells which consist of methicillin-sensitive, borderline resistant and 
methicillin resistant sub-populations. The authors further discuss differences between the 
MSSA and MRSA (Rozgonyi et al. 2007) however they and others (Hallin et al. 2007) call 
for further genetic studies to understand the differences and interaction between MRSA 
and MSSA as knowledge of this would help in tackling the associated infections. The 
results presented in Chapter 7 suggest that there is a difference in the expression of 
certain genes in MRSA and MSSA however more studies would be needed with a larger 
number of strains for efficient comparison before any conclusions can be drawn from 
these observations.
The changes in gene expression observed following grapefruit EO exposure could be 
attributed to different factors. In terms of the expressed genes, it is possible that the 
responses observed in the icaD and the sodA genes were responsible for the changes in 
metabolic activity in the PVL CA MSSA strain. The increase in sodA and decrease in icaD 
gene expression in PVL CA MSSA may be as a result of oxidative stress however, this 
needs to be investigated further as the experiment was only performed once.
In recent studies, changes in gene expression following exposure of S. aureus and 
Saccharomyces cerevisiae to essential oils and components have been demonstrated 
using DNA microarrays (Bi et al. 2010; Cuaron et al. 2012; Muthaiyan etal. 2012). Due to 
time and resource constrains, this was not performed in this current study. Data on the 
changes in gene expression in biofilms exposed to EO’s is currently unavailable and 
armed with the knowledge that biofilm development in S. aureus is multifactorial (Belion 
et al 2004; Belion and Gigho, 2005; Lin et al. 2012) performing a global gene expression 
analysis using microarray technology with the same strains and treatment would provide
more information about the metabolic changes in the biofilms observed following EO 
exposure.
8.6 Conclusion
Biofilm formation is an important factor in survival and virulence of S. aureus and in all the 
S. aureus isolates tested in this study were of a biofilm positive phenotype however the 
VRE strain (E.faecium NCTC 12202) was biofilm negative. The CA S. aureus isolates 
demonstrated the characteristic antibiotic susceptibility profiles as the isolates were 
generally sensitive to the different antibiotic groups however one of the isolates (CA 
MRSA SR) was multi drug resistant as this strain was resistant to four of six antibiotics 
(ciprofloxacin, gentamicin, cefoxitin and erythromycin),
Although this CA MRSA isolate was multidrug resistant, this isolate and the other S. 
aureus isolates were sensitive to the effect of five EOs (bergamot, lime, lemongrass, 
grapefruit, geranium) and citral. The effect of lemongrass EO also included prevention of 
biofilm formation and inhibition of metabolic activity and viability of the cells in the biofilm 
of all six S. aureus isolates.
In this study, the effect of disinfectants was also demonstrated against both S. aureus 
isolates and the VRE strain. Both household bleach and NaDCC were effective against 
the isolates tested in suspension with >5 log (10) reduction although on surface-attached 
cells and biofilms they were less efficient. However, the EFCP was ineffective against 
both S. aureus and VRE isolates in suspension or against biofilms.
As this study demonstrates, disinfectants when used correctly are still effective in 
reducing bacterial contamination even against CA S. aureus isolates and the effect of 
lemongrass EO demonstrated in this study suggests that EOs could provide another
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option for antimicrobial interventions in clinical, domestic, food and industrial 
environments.
8.7 Future work
Following all the investigations described in this thesis, a number of aspects have been 
identified that could result in further research. Firstly, the multidrug resistant MRSA (SR) 
isolate needs to be characterised further due to the different antibiotic profiles from the 
traditional CA-MRSA strains. Also this isolate possessed the ccrB2 gene suggesting this 
isolate belonged to the SCCmec type IV however, as there are different subtypes of the 
SCCmec IV further typing of this strain would be provide some important clues about the 
origin of this isolate.
Secondly, as there was no antimicrobial activity observed with the ecofriendly cleaning 
product used in this study, investigating antimicrobial activity in other products advertised 
as ‘green’ or ecofriendly from other manufacturers should be performed. Also, a survey to 
assess the awareness and attitudes of consumers to ecofriendly products and their 
understanding of the exact function and performances of these products in comparison to 
conventional sanitizers and disinfectants, would inform consumers and retailers.
As the results from Chapter 7 on the effect of grapefruit EO on the biofilms of the S. 
aureus isolates were preliminary, there is a need to perform further RT-PCR to provide 
clearer and conclusive results on the changes in gene expression observed. This should 
also be supported with an initial determination of the amplification efficiencies of the 
housekeeper and target genes. At present, no published data on the global changes in 
gene expression in biofilms of S. aureus is available. With this in mind, it would be 
important to determine the changes in gene expression using microarray technology to 
identify the genes involved in cellular metabolism and oxidative stresses in the PVL CA 
MSSA biofilm following exposure to grapefruit EO.
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Appendix I - Materials and Methods
Table I. List of culture media, chemicals and reagents.
Media and Reagents Codes Source
Brain Heart Infusion - -
Agar 70138-500G Fluka Analytical, Sigma- Aldrich, UK
Broth CM1135 Oxoid Ltd, Basingstoke, UK
Mannitol Salt Agar CM0085 Oxoid Ltd, Basingstoke, UK
Congo Red dye
Tween 20 (Polyoxyethylene 20- 
Sorbitan Monolaurate) BP337-500
Fisher Scientific, 
Loughborough, UK
Peptone from casein 1.07213.1000 Merck Darmstadt, Germany
L-alpha-Phosphatidylcholine (lecithin) 61755-25G Sigma-Aldrich, UK
Albumin, from bovine serum (BSA) A7906-10G Sigma-Aldrich,Dorset, UK
XTT Sodium salt X4626 Sigma-Aldrich, Dorset, UK
Menadione M5625 Sigma-Aldrich, Dorset, UK
Methylated spirit M/4450/17 Fisher Scientific, 
Loughborough, UK
Crystal Violet C.1.42555 SLS, Nottingham, UK
Acetic Acid Glacial A/0360/PB08 Fisher Scientific, 
Loughborough, UK
Glutaraldehyde
D-Glucose anhydrous G/0500/53 Fisher Scientific, 
Loughborough, UK
Sodium thiosulphate
DNA Extraction - GenElute™ Bacterial Genomic DNA Kit
Protocol specific for Gram-Positive Bacterial Preparation 
Prepare Lysozyme Solution
Prepare a 2.115 x 106 unit/mL Lysozyme Solution using the included 
Gram-Positive Lysis Buffer as the diluent. 200 pL of Lysozyme Solution 
is needed for each prep. Make extra to account for pipetting error.
1. Harvest Cells
Pellet 1.5 mL of bacterial broth culture at 12,000-16,000 x g for 
2 minutes, discard media.
2. Digest Cell Wall
Resuspend pellet in 200 pL Lysozyme Solution and incubate at 37 °C for 30 minutes.
3. Lyse Cells
Add 20 pL Proteinase K and 200 pL Lysis Solution C to cell suspension, vortex or pipette to mix. 
Incubate at 55 °C for 10 minutes.
4. Prepare Column
Add 500 pL of Column Preparation Solution to each binding column. Spin at >12,000 * g for 1 
minute. Discard flow-through.
5. Bind DNA to Column
Add 200 pL ethanol to the lysed cells, vortex or invert to mix. Transfer EtOH mixture to binding 
column. Spin at > 6500 * g for 1 minute.
6. Wash Column
Transfer column to new collection tube. Add 500 pL Wash Solution 1 to column. Spin at > 6500 * g 
for 1 minute. Transfer column to new collection tube. Add 500 pL Wash Solution Concentrate to 
column. Spin at >12,000 * g for 3 minutes to dry column.
7. Elute DNA
Transfer column to new collection tube. Add 200 pL of Elution Solution. Spin at > 6500 * g for 1 
minute.
Full details of extraction protocol can be found at
http://www.sigmaaldrich.eom/etc/medialib/docs/Sigma/Bulletin/na2110bul.Par.0001.File.tmp/na211
0bul.pdf
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RNA Extraction -  Qiagen RNAprotect Bacteria Reagent 
Stepwise procedures from manufacturer.
P r o t o c o l  4 :  E n z y m a t ic  L y s is  a n d  P r o t e in a s e  K  D ig e s t io n  
o f  B a c t e r ia
Important points before storting
■  Before growing and harvesting bacteria read 'Optimal culture conditions’ 
(page 13)
®  ^  preparing RNA for the first time, read Appendix A (page 38).
■  Perform all steps of the procedure at room temperature (15—25°C) without 
interruption.
•  If RNeasy Kits w ill not be used for RNA purification, follow the procedure up to 
step 7  only.
■  If RNeasy Kits will be used for RNA purification, read Determining the correct 
amount o f starting material" and ‘Quantifying bacterial cells” (pages 13—14). 
C^P^nding on the amount o f starting material, choose whether to use the RNeasy 
M in i Kit or RNeasy M id i Kit.
■  Bacterial lysis in this protocol consists of treatment with 15 m g/m l lysozyme for 
lO  min, which is optimal for B .  s u b f i h s .  Since the conditions for enzymatic lysis 
are affected by bacterial species, cell number, and culture medium, it may be 
necessary to adjust enzyme concentration and /o r to adjust enzyme incubation 
time. For some bacteria, other enzymes may be more effective (e g ., we 
recommend lyso staph in for disrupting the cell wall o f S t o p h  y l o c o  e c u s  aureus).
Things to do before starting
■  If using RNeasy Kits for RNA purification, add 1 O pi JVmercaptoethanol 
Buffer RLT, and mix. Buffer RLT is stable for 1 month after addition 
mercaptoethanol.
9
O
1 Prepare Tl buffer (30 mM Tris-Cl, 1 mM EDTA, pH 8.0) containing 15 m g/m l 
lysozyme.
Calculate the required volume of bacterial culture (1 volume).
See "Determining the correct amount of starting material” , page 13.
■§
Pi pet 2 volumes of RNAprotect Bacteria Reagent into a tube (not supplied).
For example, if the volume of bacterial culture is 500 pi, add 1 OOO pi RNAprotect 
Bacteria Reagent.
The volume of the tube must be 4-times that of the bacterial culture (e g., if the 
volume of bacterial culture is 500  pi, use a 2 ml tube).
Optional: Entire bacterial cultures can be stabilized by adding 2 volumes of 
RNAprotect Bacteria Reagent to the culture.
Add 1 volume of bocterial culture to the tube. M ix immediately by vortexing for 
5 s. Incubate for 5 min at room temperature (15— 25CC).
Centrifuge for 10 min at 5000 x g.
A pellet may not be visible after centrifugation. This is due to an interaction 
between the cells and the stabilization reagent that causes a change in the optical 
density of the cells. The procedure is not affected.
Note For tubes larger than 50 ml, the centrifugal force or centrifugation time may 
be increased However, using excessive centrifugal force may make resuspension 
of the pellet difficult.
Decant the supernatant. Remove residual supernatant by gentfy dabbing the 
inverted tube once onto a paper towel.
After dabbing the tube onto a paper towel, do not remove the remaining 
supernatant by pipetting, as this may lead to loss of the pellet If the tube is larger 
than 1 5 ml, we recommend removing residual supernatant by leaving the tube 
inverted on a paper towel for 10 s.
Note The remaining supernatant should not exceed approximately 80 pi per 
1 OO pi TE buffer containing lysoyzme used in step 7.
Optional Pellets can be stored at —20 C for up to 2 weeks or at — 70 C for up to 
4 weeks. For subsequent RNA purification, thaw pellets at room temperature 
(1 5—25 C) and proceed with step 7 of the procedure.
Add 10—20 pi QIAGEN Proteinase K to the appropriate volume of TE buffer 
containing lysozyme (see Table 6), and add the mixture to the pellet. Carefully 
resuspend the pellet by pipetting up and down several times.
The amount of QIAGEN Proteinase K required depends on the bacterial species. 
If using the RNeasy M idi Kit for RNA purification, use 20 pi QIAGEN Proteinase
Num ber o f bocterio*
RNeasy
spin
column
TE buffer 
containing 
lysozyme 
(step 7)
Buffer
RLT
(step 9)
Ethanol 
(9^-100% ) 
(step TO)
Ethanol 
(80%) 
(step 10)
<1 X  lO5 M ini IOO Ml 3 5 0  pi 2 5 0  pi m m m
1 X I O * - 2 . 5 x  IO” M ini 2 0 0  pi 7 0 0  pi 5 0 0  pi MM
< 2 .5  x 10» -
< 1.5 x  ic r
M id i 200 pi 2000 pi — 1750 pi
7 .5  X l O ' -
1.5 X 10°
A  V  «  m  *
M id i 2 0 0  pi 4 0 0 0  pi — 3 5 0 0  pi
_—  ~ ~ ~  ■ -  — •  > o a n a  m a y  n o o j  po  d «
LWwmining tho c o «t »c9 amount o/ Parting muJw ioT. pag« 13
1 0 .
M ix by vortexing for 10 *. Incobote at room  temperature 11 S-25 C) fo r 10 min.
During incubation, incubate on a shaker-incubator, or vortex for IO s a t least 
every 2 min.
^ of®: Since the RNIA is stabilized, the incubation time can be extended without 
causing any adverse effects, and may increase the RNA yield.
Add the appropria te  volume o f Buffer RLT (see Table 6) and vortex vigorously. 
^  particulate m aterial is visible, pellet it by centrifugation, and use only the 
supernatant in step 10.
For tubes o f up to 2 ml, centrifuge for 2 min at maximum speed in a 
m icrocentrifuge. For tubes larger than 2 ml, centrifuge for 5 min at 3 0 0 0 — 
5 0 0 0  x g.
Note Ensure that p-meracaptoethanol is added to Buffer RLT before use (see 
~ Important points before starting", page 25).
Add the appropria te  volume o f ethanol (9 ^ - 1 00% fo r the RNeasy M ini procedure, 
or 80% for the RNeasy M id i procedure) (see Table 6). M ix by pipetting (RNeasy 
M in i procedure) o r by shaking vigorously (RNeasy M id i procedure). Do not 
centrifuge.
f
Q
After add ing  ethanol, a precipitate may form This w ill not affect the RNeasy 
procedure
M If using the RNeasy M in i Kit, proceed to Protocol 7. If using the RNeasy M idi Kit,
Appendix B: Optional On-Column DNase Digestion 
Using the RNase-Free DNase Set
The QLAGEN RNase-Free DNase Set provides efficient orvcolumn digestion of DNA 
during RNA purification using the RNeasy Mini or Midi Kit. The DNase is efficiently 
removed in subsequent wash steps.
Note: Standard DNase buffers are not compatible with on-column DNase digestion. 
Using other buffers may affect the binding of the RNA to the RNeasy spin column 
membrane, reducing the yield and integrity of the RNA.
Preparation of bacterial lysates and binding of RNA to the RNeasy spin column 
membrane are performed according to the protocols in this handbook. After washing 
with a reduced volume of Buffer R W 1, RNA is treated with DNase I while bound to 
the spin column membrane. DNase I is removed by a second wash with Buffer RW1 . 
Washing with Buffer RPE and elution are then performed according to the protocols in 
this handbook.
Important points before starting
■  Generally, DNase digestion is not required since RNeasy silica-membrane 
technology enables efficient removal of most of the DNA without DNase 
treatment. However, further DNA removal may be necessary for certain RNA 
applications that are sensitive to very small amounts of DNA (e g , RT-PCR 
analysis with a low-abundant target). DNA can also be removed by a DNase 
digestion following RNA purification.
■  Do not vortex the reconstituted DNase I. DNase I is especially sensitive to physical 
denaturation. Mixing should only be carried out by gently inverting the vial.
Things to do before starting
■  Prepare DNase I stock solution before using the RNase-Free DNase Set for the 
first time. Dissolve the solid DNase I (1500 Kunitz units) in 550 pi of the RNase- 
free water provided. To avoid loss of DNase I, do not open the vial. Inject RNase- 
free water into the vial using an RNase-free needle and syringe. Mix gently by 
inverting the vial Do not vortex.
■  For long-term storage of DNase I, remove the stock solution from the glass vial, 
divide it into single-use aliquots, and store at -2 0 CC for up to 9 months. Thawed 
aliquots can be stored at 2-3 C for up to 6 weeks Do not refreeze the aliquots
Procedure
Prepare bacterial lysates as described in Protocols 1-6. Then perform Protocol 7 (■) 
or Protocol 8 (A). Instead of following step 2 of Protocol 7 or 8 (i.e., the wash with 
Buffer RW1), follow steps B1-B4 below.
B l. Add ■  350 pi or A  2 ml Buffer RW1 to the RNeasy spin column, and centrifuge 
for ■  1 5 s at 8000 x g or A 5 min at 3000-5000 x g to wash the spin column 
membrane. Discard the flow-through.* Reuse the collection tube in step B4.
B2. Add ■  10 pi or A 20 pi DNase I stock solution (see above) to ■  70 pi or 
A  140 pi Buffer RDD. Mix by gently inverting the tube, and centrifuge briefly to 
collect residual liquid from the sides of the tube.
Buffer RDD is supplied with the RNase-Free DNase Set.
Note DNase I is especially sensitive to physical denaturation. Mixing should only 
be carried out by gently inverting the tube. Do not vortex.
B3. Add the DNase I incubation mix (■ 80 pi or A  160 pi) directly to the RNeasy spin 
column membrane, and incubate at room temperature (20-30°C) for 15 min.
Note Be sure to add the DNase I incubation mix directly to the RNeasy spin 
column membrane. DNase digestion will be incomplete if part of the mix sticks to 
the walls or the O-ring of the spin column.
B4. Add ■  350 pi or A 2 ml Buffer RW1 to the RNeasy spin column, wait for 5 min, 
and then centrifuge for ■  15 s at >8000 x g or A 5 min at 3000-5000 x g. 
Discard the flow-through and collection tube.* Continue with step 3 of 
■  Protocol 7 or A Protocol 8 (i.e., the first wash with Buffer RPE).
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RNA Extraction - PowerBiofilm™ RNA Isolation Kit 
Important Notes Before Starting
Solution BFR1 must be warmed at 55°C for 5-10 minutes to dissolve precipitates prior to each use. 
Solution BFR1 should be used while still warm. Shake to mix Solution BFR6 before use.
Prepare Solution BFR1 by adding P- mercaptoethanol (pME)
Add 5 pi of p- mercaptoethanol (PME) for every 345 pi of the Solution BFR1 for all samples to be 
processed. For each prep, 350 pi of the Solution BFR1/ P- mercaptoethanol (PME) will be needed. 
Note: Prepare Solution BFR1 in smaller aliquots with fresh PME according to the number of 
samples you need to process that day instead of adding pME to the whole bottle. Use a fume hood 
when opening PME to avoid exposure to the chemical.
DNase I Preparation and Storage
To prepare DNase I stock solution add RNase-Free water (Solution BFR9) to the lyophilized DNase 
I according to the table below and mix gently. Aliquot the enzyme in 50 pi portions and store at - 
20°C for long term storage. Note: The enzyme can be freeze/thawed up to three times without loss 
of activity.
To prepare the DNase I Solution, thaw the volume of enzyme needed according to the number of 
samples. Per prep, combine 5 pi of DNase I enzyme with 45 pi of Solution BFR7.
PowerBiofilm™ RNA extraction -  Procedure
In .
PowerBiofilm™ RNA Isolation Kit
P re p a re  S *m p U Add b*oWm lo Pu**5fGiOfllrr
Bead T _d c  
Add Solution B FR l 
Add S cM «nB F R 2
C e ll L y s is h m i  «  65 C
Attach to Vone* Adapter
Vc*te*
OMlnfaQ*
In h ib ito r  R e m o va l T e c h n o lo g y
1
Add Solution BFR3
• incubate at 4 'C
Cortnt.jQ^
Bind RNA Add Solutions BFR4 d ra  BFRS 
VOrte*
Load n to  S p n  Filter
Cevtfnfbge
D N ase  l T rea tm en*
W ash
I
I
W ash Solution 8F RC 
Aoo DNm # 1 and So M e n  B ^R f 
mcuWiro *1  room t*nno*fQtur+
• W a in  v»9t S<tfu?K>n BFR8
• Wash Solution 6FR6
Wash Solution BFR5
E lu te
l
Cenfnfuje
- Fkifie vwlh Sduson B* R9
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Appendix II (Chapter 4 - Statistics)
Biofilm formation in S. aureus strains
Strains
Between Groups 
Within Groups 
Total
ANOVA
| Sum of Squares df Mean Square F
3.165 5 .633 21.199
896 30 030
_______________ 4 061 35
Multiple Comparisons
Dependent Vanable Strains
(I) (J)
Games-Howell
The mean difference is significant at the 0 05 level
95% Confidence Interval
VAR000
07
VAR000 1 
07 |
Mean Difference
(l-J) Std Error | cn (O --
--
-r
Lower Bound Upper Bound
1 2 I - 7343' 1198 0041 -1.190 -278
3 1 -.2077 1396 679 -698 .282
4 1 -.1318 1189 863 -.588 324
5 1 .1252 .1134 863 -334 584
6 1 -5222' 1303| 0281 -9 9 11 - 054
2 1 1 .7343' 11981 004 278 1.190
3 I 5267' 0993 007 162 891
4 I 6025' 0671 000 369 836
5 I 8595' 0568 000 653 1 066
6 I 2122 0858| .2291 -.0941 518
3 1 1 2077 13961 679 -.2821 698
2 I -.5267' 0993 007 -891 -.162
4 I 0758 0982 965 -287 439
5 I 3328 0915 070 - 028 694
6 I -.3145 .11181 138 -.7061 .077
4 1 1 .1318 .11891 863 -3 2 4 1 588
2 I -6025' 0671 000 -836 -.369
3 I - 0758 0982 965 -439 287
5 I 2570' 0548 012 060 454
6 I - 3903' 0845 012 -694 -.087
1 1 -.1252 .1134 863 -584 334
2 1 - 8595' 0568 000 -1.066 -653
3 1 -.3328 0915 070 -694 028
4 1 -2570' 0548 012 -454 -060
6 1 - 6473' .0766 001 - 942 -353
1 1 5222' 1303 028 054 991
2 1 -.2122
0858 229 -518 094
3 1 3145 1118 138 -077 .706
4 1 3903' 0845 012 087 694
5 I 6473' 0766 001 353 942
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Effect of nutrient media change
CA MRSA MW2
Independent Samples Test
Levene's Test for 
Equality of 
Variances t-test for Equality of Means
95% Confidence 
Interval of the 
Difference
F | Sig. t df
Sig (2- 
tailed)
Mean
Difference
Std Error 
Difference Lower Upper
MRSA
MW2
Equal
variances
assumed
001 978 2 954 14 010 .71488 24200 19583 1.2339
2
Equal 
variances 
not assumed
2 954 13 866 011 71488 24200 19536 1.2343
9
PVL CA MRSA
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
95% Confidence 
Interval of the 
Difference
F Sig t df
Sig (2- 
tailed)
Mean
Difference
Std Error 
Difference Lower Upper
PVL Equal variances 
MRSA assumed
11.014 005 8 762 14 000 1.09013 .12442 82328 1.35697
Equal variances 
not assumed
8 762 10 004 000 1.09013 12442 81292 1.36733
Time dependent measurement of biofilm formation
MSSA NCTC 13297
ANOVA
Sum of Squares df Mean Square F Sig
Between Groups 4 130 2 2065 45 049 000
Within Groups 1.513 33 046
Total 5 643 35
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Multiple Comparisons
Games-Howell
95% Confidence Interval
(I) VAR00002 (J) VAR00002 |[Mean Difference (l-J) Std Error Sig. Lower Bound Upper Bound
24 hours 48 hours -.16942 07413 .093 -3645 0257
72 hours || 61867' 10453 000 .3559 8814
48 hours 24 hours 16942 07413 093 -.0257 3645
72 hours || .78808' 08062 000 .5751 1.0010
72 hours 24 hours I -.61867' 10453 000 -8814 -.3559
48 hours I| -.78808* 08062 000 -1.0010 -.5751
The mean difference is significant at the 0 05 level
PVL CA MSSA
PVL CA MSSA
Between Groups 
Within Groups 
Total
1 941 
466 
2407
ANOVA
2
33
35
Mean Square F Sig
68 725 000
Multiple Comparisons
PVL CA MSSA 
Games-Howell
95% Confidence Interval
Mean Difference (l-J) Std Error Sig Lower Bound | Upper Bound
15158' 03901 002 0535 2496
-.39900' 05197 000 -.5318 -.2662
-.15158' .03901 002 -.2496 -.0535
-.55058' 05328 000 -.6861 -.4151
.39900' 05197 000 2662 5318
55058' 05328 000 4151 6861
R
R
48 HR 24 HR
72 HR
R 24 HR 
48 HR
The mean difference is significant at the 0 05 level
PVL CA MSSA vs MSSA NCTC 13297
Independent Samples Test
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A p p e n d ix  III -  (C h a p te r 5 - S ta tis tics )
Surface test data output
Hospital MSSA isolate (clean vs. dirty -  5 minutes) with 500 ppm household bleach
Independent Samples Test
Levene's Test for 
Equality of 
Variances t-test for Equality of Means
95% Confidence 
Interval of the 
Difference
F Sig t df
Sig (2- 
tailed)
Mean
Difference
Std Error 
Difference Lower Upper
3.391 084 -3.713 16 002 -1.73000 46595 -2.71778 -.74222
-3.713 14 463 002 -1.73000 46595 -2.72638 -.73362
Hosp Equal vanances 
MSSA 5 assumed 
min HB
Equal variances not 
assumed
E. faecium NCTC 12202 isolate (clean vs. dirty -  5 minutes) treated with 500 ppm household 
bleach
Test Statistics
E faecium NCTC 12202 5 min HB
Mann-Whitney U 15 500
Wilcoxon W 60 500
Z -2 209
Asymp Sig (2-tailed) 027
Exact Sig [2*(1-tailed Sig.)] 024a
a Not corrected for ties
b Grouping Variable VAR00002
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E. faecium NCTC 12202 isolate (clean vs. dirty -  5 minutes) treated with 1000 ppm NaDCC
Test Statistics
Mann-Whitney U 
Wilcoxon W 
Z
Asymp Sig (2-tailed)
Exact Sig [2*(1 -tailed Sig.)]
a Not corrected for ties 
b Grouping Variable VAR00002
E faecium NCTC 12202 isolate (clean vs. dirty -  10 minutes) treated with 500 ppm Household 
bleach
Test Statistics
VRE NCTc 12202 10 min HB
Mann-Whitney U 15.000
Wilcoxon W 60.000
Z -2.253
Asymp Sig. (2-tailed) 024
Exact Sig [2*(1-tailed Sig.)] 024a
a Not corrected for ties 
b Grouping Variable VAR00002
E faecium NCTC 12202 isolate (clean vs. dirty -  5 minutes) treated with 1000 ppm NaDCC
Independent Samples Test
Levene's Test 
for Equality of 
Variances
Sig
t-test for Equality of Means
t df
Sig (2- 
tailed)
Mean
Difference
Std Error 
Difference
95% Confidence Interval of 
the Difference
Lower Upper
VRE 10 Equal
min variance
NaDCC s
assume
d
Equal
variance
s not 
assume
26 69 
2
000 4 466 14 001 2.35750
4 466 7 579 002 2.35750
52782 1 22544 3 48956
52782 1 12846 3.58654
194
Biofilms
MSSA NCTC 13297 biofilm vs 500 ppm household bleach
ANOVA
Biofilms v HB)
Sum of Squares df Mean Square F || Sig.
Between Groups (Combined) 444 2 222 450 643
Linear Term Contrast .007 1 .007 .015 903
Deviation 437 1 .437 .885 356
Within Groups 11 846 24 494
Total 12 291 26
PVL CA MSSA biofilm vs 500 ppm household bleach
Test Statistics a .b
PVL CA MSSA
Chi-Square
df
Asymp Sig
2668
263
a Kruskal Wallis Test
b Grouping Variable ContactTime
MSSA NCTC 13297 biofilm vs 10,000 ppm NaDCC
Test Statistics
CONCENTRATIONS
Mann-Whitney U 12.000
Wilcoxon W 57.000
Z -2.517
Asymp Sig (2-tailed) 012
Exact Sig [2*(1-tailed Sig.)] .011a
a Not corrected for ties
b Grouping Variable VAR00002
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MSSA NCTC 13297 biofilm vs 1,000 ppm NaDCC
Independent Samples Test
PVL CA MSSA biofilm vs 10,000 ppm NaDCC
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
95% Confidence 
Interval of the 
Difference
F Sig t df
Sig 02- 
tailed)
Mean
Difference
Std Error 
Difference Lower Upper
CONCENTRA
TIONS
Equal variances 
assumed
6 651 020 -5 019 16 000 -1.26189 25142 -1.79488 -.72890
Equal variances 
not assumed
-5 019 10.295 000 -1.26189 25142 -1.81992 -.70386
PVL CA MSSA biofilm vs 1,000 ppm NaDCC
Independent Samples Test
Levene's Test for 
Equality of Variances t-test for Equality of Means
95% Confidence 
Interval of the 
Difference
F Sig t df
Sig (2- 
tailed)
Mean
Difference
Std Error 
Difference Lower Upper
concentrati Equal variances 
ons assumed
8 881 009 -3.707 15 002 -1 04812 .28277 -1.65084 -44541
Equal variances 
not assumed
-3.525 8 404 007 -1 04812 29733 -1.72806 -.36819
1 %
Appendix IV (GC-MS analysis and Chapter 6 statistics)
Belmay Fragrances Ltd Analytical Report.
Table I. GCMS analysis of Lemongrass essential oil.
Component Typical Value—  
alpha Pinene 0.20
methyl heptenone 2.00
myrcene 1.00
limonene 0.40
linalool 1.50
citronellal 1.00
neral 33.00
geranial 47.00
geranyl acetate 1.50
beta carypohyllene 4.00
Table II. GCMS analysis of Geranium essential oil (African).
Component Typical Value
rose oxide 1.50
laevo menthone 1.50
isomenthone 6.00
citronellol 30.00
geraniol 15.00
citronellyl formate 8.00
geranyl formate 3.00
beta bourbonene 1.00
guaia-6,9-diene 0.10
10-epi gamma eudesmol 4.00
Table III. GCMS analysis of Grapefruit oil Expressed
Component Typical Value
alpha pinene 0.50
beta pinene 0.40
myrcene 2.32
limonene 93.50
decanal 0.26
nootkatone 0.10
Table IV. GCMS analysis of Lime essential oil (Expressed Mexico).
Component Typical Value
alpha pinene 2.30
beta pinene 22.70
myrcene 1.30
alpha terpinene 0.25
para cymene 0.25
limonene 47.30
gamma terpinene 7.50
linalool 0.15
neral 2.00
geranial 2.90
beta caryophyllene 1.00
trans alpha bergamotene 1.10
beta bisabolene 2.70
Table V. GCMS analysis of Bergamot essential oil Reggio (bergaptene free)
Component Typical Value
alpha thujene 0.30
alpha pinene 1.30
sabinene 1.10
beta pinene 7.20
myrcene 1.00
alpha terpinene 0.15
para cymene 0.50
limonene 38.50
gamma terpinene 6.00
terpinolene 0.30
linalool 11.40
neral 0.20
linalyl acetate 27.90
geranial 0.40
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Data output for 1% Grapefruit EO (All strains excluding PVL MSSA)
ANOVA
1% No PVL CA MSSA
Between Groups 
Within Groups 
Total
Mean Square
422
241
1.753
Data output for 2% Grapefruit EO (All strains excluding PVL MSSA)
ANOVA
Sum of Squares df Mean Square F Sig
Between Groups 2.271 4 568 2.248 .076
Within Groups 13.886 55 .252
Total 16.157 59
Data output for 4%  Grapefruit EO (All strains excluding PVL CA MSSA)
ANOVA
4% No PVL MSSA
Sum of Squares df Mean Square F Sig
Between Groups 6 409 4 1.602 2.793 035
Within Groups 31.553 55 574
Total 37.961 59
1
Post Hoc Tests
Multiple Comparisons
4% No PVL MSSA Games-Howell
(I) VAR00002 
Hosp MSSA
(J) VAR00002 
MSSA NCTC 13297
CA MRSA MW2 
PVL CA MRSA 
CA MRSA SR
MSSA NCTC 13297 Hosp MSSA
CA MRSA MW2 
PVL CA MRSA 
CA MRSA SR
CA MRSA MW2
PVL CA MRSA
Hosp MSSA
MSSA NCTC 13297 
PVL CA MRSA 
CA MRSA SR 
Hosp MSSA
MSSA NCTC 13297 
CA MRSA MW2 
CA MRSA SR
Mean Difference
M
-.40400
40400
11133
.57433
20667
29267
11133
68567
31800
97833'
57433
68567
36767
Std Error 
34307
28316 
19903 
15991 
34307
42645
37589
35672
28316
42645
32214
29955
19903
37589
32214
22173
Sig
764
764
836
001
95% Confidence Interval
Lower Bound Upper Bound
-1.4893
-1.1803 
-1.5870 
-1.0908 
-.6813
1 1585 
1.7191 
1.3137 
- 5949
1.3812 
1.6540 
1.2354 
3696
6813
1 4893
1 3812 
5704 
9003 
1 1803
1.5870
1.7191 
1 6540 
1.0301
CA MRSA SR Hosp MSSA
MSSA NCTC 13297 
CA MRSA MW2 
PVL CA MRSA
61067
20667
31800
36767
15991
35672
29955
22173
009
* The mean difference is significant at the 0 05 level
1306
-9003 
- 5994 
1 0301
1 0908
Data output for all strains (including PV L CA MSSA) following exposure to 1% Grapefruit  EO
ANOVA
1% All strains (inc PVL MSSA)
Sum of Squares df Mean Square F Sig
Between Groups 3 585 5 .717 3.013 016
Within Groups 15.709 66 238
Total 19.294 71
Multiple Comparisons
1% All strains (inc PVL MSSA) Games-Howell
95% Confidence Interval
(1) VAR00002 (J) VAR00002 |Mean Difference (l-J) Std Error Sig Lower Bound Upper Bound
Hosp MSSA PVL CA MSSA I - 68558' .14933 .004 -1.1708 -.2004
MSSA NCTC 13297 I -.31125 .23080 .755 -1.0808 .4583
CA MRSA MW2 I  -.12017 13668 946 -.5610 .3207
PVL CA MRSA I -.35008 .11466 .064 -.7142 .0140
CA MRSA SR | -.46783 16040 .093 -.9918 .0562
PVL CA MSSA Hosp MSSA I 68558' .14933 004 .2004 1.1708
MSSA NCTC 13297 I 37433 .26174 .709 -.4562 1.2048
CA MRSA MW2 I 56542 .18418 .055 -0089 1.1397
PVL CA MRSA I 33550 ,16848 .381 -.1943 8653
CA MRSA SR I 21775 20241 886 -.4132 8487
MSSA NCTC 13297 Hosp MSSA I .31125 23080 .755 -4583 1.0808
PVL CA MSSA I - 37433 .26174 .709 -1.2048 4562
CA MRSA MW2 I 19108 25474 .972 -.6230 1 0052
PVL CA MRSA I - 03883 24363 1.000 - 8297 .7520
CA MRSA SR | -.15658 26822 991 -1.0032 6900
CA MRSA MW2 Hosp MSSA I .12017 13668 946 -.3207 5610
PVL CA MSSA I -56542 .18418 .055 -1.1397 0089
MSSA NCTC 13297 I -.19108 25474 972 -1.0052 6230
PVL CA MRSA I -22992 15738 .691 -.7224 .2626
CA MRSA SR | - 34767 .19327 487 -.9517 2563
PVL CA MRSA Hosp MSSA I 35008 11466 064 -0140 .7142
PVL CA MSSA I -.33550 .16848 .381 -.8653 1943
MSSA NCTC 13297 I 03883 24363 1.000 -.7520 8297
CA MRSA MW2 I 22992 .15738 .691 -.2626 .7224
CA MRSA SR | -.11775 .17838 984 -6813 4458
CA MRSA SR Hosp MSSA 1 46783 16040 093 -.0562 9918
PVL CA MSSA I -21775 .20241 886 -8487 4132
MSSA NCTC 13297 I .15658 .26822 .991 -6900 1 0032
CA MRSA MW2 I .34767 .19327 487 -.2563 9517
PVL CA MRSA | .11775 .17838 984 -4458 6813
* The mean difference is significant at the 0 05 level
Data output for all strains (including PVL CA MSSA) following exposure to 2% Grapefruit EO
2% GRA Inc PVL CA MSSA
ANOVA
Sum of Squares df Mean Square F Sig
Between Groups 3.685 5 737 3.010 017
Within Groups 16.162 66 245
Total 19.847 71
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Multiple Comparisons
2% GRA Inc PVL CA MSSA 
Games-Howell
(I) VAR00002 
Hosp MSSA
(J) VAR00002 
PVL CA MSSA
MSSA NCTC 
13297
CA MRSA MW2 
PVL CA MRSA 
CA MRSA SR
PVL CA MSSA Hosp MSSA
MSSA NCTC 
13297
CA MRSA MW2 
PVL CA MRSA 
CA MRSA SR
Mean Difference (I-
J).
- 56583'
- 22883
03625
25617
49992
56583
33700
60208'
30967
06592
Std Error 
17311
22523
17330
18532
16814
17311
.23503
18586
19712
18107
Sig
037
906
1 000 
737 
067
037 
707
038 
625 
999
95% Confidence Interval
Lower Bound 
-1 1062
- 9463
- 5047
- 8370 
1 0242
0255
-.4045
0231
-.3051
-.4983
Upper Bound 
-0255
4886
5772
3246
0243
1 1062 
1 0785
1.1811
9244
.6301
MSSA NCTC 13297 Hosp MSSA
PVL CA MSSA 
CA MRSA MW2 
PVL CA MRSA 
CA MRSA SR
22883
33700
26508
02733
27108
22523
23503
23517
24417
23140
906
.707
864
1.000
845
- 4886
1 0785 
-4768 
-7931 
1.0034
9463
4045
1.0070
7385
4613
CA MRSA MW2 Hosp MSSA
PVL CA MSSA
MSSA NCTC 
13297
PVL CA MRSA 
CA MRSA SR
-.03625
- 60208' 
-.26508
-.29242
-.53617
17330
18586
23517
19729
18125
1.000
038
864
678
069
- 5772
1 1811 
1 0070
- 9077 
1 1009
5047
-.0231
4768
3228
0286
PVL CA MRSA Hosp MSSA
PVL CA MSSA
MSSA NCTC 
13297
CA MRSA MW2 
CA MRSA SR
25617
30967
02733
29242
24375
18532
19712
24417
19729
19278
737
625
1.000
678
800
-.3246
-.9244 
- 7385
-.3228
-.8457
8370
3051
.7931
9077
3582
CA MRSA SR Hosp MSSA
PVL CA MSSA
MSSA NCTC 
13297
CA MRSA MW2 
PVL CA MRSA
49992
06592
27108
53617
24375
16814
18107
23140
18125
19278
067
999
845
069
800
-.0243
-.6301
-.4613
-.0286
-.3582
1 0242
4983 
1 0034
1.1009
8457
* The mean difference is significant at the 0 05 level
Data output fo r a ll strains (inc lud ing  PV L CA MSSA) fo llow ing exposure to 4%  G ra p e fru it EO
ANOVA
4% GRA incl PVL CA MSSA
Sum of Squares df Mean Square F Sig
Between Groups 6 661 5 1.332 2.574 035
Within Groups 34.162 66 518
Total 40 824 71
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Multiple Comparisons
4% GRA incl PVL CA MSSA 
Games-Howell
|(l) VAR00002 
Hosp MSSA
PVL CA MSSA
MSSA NCTC 13297
CA MRSA MW2
PVL CA MRSA
CA MRSA SR
(J) VAR00002 
PVL CA MSSA
MSSA NCTC 13297 
CA MRSA MW2 
PVL CA MRSA 
CA MRSA SR 
Hosp MSSA
MSSA NCTC 13297 
CA MRSA MW2 
PVL CA MRSA 
CA MRSA SR
Hosp MSSA
PVL CA MSSA 
CA MRSA MW2 
PVL CA MRSA 
CA MRSA SR 
Hosp MSSA
PVL CA MSSA 
MSSA NCTC 13297 
PVL CA MRSA 
CA MRSA SR
Hosp MSSA
PVL CA MSSA 
MSSA NCTC 13297 
CA MRSA MW2 
CA MRSA SR
Hosp MSSA 
PVL CA MSSA 
MSSA NCTC 13297 
CA MRSA MW2 
PVL CA MRSA 
The mean difference is significant at the 0 05 level
Mean Difference (l-J) Std Error Sig
95% Confidence Interval
Lower Bound Upper Bound
-.61608' 16668 017 -1.1438 -.0884
-.40400 34307 839 -1 5473 .7393
-.29267 .28316 898 -1.2272 6419
-.97833' 19903 002 -1.6185 -.3382
-.61067' .15991 .012 -1.1151 -.1063
61608’ .16668 .017 0884 1.1438
.21208 35981 990 -9586 1 3828
.32342 30322 888 -6492 1.2960
-.36225 22666 609 -1.0717 3472
.00542 19321 1.000 -.5967 6075
40400 34307 .839 -.7393 1.5473
-.21208 35981 990 -1 3828 9586
.11133 42645 1.000 -1 2222 1 4449
-.57433 37589 652 -1 7779 6293
-.20667 35672 991 -1 3717 9584
.29267 28316 898 -6419 1.2272
-.32342 .30322 888 -1 2960 6492
-.11133 42645 1.000 -1 4449 1 2222
-.68567 .32214 .315 -1 7031 .3317
-.31800 29955 889 -1 2828 6468
97833' 19903 .002 .3382 1 6185
36225 .22666 609 -.3472 1.0717
57433 37589 652 -.6293 1.7779
68567 32214 .315 -.3317 1.7031
36767 22173 .572 -.3281 1 0635
61067' .15991 012 1063 1.1151
-.00542 .19321 1.000 -.6075 5967
.20667 .35672 991 -9584 1.3717
.31800 29955 889 -6468 1 2828
-.36767 22173 572 -1 0635 .3281
Lemongrass EO Treated cells (Cell viability data output)
Comparison between the recovered cells from all six S. aureus strains
ANOVA
Biofilm viability
Between Groups 
Within Groups
Total
Sum of Squares
037
480
.517
df
41
46
Mean Square
007
012
Multiple Comparisons
Biofilm viability 
Games-Howell
(I) VAR00002 (J) VAR00002
I Mean Difference
(l-J) Std Error Sig
95% Confidence Interval
Lower Bound Upper Bound
Hosp MSSA No treatment control
3.00
4.00
5.00
6.00
| 05386
|  01400 
|  -04432
I  .00011 
|  00161
05603
03255
03575
.05112
05787
920
998 
810 
1.000 
1 000
-.1425
- 0909 
-.1639 
-.1908 
-.2019
2502
1189
0752
1910
.2052
No treatment control Hosp MSSA |  - 05386 05603 920 -.2502 1425
3.00 |  - 03986 05660 977 -.2369 .1571
4.00 |  -.09818 05850 .571 -.2989 1025
5 00 |  -.05375 06898 966 - 2856 .1781
6 00 |  -.05225 07411 978 -.2954 1909
3.00 Hosp MSSA 1 -.01400 03255 998 -.1189 0909
No treatment control |  03986 05660 977 -.1571 2369
4 00 |  -.05832 03663 617 -.1801 0635
5 00 |  -.01389 05174 1 000 -.2050 .1772
6 00 |  -.01239 05841 1 000 -.2166 1918
[4 .OO Hosp MSSA |  04432 03575 810 -.0752 1639
No treatment control |  09818 05850 .571 -.1025 2989
3 00 |  05832 03663 617 -.0635 1801
5 00 |  04443 05382 955 -.1497 2386
6 00 |  04593 06026 968 -.1616 .2534
[5 00 Hosp MSSA I -.00011 05112 1 000 -.1910 1908
No treatment control |  05375 06898 966 -.1781 2856
3 00 |  01389 05174 1 000 -.1772 2050
4 00 |  -.04443 05382 955 -.2386 1497
6.00 |  00150 07047 1 000 -.2352 2382
[6 00 Hosp MSSA |  -.00161 05787 1.000 -.2052 2019
No treatment control |  05225 07411 978 -.1909 2954
3 00 [  01239 05841 1 000 -.1918 2166
4 00 |  -04593 06026 968 -.2534 1616
5.00 I_________ -.00150 07047 1 000 -.2382 .2352
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Appendix V (List of publications and presentations)
SCIENTIFIC PUBLICATIONS
Adukwu EC, Allen SCH, Phillips CA. (2012). The effect of lemongrass (Cymbopogon 
flexuosus) and grapefruit (Citrus paradisi) essential oils on Staphylococcus aureus 
biofilms. Journal of Applied Microbiology. 113(5), 1217-27.
CONFERENCE PRESENTATIONS & SEMINARS
Adukwu EC, Allen SCH, Phillips CA. Antimicrobial activity of Lemongrass essential oil 
(Cymbopogon flexuosus) against Staphylococcus aureus biofilms. 112th General Meeting, 
ASM, San Francisco, California, USA. June 2012
Adukwu EC Research Dissemination: Challenges and Opportunities. CHWR seminar, 
The University of Northampton, Northampton, UK. Oct 2011
Adukwu EC. Allen SCH, Phillips CA. Antimicrobial activity of disinfectants against 
different strains of Staphylococcus aureus' SfAM Summer conference, Dublin, Ireland. 
July 2011
Adukwu EC, Allen SCH, Phillips CA. Investigating the potential of commercially available 
environmental decontaminants against strains of Staphylococcus aureus and antibiotic 
resistant enterococci’ 111th General Meeting, ASM, New Orleans, Louisiana, USA. May 
2011
Adukwu EC, Allen SCH, Phillips CA. Community acquired infections and its implications 
in the elderly’. East Midlands Universities Association annual research conference, 
Nottingham, UK. October 14th 2010
Adukwu EC, Allen, S.C.H, Phillips, C A. Antimicrobial effect of sodium hypochlorite, 
sodium diisochlorocyanurate and a commercial available cleaning product on VRE and 
Clostridium difficile”. SfAM Summer conference, Brighton, UK. July 2010
Adukwu EC, Allen SCH, Phillips CA. Community acquired infections (CAIs) -  reducing 
the burden of infections. Annual poster competition, The University of Northampton, UK. 
May 19th 2010
Adukwu EC Community acquired infections (CAIs). The School of Health Learning and 
Teaching Conference. The University of Northampton, UK. Dec 2009
Adukwu EC. Allen SCH, Phillips CA. Community acquired infections (CAIs). CHWR 
annual conference, Northampton, UK. Sep 2009
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INVITED SEMINARS AND PRESENTATIONS
Adukwu EC. Antimicrobial activity of disinfectants and natural products against 
Staphylococcus aureus in culture and biofilms. Research Group Seminar, OARDC, Ohio 
State University, Wooster, Ohio, USA. August 1st 2012.
Adukwu EC. Antimicrobial activity of Lemongrass essential oil (Cymbopogon flexuosus) 
against staphylococcus aureus biofilms. Research Group Seminar, Haverford College, 
Philadelphia, USA. June 22nd 2012.
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